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INTRODUCTION and DISCUSSION OF RELEVANT 
PUBLISHED WORK
It is difficult to determine the frequency of depressive 
illness. This is partly because of the difficulty of 
defining affective disorder. There is no clear boundary 
between the milder manifestations of affective illness and 
the "well founded moodiness of health" (Kraepelin, 1913).
The point at which lowered mood becomes depressive illness 
is arbitrary and for this reason estimates of the incidence 
of the condition are bound to vary. Many patients with 
depressive illness do not come into contact with the 
hospital services but are treated by their general 
practitioners. In a study in general practice in 
Birmingham Crombie (1957) found an incidence of 10 cases 
of endogenous depression and 5 cases of endogenous 
depression per 1000 of the population per annum. Working 
in a country general practice in Leicestershire Watts 
(1966) found an average of 12 new cases of depression and 
4.5 chronic cases of depression per 1000 of the population 
per annum. Studies in hospital practice give a much 
lower incidence. Norris (1959) estimates the lifetime's 
risk, for people living in London, of being admitted to 
hospital with an affective illness, which in 88% of cases 
would be a depressive illness, as 11.2/1000. From these 
figures it may be concluded that the milder forms of 
depressive illness are very common and the more severe 
forms are not rare.
The cause of depressive illnesses is not known.
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although there are many theories concerning their 
aetiology. Prominent among the tlieories which assert 
that depression is a biological disorder is the 
monoamine theory. According to this theory certain 
neuronal systems in the brain are important in the 
control of mood. Monoamines are thought to act as 
transmitters or to modify transmission in these 
systems. Deficiency of monoamine at the synapses in 
these neuronal systems is said to result in depression 
and excess in mania. This theory was originally put 
forward in the late 1950*s (Schildkraut, 1965). It has 
been reviewed more recently by various authors and both 
catecholamines, principally noradrenaline although 
dopamine is mentioned at times, (Schildkraut, 1965? 
Schildkraut & Kety, 1967? Goodwin & Sack, 1973) and 
the indolalkylamine, 5-hydroxytryptamine (Curzon,
1969? Lapin & Oxenlorug, 1969) have been regarded as 
important.
It is not possible to confirm or refute this 
theory on the basis of currently available evidence. 
Confirmation of the theory must ultimately depend upon 
direct demonstration of deficiency or excess of the 
relevant substances at appropriate sites in the brain 
in the naturally occurring illness. At present such 
a demonstration is not possible. Pharmacological 
studies in animals and in man have however produced 
findings which are compatible with this theory.
These concern two main topics s-
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1. Substances which deplete monoamines at synapses 
are associated with sedation in animals and 
depression in man.
2. Drugs which elevate mood have properties which 
enable them to increase the amount of monoamine 
available at synapses.
The information concerning the first of these topics 
is as follows
Reserpine has been shown to deplete the brains of 
animals of 5™hydroxytryptamine (Pletscher, Shore and 
Brodie, 1956) and of noradrenaline (Holzfoauer & Vogt, 
1956? Shore, 1962). Administration of the drug 
produces a state of sedation in animals (Shore, 1962). 
Tetrabenazine, a synthetic analogue of reserpine, has 
been shown to deplete the brains of animals of 
5-“hydroxytryptamine and noradrenaline and to produce 
sedation in animals (Quinn, Shore and Brodie, 1959). 
Reserpine is a derivative of rawolfia the sedative 
properties of which have been known for many centuries, 
The first reference to the curative properties of this 
drug in Western literature was contained in a 
Portuguese work published in Goa in 1563 (Bein, 1956). 
In tiie 1950* s reserpine began to be used in fairly 
high doses as a hypotensive agent and it was found 
that administration of this drug was associated with 
the development of depression. This may be severe, 
may require electro-convulsive therapy and may occur 
in up to 15% of patients treated with reserpine
(Freis, 1954; Acîior, 1955; Bunney and Davis, 1965). 
Tetrabenazine has sedative properties in man and its 
administration has occasionally appeared to give rise 
to severe depression (Ashcroft, McDougall & Barker,
1961; Lingjaerde, 1963)•
Drugs which elevate mood fall into three classes; 
monoamine oxidase inhibitors, aniphetamines and 
tricyclic antidepressants. The evidence concerning 
these drugs relevant to the monoamine theory of 
depression is as follows:
Iproniazid was shown in 1952 to inhibit monoamine 
oxidase in the liver and brain in rats and guinea pigs 
(Zeller and Barsky, 1952). This drug was later shown 
to be an effective antidepressant (Boomer, Saunders & 
Kline, 1957) and it was suggested by these authors that 
the fact that iproniazid acted as a monoamine oxidase 
inhibitor might "in part explain its effect upon 
nervous and mental function, i.e. by altering the 
metabolic degradation of epinephrine, norepinephrine and 
serotonin". It was then shown that iproniazid increased 
brain levels of noradrenaline and 5-hydroxytryptamine 
in animals (Spector, Prockup et al, 1958) and it was 
later demonstrated that iproniazid, isocarboxazid and 
nialamide administration increased the levels of 
monoamines in human brain (Ganrot, Rosengren & Gottfries, 
1962; Maclean et al, 1956). The state of sedation 
produced in animals by administration of reserpine is 
at times used as an animal analogue of depression in
man (Schildkraut & Kety, 1967). Monoamine oxidase 
inhibitors have been found to counteract this 
reserpine induced sedation in animals (Chessin,
Kramer and Soott, 1957; Stein and Ray, 1960), It was 
largely on the basis of the effects of reserpine and 
monoamine oxidase inhibitors that the monoamine theory 
of depression was evolved (Jacobsen, 1964).
Amphetamines were Introduced in the 1930*s for 
the treatment of depression, in some depressed 
persons they produce a temporary alertness and 
euphoria (Klerman, 1972). There is evidence that 
amphetamines are able to increase the amount of 
monoamines available at synapses. Amphetamine releases 
noradrenaline from nerve cells and blocks its 
inactivation by cellular re-uptake in animals (Iverson, 
1964; Glowinski and Axelrod, 1965).
In 1958, the antidepressant properties of 
imipramine were demonstrated (Kuhn, 1958). Various 
studies have shown this and related drugs to be at 
least as effective antidepressants as MAOIs and
probably rather more so (Klerman & Cole, 1965), The 
fact that imipramine and similar compounds do not 
inhibit the monoamine oxidase or catechol-O-methyl- 
transferase systems which control monoamine degradation
at synapses (Pletscher and Gey, 1962) initially cast^ 
doubt upon the monoamine hypothesis of the affective 
disorders• In one of the early formulations of the 
hypothesis Jacobsen (1964) said "Where the effect of
imipramine stands in this matter is still a complete 
riddle which must await elucidation. Here our present 
ignorance is such that not even a preliminary 
hypothesis can foe offered". Imipramine was then 
shown to interfere with the uptake of infused 
noradrenaline. This blocking action by imipramine 
of the uptake of noradrenaline was first shown in 
peripheral tissues (Axelrod, Whitby & Hertting, 1961) 
and in brain slices (Deng1er, 1961). Glowinski and 
Axelrod (1964) then demonstrated inhibition of uptake 
of tritiated noradrenaline in intact rat brain by the 
antidepressants imipramine, desmethylimipramine and 
amitriptyline thus demonstrating that tricyclic 
antidepressants have the ability to increase the 
amounts of monoamine available at synapses in the 
brain. It therefore became possible to reconcile the 
mode of action of imipramine and other tricyclic 
antidepressants with the monoamine theory of the 
affective disorders.
Although this theory was originally based upon 
evidence connected with the effects of drugs, further 
pieces of information relevant to the theory but not 
associated with the effects of drugs have come to 
light. They concern investigations designed to show 
whether or not there is evidence of reduced cerebral 
monoamine metabolism in depressed patients. This 
evidence is as follows :
Firstly, numerous studies have been conducted
to investigate the concentrations in cerebro spinal 
fluid of 5-hydroxy indole acetic acid (5HÏAA), a 
metabolite of 5-hydroxytryptamine (SET), homovanillic 
acid (EVA), a metabolite of dopamine, and 3-methoxy
4-hydroxyphenylglyool (MHPG) the major metabolite of 
noradrenaline in the brain ^ (Maas & Landis, 1968).
CSP 5HXAA levels have been shown to be lower in 
depressed patients than in neurological controls 
(Ashcroft et al, 1966), than in normal volunteers 
(Dencher et al, 1966) and than in non-affectively 
disturbed controls (Van Praag and Korf, 1971; Coppen 
at al, 1972). CSF EVA levels have been shown to be 
lower in depressed patients than in neurological 
patients (Papeschi & McClure, 1971). CSP MEPG levels 
have been shown to be lower in depressed patients 
than in manic patients or in a mixed group of normals 
and neurological patients(Post et al, 1973).
Profoenicid inhibits the transport of acid 
monoamine metabolites from the central nervous system 
to the blood stream (Neff, Toser & Brodie, 1967), the 
resulting accumulation of 5HIAA and EVA in the lumbar 
cerebro spinal fluid is used as an index of the 
central turnover of the corresponding parent amines• 
It has been shown that in depressed patients as 
compared with normals (Roos and Sjostrom, 1969) and 
as compared with non-affectively disturbed controls 
(Van Praag and Korf, 1973) there is a reduction in 
the increase in 5HIAA following profoenicid.
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Concentrations of tryptophan, the precursor of
5-hydroxytryptamine, in the CSF have been found to 
foe lower in depressed patients than in neurological 
patients (Coppen, Brooksfoank & Peet, 1972),
Studies of blood and urine levels of some of 
these substances have also been undertaken. Levels 
of free tryptophan in plasma have been shown to be 
reduced in currently depressed patients as compared 
with patients who had recovered from a depressive 
illness (Coppen, Eccleston and Feet, 1973)• Urinary 
excretion of MHPG has been shown to be low in 
depressed patients as compared with normal controls 
(Maas, Fawcett, Dekirmenjian, 1968) and in patients 
in the depressed state as compared with a proportion 
of the same patient sample when well (Shaw et al,
1973)• Urinary tryptamine excretion has been shown 
to be low in depression and to rise with recovery to 
approximately normal levels (Coppen et al, 1965).
It was thought by the authors that this finding 
probably reflected a disturbance of tryptophan 
metabolism in the kidney but that there might foe a 
similar disturbance in the brain during depression.
The levels of monoamines and their metabolites 
have bean studied in the brains of suicides as 
compared with those of persons dying from other 
causes. SHT levels (Shaw, Camps & Eccleston, 1967? 
Pare et al, 1969) and 5HIAA levels (Bourne et al,
1968) were found to be low in the brains from suicides,
These are the positive findings from direct 
studies of monoamines and their metabolites which 
support the monoamine theory but they have by no 
means always been confirmed by other workers.
Bowers, Heninger & Gerfoode (1969) found that CSF 
5HXAA and HVÂ levels were no lower in depressed 
patients than in non-depressed patients. Roos and 
Sjostrom (1969) did not find CSF 5HIAA to foe lower 
in depressëd patients than in normal controls.
Nordin, Ottosson and Roos (1971) in a study of 
depressed patients before and after treatment found 
that the pre-treatment levels of 5HXAA in the CSF of 
depressed patients did not differ from those of 
normal controls. Moreover the pre-treatment levels 
did not differ from those after treatment despite 
considerable clinical improvement. Ashcroft et al 
(1973) studied CSF levels of HVA and 5HIAA in 
depressed patients before and after recovery. Unipolar 
depressed patients had lower values of both HVA and 
5H1AA than neurological controls but the levels did 
not alter significantly on recovery. Bipolar 
depressed patients had levels within normal limits.
In this study C8F tryptophan was also measured.
There was no significant difference in level between 
any of the groups of patients studied nor was there 
any alteration on recovery. Goodwin et al (1973) 
did not find any difference in the increase in 5HIAA 
following profoenicid between depressed patients, 
manic patients and non-affectively disturbed controls.
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Wllk et al (1972) found the CSF MHPG levels of 
depressed patients to be within the normal range and 
did not find that the levels changed with treatment.
While Bourne et al (1968), Pare et al (1969) and 
Shaw at al (1973) all found reductions in 5-hydroxy-
tryptamine or 5-hydroxyindole acetic acid in the brains 
of suicides as compared with those of persons dying 
from other causes their results conflict. Bourne et al 
found that SHIAA was reduced but that 5HT was not.
Pare et al found that 5HT was reduced but that 5HIAA 
was not. Shaw et al found that 5HT was reduced and 
did not examine their specimens for 5HIAA.
The evidence provided in support of the monoamine 
theory of depressive illness by direct studies of 
monoamines and their precursors or metabolites in 
samples obtained from depressed patients is therefore 
somewhat equivocal. The results from pharmoological 
studies are less open to question but are only of 
any relevance to the theory that depressive Illnesses 
are based upon lowered concentrations of transmitter 
amine at synaptic junctions if it can foe shown that 
the drugs involved have undoubted antidepressant 
activity. The value of the evidence would foe greatly 
enhanced if it could foe shown that not only do 
antidepressant drugs have the ability to increase the 
amount of monoamine available at synaptic junctions 
but also that this is the means foy which they act in 
naturally occurring depression. The antidepressant
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effect of imipramine is well-established. Multicentre 
trials carried out both in Britain {Clinical 
Psychiatry Committee, 1965) and in the United States 
of America (Raskin et al, 1970) showed imipramine to 
be more effective than placebo and the majority of the 
many other trials of tricyclic antidepressants show 
them to be effective drugs (Klerman & Cole, 1965;
Morris & Beck, 1974)• The animal experiments in which 
it was demonstrated that imipramine has the ability to 
prevent re-uptake of monoamines (Glowinski a Axelrod, 
1964) could not foe repeated in depressed patients and 
so it is not possible to determine whether or not it 
is by this means that imipramine exerts its 
antidepressant effect.
There are few controlled clinical trials of 
araphetamines and those which have been carried out do 
not demonstrate that they are more effective as 
antidepressants than placebo,(Hare, Dominian & Sharpe, 
1962? General Practitioner Research Group, 1964).
The fact that they are able to increase the amount of 
monoamine available at synapses cannot therefore foe 
used as evidence for the monoamine theory of depressive 
illness.
There is a great deal of controversy regarding 
the antidepressant efficacy of monoamine oxidase 
inhibitors (MAOIs)• Iproniazid, on which much of the 
early work was done, is not now used because of its 
association with serious side effects, principally
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liver damage. What evidence there is concerning 
nialamide does not suggest that this is an effective 
antidepressant (Table 1), The evidence regarding 
isocarboxazid, tranylcypromine and phenelzine is 
conflicting (Tables 2, 3 and 4). From these results 
it may foe concluded that some patients recover from 
their depressive symptoms while they are on monoamine 
oxidase inhibitors and some do not. While some of 
this variability may foe a dosage effect this does not 
explain it all. In one study it was shown that patients 
either responded well to BB.OIS or did nht respond at 
all (Hamilton, 1974), It has been suggested that it is 
in various subgroups of depressed patients referred to 
as "atypical depressive states", "hysterical depression" 
or "patients suffering from neurotic or reactive 
depressive illnesses or even sometimes anxiety hysteria" 
that MAOIs are effective (West and Dally, 1959? Dally 
and Rohde, 1961? Sargant, 1961). It is not always 
easy to define these subgroups and attempts to 
differentiate on clinical grounds those patients who 
will respond from those who will not have not been 
successful (Hamilton, 1974), It is possible that the 
responders differ from the non-responders in some way 
other than that of clinical presentation. It has been 
said that the mode of response to antidepressant drugs 
may be an inherited characteristic (Pare, Rees and 
Sainsbury, 1962? Pare and Mack, 1971). This could be 
because the illnesses from which patients suffer vary 
on a genetic basis or because their modes of responding
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to drugs vary on a genetic basis. Xf the first 
alternative is true then some depressive illnesses 
have characteristics which cause them not to respond 
to drugs which have properties enabling them to 
increase the amount of monoamine available at synapses. 
It would follow from this that for some depressive 
illnesses at least the monoamine theory is inapplicable. 
The alternative explanation is certainly possible. 
Although in the past it tended to be assumed that the 
variability of drug metabolism and response was of the 
unimodal continuous type, it has become increasingly 
apparent that for numerous drugs this is not so - 
their dose-response curves are of a discontinuous type 
with two or more modes. These modes represent two or 
more genetically determined phenotypes and when this 
position occurs the terra polymorphism is used. It is 
known that there is a polymorphism for the acétylation 
of certain drugs. Acétylation polymorphism was first 
studied with reference to the anti-tuberculous drug 
isoniazid which was shown to foe effective in the 
treatitont of tuberculosis in 1952 (Robitzek, Selikoff 
& Ornstein, 1952). Shortly afterwards it was found 
that patients differed greatly in the way in which 
they metabolised isoniaaid (Hughes, Sclmidt, & Biehl, 
1955). This and other studies suggested that the 
variability in the inactivation of isoniazid is of 
the discontinuous kind, i.e. that the population is 
divided into two classes, rapid and slow inactivators.
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Twin studies and racial studies (Bonicke & Lisboa,
1957? Harris Knight and Selin, 1958) suggested that 
there was a genetic basis for this polymorphism and 
a detailed study of 484 subjects (Evans, Manley & 
McKusick, 1960) offered definite evidence that this 
was the case. Intestinal absorption, protein binding, 
renal glomerular clearance and renal tubular absorption 
were found to be irrelevant to the polymorphism (Jenne, 
McDonald & Mendoza, 1961) and it seemed likely that the 
difference between rapid and slow inactivators was 
metabolic. The fact that the proportion of free 
unchanged drug excreted varied inversely with the 
proportion of acetyiated drug (Hughes, Schmidt and 
Biehl, 1955) tended to suggest that the difference lay 
in speed of acétylation. This idea was confirmed 
when it was shown that the livers of rapid inactivators 
of isoniazid have greater acetylating powers than those 
of slow Inactivators (Evans & White, 1964) and when it 
was demonstrated that acétylation was the primary 
metabolic reaction determining inactivator status for 
isoniazid (Peters, Miller & Brown, 1965). This 
polymorphism was shown to be of practical relevance 
by studies indicating that slow inactivators of 
isoniazid had a greater liability than fast to develop 
isoniazid induced peripheral neuropathy (Hughes et al, 
1954? Devadatta et al, 1960). It is a reasonable 
: assumption that the effects of any drug metabolised by 
polymorphic acétylation would vary as a result of it.
In fact acétylation polymorphism accounts for little
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of the widespread variability iu the respouee of 
h%man eubjeots to the vaet range of drugs whicdi they 
ingest as few dmge are metabolized by this means. 
Selphadimidiae ia polymorphlcally acetyiated (Cetera, 
Gordon & Brown, 1965) as are phthivazld (Smirnov a 
Ko#ullt8ina, 1962), hydrallaalne (Jenne, 1965), 
phenytoin (Kntt et al, 1970) and dapsone (Gelber at 
al, 1971). It aeeme poeeible that other hydrazine 
derivatives might be metabolised in a similar way. 
Several MAOIe are hydrazine derivatives. If they 
were inactivated by acétylation the slower inactivation 
among slow acetylatora might lead to a much higher 
effective dose in them than in fast acetylatore and 
this might explain the very variable reenlte which 
have been found with these dmgs (Tables 1*3). 
Furthermore, acetylator statue is genetically determined 
and if inactivation of hydrazine MAOIs %^ as dependent 
upon it an explanation for the genetic tendency of the 
response would be provided. The possibility that the 
response of depressed patients to a hydrazine MAOI 
might depend upon acetylator status was studied by 
Evans, Davison & Pratt (166S). This was an 
uncontrolled study of 24 patients with neurotic 
depression and 23 with endogenous depression who were 
given plienelsine in a dosage of 15 mg# t.i.d# for 4 
weeks# Wo significant differences in antidepressant 
effect were found between slow and fast aoetylators 
but severe side effects were reported only by slow 
aoetylators# In this study the mean age of the
16
endogenously depressed slow acetylators was 48,59 4 ' 
2.87 years while that of the endogenously depressed 
fast acetylators was 30*38 - 3.47 years. This may 
have some bearing upon the results. It is well 
established that the clinical course and symptomatic 
picture of depressions varies with the age of the 
patient (Klerman, 1972), Depressed patients under 40 
respond significantly better to treatment with drugs 
than those over 40 (Greenfolatt, Grosser & Wechsler, 
1962)• The placebo response of patients under 40 
is greater than that of those over 40 (Raskin et al, 
1970), All of these factors may have contributed 
to the negative result and a placebo controlled study 
in which the fast and slow acetylators were matched 
for age as well as other factors would be required 
to resolve this question. Although there is no doubt 
that monoamine oxidase inhibitors have the ability 
to increase the amount of available monoamine by 
inhibiting monoamine oxidase, evidence which links 
the degree of inhibition of the enzyme with 
antidepressant effect is somewhat lacking. An 
uncontrolled study of six depressed patients showed 
that monoamine oxidase inhibition, as measured by 
increase in urinary tryptamine and decrease in 
urinary VMA was greater in those patients with a 
good clinical response than in those in whom the 
clinical response was poor (Dunlop et al, 1965)*
In an uncontrolled study of a group of 21 depressed
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patients consisting of 10 psychoneurotics, 8 manic- 
depressives, 2 schizophrenics and 1 reactive 
depressive who were variously treated with 
phenelzine, isocarboxazid and nialamide, inhibition 
of monoamine oxidase was estimated by the conversion 
of orally administred SHTC^^ to 5HIAA-C^^ (Feldstein 
et al, 1965)• In those patients whose clinical 
improvement as based upon global impressions and 
ward observations was said to foe marked or moderate 
the mean MAO inhibition was 37%. Of those showing 
slight or no clinical improvement the mean MAO 
inhibition was 22%. Against these positive studies 
are the negative findings of Resnick et al (1960) 
and Dewhurst and Pare (1961). In a study of 
schizophrenic, manic-depressive, psychoneurotic and 
involutional melancholic patients, numbering 12 in 
all, treated with various MAOIs Resnick at al did 
not find any correlation between MAO inhibition and 
antidepressant effect. Dewhurst and Pare treated 18 
patients with nialamide and found no relationship 
between antidepressant effect and inhibition of MAO. 
Robinson et al (1973) carried out a trial of phenelzine 
/placebo in 60 patients with depressive-anxiety states. 
Phenelzine was shown to foe significantly more effective 
than placebo, the dosage of phenelzine being adjusted 
to maintain MAO Inhibition at 80%. No information 
was obtained about the effects of phenelzine when 
inhibition of this degree was not produced.
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It was against this background that the studies 
to be described were designed. In summary, the 
aetiology of the common and disabling disorder 
depressive illness is unknown. A theory which 
postulates that depression is associated with a 
deficiency of monoamine transmitter at synaptic 
sites has been put forward. The evidence for this 
is in two sections. Some is based on pharmacological 
studies and some on more direct studies of monoamines 
and their metabolites. The results given by the 
direct studies of monoamines are by no means 
unequivocal. The pharmacological evidence concerns 
the fact that both major groups of antidepressants, 
the tricyclics and the monoamine oxidase inhibitors, 
have properties which enable them to increase the 
amount of monoamine available at synapses. This 
evidence can only foe used to support the monoamine 
theory of depressive illness if it can be shown that 
these drugs are effective antidepressants and that 
their antidepressant efficacy is related to their 
ability to increase monoamine at synaptic sites 
rather than to some other property of the drug. The 
evidence that tricyclics are effective antidepressants 
is convincing. The direct demonstration, in human 
subjects, of the block of re-uptake of monoamine at 
synaptic sites, which these drugs have been shown to 
produce in animals, is not possible. There is 
therefore no means of relating their antidepressant 
efficacy to increase in available monoamine at
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synaptic sites. The evidence that !)!A0l8 are effective 
antidepreaaants is less convincing # From the point 
of view of the monoamine theory of depressive illness 
this ia disappointing* Very variable results have 
been obtained by different groups of investigators 
and it has not been possible to determine on 
clinical grounds which depressed patients will respond 
to these drugs* Several MAOIs are hydrazines. Other 
hydrazines have been shown to be inactivated by 
acetyl transferase, an enzyme for which there is a 
human genetic polymorphism approximately half the 
population being fast acetylators and half slow*
The clinical effects of these other hydrazine drugs 
have been shovm to relate to acetylator status.
In the one existing study relating the antidepressant 
effects of MAOIs to acetylator status the groups were 
ill-matched for age so that it is difficult to 
interpret the results. The mechanism by which 
are able to increase the amount of monoamine available 
at synapses is by inliibition of monoamine oxidase. It 
is technically possible to estimate the degree of 
inhibition of monoamine oxidase in depressed patients 
but evidence relating the antidepressant efficacy of 
MAOIs to inhibition of monoamine oxidase is somewhat 
scanty and again the results of different investigators 
are variable* The studies to be described have been 
designed to test the hypothesis that the effects of 
a hydrazine MAOI are dependent on acetylator status, 
this drug being metabolised foy acétylation, a
20.
mechanism for which there is a genetic polymorphism.
If the hypothesis is true it is predicted that
a) the antidepressant effect of the drug 
would be greater in slow acetylators
than in fast.
b) the difference between the efficacy of
phenelzine and placebo would foe greater 
in slow acetylators than the same 
difference in fast.
c) the side effects of phenelzine would foe 
greater in slow acetylators than in fast.
d) slow acetylators would achieve a greater
degree of inhibition of monoamine oxidase 
than would fast acetylators.
e) slow acetylators would achieve higher levels 
of free phenelzine than would fast acetylators.
The findings of this study will provide needed evidence 
for or against the monoamine theory of depressive 
illness.
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MATERIALS and METHODS ; 1st STUDY.
The initial step in examining this hypothesis was 
to find out if acetylator status was a significant 
determinant of the antidepressant effect of hydrazine 
MAOIs and the first experiment was designed for this 
purpose. The results of this part of the study have 
already been published (Johnstone & Marsh, 1973). In 
designing this project the following factors were 
taken into account.
EATIBNT M E C TIŒ f
The antidepressant effect of MAOIs is open to 
question (Tables 1-4). There is evidence to suggest 
that it is in patients with 'atypical* depression 
that MAOIs are effective (Sargant, 1961? West & Dally, 
1959? Dally & Rohde, 1961? Robinson et al, 1973).
They have however been shown to be no more effective 
than placebo in samples of inpatients containing a 
proportion of cases of endogenous depression (Tables 
1-4). It was therefore decided to confine the study 
to outpatients whose depressive illness was not of the 
endogenous type. It is not possible to define clear 
clinical characteristics of those patients who are
likely to respond to phenelzine (Hamilton, 1974) nor 
indeed is it easy to define the concept of atypical 
depression. The criteria for including a patient in 
the study were therefore somewhat arbitrary. They 
were as follows:-
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All patients with a complaint of depression referred 
from all sources to the psychiatric department^ Eastern 
District Hospital between 1st December, 1971 and 1st 
October, 1972 were interviewed by one of the two 
psychiatrists concerned in the project to see if they 
were suitable for the study. They were included in the 
study if they had a depressive illness not secondary to 
any other psychiatric or physical disorder, if that 
depressive illness did not have endogenous 
characteristics and if they consented to participate. 
Clearly the interviews required to foe standardised. 
Standardised psychiatric interviews have been in use 
for a number of years (Overall & Gorham, 1962; Wing 
et al , 1967)• These tend to emphasize psychotic 
features and would be inappropriate for the majority 
of the patients who would be seen. The Standardised 
Psychiatric Interview devised by Goldberg et al 
(1970) seemed suitable for this purpose. It was 
intended for use in community surveys and for this 
reason is designed to be acceptable to individuals 
who may not see themselves as psychiatrically ill. 
Although our patients were attending a psychiatric 
clinic for many of them this would be a first such 
attendance and they might well resent any implication 
that they were out of touch with reality. An 
interview designed to have this type of acceptability
therefore seemed appropriate. The Goldberg interview 
incorporates a past medical and psychiatric history
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together with questions to detect all reasonably 
coMfton psychiatric disorders and was therefore a 
convenient instrument for identifying patients with 
depressive illness which was not secondary to any 
other physical or psychiatric disorder. It was 
used modified only by questions regarding previous 
alcohol and drug ingestion. The neurotic/endogenous 
rating scale devised by Carney, Eoth and Garsida 
(1965) was administered to the patients who had 
been found to have a primary depressive illness in 
order to eliminate those with endogenous depression.
By these means we defined a population of patients 
with primary depressive illness of neurotic type and 
if they consented they were included in the study.
DRUG EEGmE
Three hydrazine MAOIs are in ordinary use, nialamide, 
isocarboxazid and phenelzine. The efficacy of none of 
these is certain although the evidence suggests that 
phenelzine and isocarboxazid are more effective than 
nialamide (Tables 1, 2, and 3). Phenelzine was chosen 
for the trial because it has been more widely studied 
than Isocarboxazid.
The high incidence of response to placebo in 
depressed patients (Greenblatt, .ê^^ser & Weclisler,
1964; Friedman et al, 1966; Klerman & Cole, 1965) 
made a placebo controlled trial essential. A double 
blind crossover design of phenelzine and placebo was 
used. This meant that none of the patients was
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deprived of active medication and it allowed us to 
examine any tendency to relapse on cessation of the 
active drug. It is a common experience that patients 
are inclined to drop out of drug trials for a variety 
of reasons (Robinson et al, 1973; Raskin et al, 1970). 
In an attempt to keep this to a minimum we wanted to 
avoid undue prolongation of the trial. The duration 
of published trials of phenelzine is variable but 
Rees and Davies (1961) found it to be effective given 
for three weeks in a dosage of 90 mg,/day* We 
decided upon a similar dosage so that the trial period 
was six weeks, each patient having three weeks of 
placebo and three weeks of active drug. Although Rees 
and Davies did not describe a high incidence of severe 
side effects 90 mg./day seemed a high starting dosage 
for outpatients and our patients were therefore given 
15 mg. phenelzine t.i.d. for the first week of active 
medication and this was followed by 30 mg. t.i.d. for 
two weeks.
pmrnmmuiŒ o f K s irm m M  m m m
In 1969 Evans introduced a much simplified method 
of determining acetylator status by means of a 
sulphonamide loading technique.(Evans, 1969). This 
was used. One week following the initial assessment 
the patients returned to the clinic in a fasting 
state and were given a body weight related dose of 




Body Weight Dose Sulphadimidine
(Kg) (mg)
<51 500
51 to 83 730
) 83 1000
Six hours later 20 mis of venous blood was removed and 
the amount of free and total sulphadimidine estimated. 
From these results the percentage of the dosage which 
was acetylated was derived and by this means the 
population was divided into fast and slow acetylaters. 
Urinary excretion of free and total drug can also foe 
used for this estimation but it was felt that among 
this group of outpatients it would be difficult to 
collect accurate-timed urine samples. The results of 
the determination of acetylator status were retained 
by the biochemist until completion of the study,
fmimrim of state
Many rating scales have been developed to provide 
objective measurements of depressed mood. Well-known 
among these are those devised by Hamilton, Beck, Sung 
and Snaith (Hamilton, 1960? Beck et al, 1961? Sung, 1965? 
Snaith et al, 1971). These ratings tend to be more 
applicable to patients with endogenous depression than 
to patients such as ours. Moreover matny depression 
scales are self-r&ted and require a degree of verbal 
sophistication not possessed by our patients. None
26
of the well-known depression scales appeared suitable. 
In many studies of depressive illness global 
impressions are used as an index of change. This has
the disadvantage that others have no means of knowing 
what the ratings used meant to the rater and it was 
felt that a more standardised mode of rating would be 
preferable. We initially assessed the patients by 
means of the Standardised Psychiatric Interview 
(Goldberg, 1970) in which 10 groups of symptoms 
(Figure 1) and 12 manifest abnormalities (Figure 2) 
ware each rated on a 5-point scale (0-4). A manual 
describing the degree of severity which is 
appropriate to each rating is provided so that the 
severity described can foe understood and replicated. 
Clearly the whole Goldberg interview was unsuitable 
for the purpose of rating change as some of:the 
items would obviously be inapplicable. It did however 
seem that a score derived from those items which were 
appropriate to our cases would be useful. It would 
be understandable to the patients and it would be 
possible for others to know what we meant by the 
varying degrees of severity. From the symptom areas 
we omitted somatic symptoms, fatigue, sleep 
disturbance, irritability, lack of concentration 
and depersonalisation. The first three were omitted 
because they are reported side effects of phenelzine.
A complaint of irritability tended to reflect changes 
in the unstable domestic environment of many of our 
patients rather than a change in mental state. Lack
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of concentration was omitted as it was a concept 
which many of the patients confused with drowsiness 
and depersonalisation was omitted because it occurred 






With regard to the manifest abnormalities persons 
showing any of the following
ELATED, EUPHORIC 
FLATTENED, INCONGRUOUS 
THOUGHT DISORDER, DELUSIONS 
HALLUCINATIONS 
INTELLECTUAL IMPAIRMENT
were excluded at the initial interview on the basis 
that these are not features of a primary depressive 
illness. Goldberg (1970) states that the reliability 
of the item "histrionic" as a description of 
interview behaviour is questionable and points out 
that it is at least as much a personality variable 
as an index of morbidity. For this reason it was 
omitted as were "lack of spontaneity" and "suspicious". 
In our non-psychotic population these would never be 
rated at a high level and seemed inclined to reflect 
personality variables and initial shyness rather than 
change in mood. "Excessive concern with bodily
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functions" was omitted for the same reason as 
"somatic symptoms" namely because it seemed possible 
that change in this item might reflect side effects 




"Depressive thought content" was also omitted. This 
was because the raters found it difficult to 
separate this variable from the symptom of depression, 
clinically observable depressed mood and depressive 
ruminations ratable under obsessions. In view of the 
fact that so many items were being omitted it seemed 
best to omit this one also and avoid any confusion 
produced by the same feature being rated twice. The 
manifest abnormalities rated were therefore:
DEPRESSED
ANXIOUS/TENSE
In the Standardised Goldberg Interview the overall 
severity is derived as follows
OVEKM.L SEVERITY = ^° ^ o M S  + «""m TOrS S iEs) ^
The overall severity of the modified score used in 
this study was derived in the same way. It was fully 
realised that this modified score used as an index 
of rate of change did not have the tested reliability 
of the Goldberg score but it was felt that it was a 
simple understandable and replicable method of
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assessing the changing mental status of our patients, 
Ratings were made immediately before medication 
was commenced and at weekly intervals during the 
six-week period of the study.
SIDE EEFiCTS
It is often difficult to assess the side effects 
of drugs. Frequently there is no objective means of 
measurement and one is dependent upon the patient’s 
subjective complaints about the relevant symptoms. 
Such complaints depend upon factors such as the 
patient’s degree of stoicism as well as upon the 
severity of the effects. This difficulty can never 
be entirely overcome but in an attempt to minimise 
it we devised a list of known side effects of the 
administration and abrupt withdrawal of phenelzine. 
Our source of these effects was a standard account 
of psychotherapeutic drugs (iBrucke, Horhÿkfë'wicz 
& Sigg, 1970) (Figure 3).
The ratings were
O - ABSENT? 1 w PRESENT? 2 “ SEVERE.
The total side effects score was devised by addition 
of the individual scores. Ratings were made 
immediately before medication was commenced and at 
weekly intervals during the six-week period of the 
study. It was thought that the fact that the side 
effects were rated in this way before commencement 
of any drugs and while the patients were on placebo
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as well as while they were on active drug would 
make the actual incidence of symptoms resulting 
from drug ingestion clearer than would dependence 
upon a spontaneous report of the symptoms from 
the patients.
m u m - w
At the end of the six week course of phenelzine/ 
placebo the drugs were stopped. The patient’s part 
in the study terminated at that point and each 
patient was thereafter treated as seemed appropriate. 
If the patienté were well they were not asked to 
continue to attend the clinic although if they still 
had symptoms their attendance was naturally continued, 
At a mean of 22 weeks from completion of the course 
of phenelzine/placebo the patients were contacted 
by letter and asked to attend for a follow-up visit 
at which the Standardised Psychiatric Interview 
(Goldberg, 1970) was administered.
OTHER OCNSIPmTTONS
Previous drug ingestions
It was determined to exclude from the study 
any patients who had had a course of MAOls in the 
previous six months, The chronic administration 
of various hypnotics, tranquillisers and other 
drugs increases the amount of drug metabolising 
enzymes in the liver (Evans, 1968(a) ) and thus 
previous drug experience may be relevant to studies 
of the effects of drugs. The enzymes for acétylation
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have been shown to foe non-inducible (Levi & Walker, 
1966? Evans, 1968(fo) ) and therefore it was felt 
that apart from MAGI ingestion previous drug 
experience was not relevant to the study. As the 
intention was to study the effects of phenelzine/ 
placebo alone and not combined with any other drugs 
patients were advised to stop all drugs at the time 
of the initial interview, i.e. one week before 
commencing phenelzine/placebo.
Dietary restrictionss
Hypertensive attacks during treatment with 
monoamine oxidase inhibitors were first described 
in tuberculous patients who were being treated with 
iproniazid (Ogilvie, 1955)• Following the 
introduction of monoamine oxidase inhibitors as 
antidepressant agents numerous reports were made of 
the occurrence of these attacks which may be serious 
and associated with fatal intracranial haemorrhage 
(Clark, 1961? McClurq, 1962? Dorre11, 1963). A 
detailed study showing the relationship between 
the consumption of certain dietary articles and the 
occurrence of hypertensive crises was carried out by 
Blackwell et al (1967)• Many of the earlier reports 
concern tranylcypromine. In Blackwell’s study 
several MAOIs were used. The incidence of 
hypertensive attacks was five times greater in 
patients on tranylcypromine than in those on 
phenelzine but hypertensive crises did occur in
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patients on phenelzine. It was clearly established 
that the occurrence of hypertensive attacks in 
patients on MAOIs was associated with the ingestion 
of tyramine-containing foods. In 1969 it was 
demonstrated that the ingestion of 
phenylpropanalamine, a common constituent of 
proprietary cough and cold remedies, by patients on 
MAOXs provoked a rapid and potentially dangerous 
rise of blood pressure (Cutlibert, Greenberg & Morley, 
1969). It had previously been shown that MAOls 
potentiate the effects of barbiturates by inhibiting 
barbiturate metabolising enzymes (Laroche & Brodie 
1960) and similar effects have been shown to take 
place with pethidine (Shee, 1960). It is therefore 
essential that patients on MAOIs avoid tyramine- 
containing foods and drugs which have not been 
prescribed for them by a physician who is aware of 
the MAGI ingestion. As this was an outpatient trial 
there was particular concern about the necessity 
of impressing the need for these restrictions upon 
the patients as this aspect could not be controlled. 
The dangers were stressed heavily and the patients 
were supplied with a card explaining about the 
prohibited substances. The patients were told to 
take no other drugs during the study without the 
permission of the trial psychiatrists. The general 
practitioners of the patients were contacted and 
informed of this arrangement•
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The results of drug trials can have little 
meaning if the patients do not take the drugs. It 
has been shown that the percentage of psychiatric 
outpatients who do not take their drugs is as high 
as 48% (Willcox, Gillan and Hare, 1965). It was 
stressed to the patients that they must take the 
drugs exactly as prescribed. The patients were 
given one week’s supply of tablets at a time and 
a small excess was provided so that tablet counts 
would give some measure of the patient’s ingestion 
of the drug. Two urine samples were taken from 
each patient and tested for phenelzine (Tilstone, 
unpublished work)* These were not taken at any 
specific week but one was taken during each three- 
week period of the study so that for each patient 
one of the two samples should have been positive. 
Where this did not happen it was put to the patient 
at follow-up that we had reason to believe that he 
had not taken his tablets. By these means we 
attempted to ensure that the patients in the study 
did take their drugs but it is realised that this 
may not have been so.
In summary, the regime for the first study 
was as follows
Week-1s initial visits assessment with Standardised 
Psychiatric Interview (Goldberg et al, 1970) 
and neurotic/endogenous rating (Carney, Roth 
and Garsida, 1965). Decision made re
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inclusion in study; patient advised to 
stop all drugs.
Week-0: Estimation of Acetylator Status (Evans,
1969): Administration of side effects
scores Administration of modified
Goldberg scores One week’s supply of 
phenelzine/placebo given3 warning given
re dietary and drug restrictions.
Week 1-5: Administration of side effects scores
Administration of modified Goldberg score: 
One week’s supply of phenelzine/placebo 
givens warning re dietary and drug 
restrictionss urine samples taken on two 
occasions*
Week-6s Administration of side effects scores
Administration of modified Goldberg scores 
Drug stopped: patient advised to maintain
dietary restrictions for ten days; 
patient's part in trial terminated.
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RESULTS OF FIRST STUDY
During the study 257 patients were referred to the 
clinic because of a complaint of depression. The 
outcome of these referrals is seen in Table 6. 97
patients who were diagnosed as having neurotic 
depression according to the criteria previously 
described began the study. The outcome in these 97 
patients is seen in Tables 7 and 8. Of the 79 who 
finished, 7 were not shown to have phenelzine in 
either of the urine specimens which were tested. It 
was put to them that they had not been taking the 
tablets and they agreed that this was so. Our final 
population therefore consisted of 72 patients and it 
is only to these patients that the results refer.
An obvious criticism of this study would be that the 
side effects might make the allocation of placebo/ 
phenelzine apparent to the raters. For this reason 
each rater independently made a note of at which 
three-week period he/she thought that the patient 
was taking the active drug. In 27 of the 12 cases 
at least one rater was wrong. The final population 
of 72 patients was found to consist of 33 fast and 
39 slow acetylators and they are best considered in 
4 groups
FAST ACETYLATORS on PLACEBO FIRST 
FAST ACETYLATORS on DRUG FIRST 
SLOW ACETYLATORS on PLACEBO FIRST 
SLOW ACETYLATORS on DRUG FIRST
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Comparisons between the groups were made by Students 
’t* test (unpaired). The starting scores of the 4 
groups were not significantly different from one 
another (Table 9). There was no significant 
difference between fast and slow acetylators with 
regard to placebo response (Tables lo and 11) and 
indeed there was no consistent trend (Table 12).
On drug, however, the slow acetylators improved more 
than did the fast and in the first three-week period 
this difference was statistically significant. In 
the second three-week period the trend remained but 
statistical significance was not reached (Tables 
13 and 14)« When drug was compared with placebo it 
was found that for fast acetylators the drug was not 
significantly more effective than placebo but that 
for slow acetylators phenelzine was more effective 
than placebo to a highly significant degree (Tables 
15 and 16),
In this study the side effects check list 
previously described was used to assess side effects.
The patients achieved high scores before drug 
treatment was commenced and while on placebo as well 
as while taking active medication (Figures 4-7).
It was felt that the tendency of the patients to 
complain of the symptoms in the side effects check 
list while depressed might be obscuring differences 
in the physical symptoms actually produced by the 
drug. For this reason, in the second study, a
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description of which follows, although the entire 
score was administered individual side effects were 
examined and a new score was evolved composed only 
of those symptoms which showed a tendency to 
increase at some point while the drug was being taken. 
Retrospectively this was done with the results of 
the first study (Tables 17-20). The symptoms which 
showed a tendency to increase were fairly consistent 
in the four groups. They were - headaches, Insomnia, 
tremor, ataxia, fatigue, apathy, sweating, 
constipation, faints/dizziness, micturition difficulty 
and blurred vision. Scores using these symptoms plus 
any other new symptoms spontaneously reported by the 
patients were made and the groups were compared in 
terms of these (Tables 21 and 22) (Figures 8 and 9)•
In general terms the patients improved considerably
during the study. On the Modified Goldberg Score, 
the mean score of all the patients at the outset of the 
study was 15.2. For those who went on to complete the 
course it was 14.9 and their mean finishing score was 
1.9. The patients were seen for a follow-up visit at 
a mean of 22 weeks after completing the course of 
phenelzine/placebo. 85% attendance was achieved and 
at that time the mean score was 2.2. In view of the 
fact that this 22 week period was uncontrolled with 
respect to further treatment, intercurrent illness 
or changed circumstances this result was not examined 
in any further detail.
MATERIALS and METHODS: 2nd STUDY
INTRCDUCUim
These studies were undertaken to examine the 
hypothesis that the effects of hydrazine MAOIs, of 
which phenelzine was used as the most studied 
example, are dependent upon acetylator status, the 
drug being metabolised by acétylation. The results 
of the first study showed that the first two 
predictions namely:
1) The antidepressant efficacy of the drug will 
be greater in slow acetylators than in fast
2) The difference between the efficacy of phenelzine 
and placebo will be greater in slow acetylators
than in fast
were correct. The results regarding the third 
predictions
3) The side effects of phenelzine will foe greater 
in slow acetylators than in fast
were inconclusive.
These results support the hypothesis and
therefore a second study was carried out in which 




4) Degree of inhibition of monoamine oxidase
5) Levels of free phenelzine.
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Study of these variables would make it possible to 
determine whether or not the last two predictions 
namely:
4) Slow acetylators will achieve a greater degree
of inhibition of monoamine oxidase than fast
5) Slow acetylators will achieve higher levels
of free phenelzine than fast.
were correct.
The studies of MAO inhibition and phenelzine 
levels necessitated strict control of the timed 
ingestion of the drug and repeated collections 
of blood and urine. This study could therefore 
only be carried out on inpatients. This meant 
that an opportunity would be provided for checking, 
in patients known to foe taking their medication, the 
findings of the first study relating antidepressant 
effect and incidence of side effects to acetylator 
status. It is known that a high proportion of 
psychiatric outpatients do not take their drugs 
(Willcox, Gillan and Hare, 1965). Despite our 
precautions some of the patients in the first study 
may not have taïsen their tablets and this could 
obviously affect the results. In order that the two 
studies would foe comparable the methods used in the 
second study closely resembled those of the first.
This study concerned depressed patients of
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non-endogenous type whose Illness was not secondary 
to any other physical or psychiatric disorder. This 
trial was confined to patients conforming to these 
criteria, who agreed at the outset to come into 
hospital for four weeks. Most of the patients were 
selected from those referred with a complaint of 
depression to the psychiatric clinic at Eastern 
District Hospital, Glasgow or to the outpatient 
clinic of the Glasgow University Department of 
Psychological Medicine. Six to eight patients per 
week were seen from 1.3.73 until 31.7.74, A few 
other patients were referred by other psychiatrists 
in both hospitals as possibly suitable and the 
selection procedures also applied to them. The means 
of selection were similar to those used in the first 
study. The Standardised Psychiatric Interview 
(Goldberg et al, 1970) was used and the Neurotic/ 
Endogenous rating (Carney, Roth and Garside, 1965) 
was applied to those who had a depressive illness 
not secondary to any other physical or psychiatric 
disorder. The study was explained to those patients 
who were suitable and if they agreed to participate 
their admission was arranged and they were included 
in the study.
DRUG mom:
As in the first study phenelzine was used. It
was felt that the estimation of phenelzine levels 
would be simplified if the dosage was constant
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throughout the period of the study and the drug 
was therefore given in a dosage of 30 mg, t.i.d. 
for 21 days. This second study was not placebo 
controlled. On theoretical grounds placebo control 
would have been desirable but it was thought to be 
impracticable in this inpatient study. The 
depressive illnesses of neurotic type, from which 
these patients suffered, are frequently treated on 
an outpatient basis. The patients in this study 
were being asked to agree to a four-week admission 
which could possibly have been avoided, at least in 
some cases. Extending this admission to at least 
six weeks, which would have been necessary had the 
phenelzine/placebo crossover design of the first 
study been used, would have placed an unreasonable 
burden upon the patients and upon the hospital 
services. It would have been possible to give half 
of the patients phenelzine and half of them placebo. 
This would have meant asking patients, who could 
possibly have been managed as outpatients, to agree 
to a four-week period of hospital care during which 
they would be deprived of effective treatment. It 
was not felt that patients could be treated in this 
way. Because of these objections and because the 
effects of phenelzine/placebo, as related to 
acetylator status, had already been examined in the 
first study, all of the patients were given a three- 
week course of phenelzine 30 mg. t.i.d. without 
placebo control.
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pmB&amTiCN of ACEgmapR status
This was done by means of the sulphadimidine loading 
technique initially described by Price Evans (1969) and 
further discussed by Rao et al (1970), Eze and Evans 
(1972) and Schroder (1972). Using the sulphadimidine 
loading method either urine or blood samples can be 
used for estimation of free and total sulphadimidine. In 
the first study blood samples were used. In the more 
controlled conditions of this inpatient study it was 
possible to use urine samples collected for one hour 
between five and six hours after ingestion of the drug 
which was given according to the dosage schedule 
described in Table 5. Urine samples were used in order 
to minimise the number of venepunctures that would be 
required. In ten of the patients the estimation was 
also performed on a blood sample. This was done to 
confirm that the results with urine are comparable with 
those with blood and to clarify the result in those 
patients in whom the percentage acetylated was close 
to the dividing line between fast and slow acetylators. 
There is some difference of opinion about the point at 
which this division should foe made, figures of 65% and 
70% being used in different studies and in patients 
whose result fell between these points the test was 
repeated using a blood sample. The sulphadimidine was 
estimated both by the method described by Price Evans 
(1969) and by that described by Schroder (1972).
E\mmrim of m h a l  s tm e
The changing mental states of the patients were
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assessed using the modification of the Goldberg (1970) 
interview earlier described. This rating was made at 
the time of the initial assessment, following hospital 
admission but prior to commencing medication and on the 
7th, 14th and 21st days of treatment. A further rating 
was made on the third day after stopping the drug to 
assess the mental state when the patient was drug-free. 
Further ratings were made after discharge, four weeks 
and eight weeks after cessation of the drug, to assess 
any tendency to relapse. In the initial study many 
patients stated that they had improved suddenly over a 
period of about twenty-four hours at some point 
between the weekly ratings. For this reason it was 
felt that ratings should be carried out at least once 
per day. For such frequent assessments to be made 
the rating required to be very simple : Visual
Analogue Scales (Aitken, 1969; Zealley & Aitken, 1969) 
seemed appropriate. The patients rated themselves on 
3 variables: anxiety, tension, and depression,
morning and evening throughout the study. This 
allowed the patients* mental states to foe sampled 
frequently, simply and without causing them any 
distress. It also meant that a self-rating scale 
was included in the study. As all of the other 
assessments were being carried out by the author this 
was useful as it would corobat any personal preconception 
and prejudice.
SIDE EFFECTS
Side effects were rated using the same side effects
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check list as was used in the first study, The rating 
was made the day before treatment was begun, on the 
7th, 14th and 21st days of treatment and on the 3rd 
day after it was stopped (Day 24). It was evident 
from the first study that many of the somatic 
complaints to which the patients admitted when the 
side effects score was administered reflected depressed 
mood rather than effects of the drug as many of the 
patients had higher scores before starting the drug 
than they had while on it. Therefore, although the 
score was administered unchanged it was determined 
to assess which of the items did in fact show any 
tendency to increase while the patients were on the 
drug and to assess the side effects in terms of these.
E&TBmiQN æ  hmmiTim œ  M M m m E  ommsE
Monoamine oxidase (MAO) occurs in many tissues 
of the body including the liver, the kidney, the 
plasma and the platelets as well as the nervous system. 
Some investigators have found that MAO exists in 
multiple forms in a single tissue. Although there are 
authors (Houslay & Tipton, 1973) who suggest that 
these findings may be due to artefact, Youdim et al 
(1972), studying the brains of deceased persons, 
concluded that in human brain MAO exists in four forms 
and that the degree to which each of these is 
inhibited by various MAOIs is variable. Squires (1972) 
showed that MAO existed in two forms in various tissues 
in several mammalian species. Platelet and plasma MAO 
have been shown in man to differ from each other and
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from liver MAO (Robinson et al, 1968) and these authors 
showed that the degree of inhibition produced by 
various MAOIs in plasma and platelet MAO is not the 
same*
From the point of view of considering the 
relevance of inhibition of MAO to antidepressant 
activity and the implications of this for the mono­
amine theory of depressive illness, it is the 
inhibition of MAO within the brain which is important• 
At present it is not possible to estimate in living 
subjects inhibition of total brain MAO and certainly 
not inhibition of the various forms of brain MAO*
There are various methods of estimating inhibition of 
MAO. The use of these in connection with testing the 
monoamine theory of depression involves making the 
assumption that the degree to which MAO is inhibited 
in the site tested is a measure of the degree of 
inhibition of MAO in the brain. Methods of estimating 
inhibition of MAO include the following. Firstly, 
there are those involving urinary estimation of a 
monoamine substrate of MAO. The most commonly used 
substrate is tryptamine. Normally tryptamine is 
metabolised by MAO to indole-3-acetic acid and if MAO 
were inhibited this would be expected to lead to 
increased urinary excretion of tryptamine. This was 
shown to occur in 1959 (Sjberdsma et al, 1959) and 
these authors stated that the level of urinary 
tryptamine was a sensitive index of monoamine oxidase 
inhibition. Secondly, there are those involving
46
urinary estimation of a metabolite of a monoamine substrate 
of MAO. When MAO is inhibited the normal metabolic path 
is blocked and the urinary level of the metabolite will 
fall, 5HXAA and VMA can be used for this purpose but the 
changes in level are much less marked than the changes in 
tryptamine level (Dunlop et al, 1965). Moreover the 
metabolites are present in such low concentrations that 
estimation is difficult (Dewhurst and Pare, 1961)* For 
this reason a loading dose of enzyme substrate, e.g. 
5-hydroxytryptamine, may foe given before its major 
metabolite, in this case 5HIAA, is estimated in the urine 
(Dewhurst and Pare, 1961; Sjoerdsma, Gillespie and 
Udenfriend, 1958), Related to this method is that using 
a loading dose of labelled adrenaline (Resnick et
al, 1960). In this method the amount of radioactivity 
in the urine is used as an index of MAO inhibition. All 
of these methods are indirect. In 1968 a technique of 
direct assay of MAO in platelets and plasma using 
radioactive substrates was introduced (Robinson et al,
1968). Of these methods the estimation of urinary 
tryptamine is the simplest and the method of Robinson 
et al the most direct. Results with urinary tryptamine 
correlate well with inhibition of platelet MAO 
(Robinson et al, 1968). Estimation of platelet MAO 
could not be undertaken in Glasgow and repeated 
estimations would have involved repeated venepunctures. 
Estimation of urinary tryptamine is simple and could 
be done locally. As only urine samples are required 
repeated testing could foe carried out with minimal
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inconvenience to the patients. For these reasons it
was decided to use estimation of urinary tryptamine to 
measure inhibition of MAO. 24 hour urine collections 
were carried out continuously for the 21 days of 
pheneleine administration and for 3 days after it was 
stopped. There was no intention of doing daily 
estimations but it was felt that it would be less 
confusing for the patients if continuous collections 
were carried out than if collections were carried out 
some days but not others. The urine was frozen following 
collection and 100 ml. aliquots stored at -20^C without 
preservative until the estimations could foe carried out. 
This was done by the method described by Bjoerdema et 
al (1959).
FBEMBLZINE BEVELS
Estimation of monoamine oxidase inhibitors in 
biological samples is difficult, A method of detecting 
monoamine inhibitors in biological samples was published 
in 1970 (Curry and Mercier 1970) . This method is based 
on the inhibitory action of these drugs on the activity 
of MAO, This being the case this method was unsuitable 
for this study as it was hoped to examine the levels of 
the drug and the degree of inhibition of MAO separately 
and see if there was a relationship between these two 
variables. During the initial study a gas 
chromatographic method of detecting phenelzine in the 
urine was developed (Tilstone unpublished). Samples 
from poisoning cases are dealt with in the same 
laboratory and at the time of the first study samples
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ware ohtaiued from m man who had committed
sq&oide by Ihgeatlng &n w&k&owm quantity of phoaolBlAe 
tablet#. ^hl& man waa Mot in the #%#dy &n# wa# not 
k&owa to th# doetor& imvolvod. in h&ood from thi# patient 
a level of phe&olælae of 2 %g/ml wae dateot&d by the 
method evolved la thi# laboratory from the l&ltl&l urine 
0t%dlo&, This mathod wa$ further developed that free 
pho&0l8lae was detected and it wag decided that It. warn 
pr&gtieahle to make the dotermlAAtlon of fro# pheael&lne 
lev%l# part of the second mtmdy. This mothod involve# 
th# ooavoraioa of free phenel^in# to pha&elBlno acetenido 
and th® measurement of this substance by ga# chromatography, 
Aoetyl&t^ '^ ph#n#l&imo la mot deteotBbl# by thl# method which 
was devi&ed by Caddy & TllGtome (unpubllahed). The method 
is &B follow# r»
Phmnolæine waa acsayed by #&& liquid chromatography 
a# the aootonlde derivative em 10# apie#on  ^& on #a& 
chrom 0 at l&d^C* BO ml of urine was added to 10 ml 
of a 1*1 mixture of ether and acetone and shaken. 1 ml 
of phendimetr##l&e hit&rtrat# 11«# ug/ml was added am an 
Internal wt&nd&rd and 3 drop# of saturated sodium carbonate 
were al&o added, #hmnolsine acetonide was o&traoted in the 
other layer on a roller mlaor for half an hour. The other 
phase wa$ removed and ^ oao&ntrated to 100 ul, 2 ul 
aliquot# were injected onto the G&C, Quantitation waa by 
peak height ratio# of phomol&ine to phendimetrasine by 
reference to a standard curve of 1^10 ug/ml. Complot# 
recovery of phonolslne wa# attained and the standard 
deviation was better than The identity of the
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phenelalne aoetonide peak was confirmed by reference to 
the retention times of standard material and by maea 
spectrometry.
It was hoped that this method could be used to detect 
plasma levels of phenelzine although it was not known 
whether or not therapeutic dosages of phenelzine would 
give levels above the detection limit of 0,5jag/ml in 
all or any of our patients. Drug concentrations in 
urine are up to 100 times higher than those In plasma, 
the exact relationship depending on the extent of tubular 
reabsorption, Moreover it is possible to use much larger 
volumes of urine than can reasonably foe obtained of plamna. 
For these reasons the detection of free phenolsin© in 
urine was expected to be much simpler and we were hopeful 
of obtaining clear-out results using urine.
The relationships between the amount of drug excreted
in urine over a given period (e.g. 24 hours)and the
concentration of the drug In the plasma is
Qu w Vu X /  Cp, dt,
6
where Vu Is the renal clearance of the drug
y  Cp.dt. is the area under the plasma
o
concentration time curve for the period 
o-t (e.g. 0-24 hr s.)
and Qu is the quantity excreted in the time 
period considered,
Thus measuring Qw will give a relative measure of plasma 
concentration. It was intended to obtain this measurement
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using 24 hr. urine collections but samples of plasma 
were also collected in the hope éf obtaining direct 
measurements. To this end 30 mg. phenelzine was given 
at 8 a.m., 12,30 p.m. and 5 p.m. for 21 clays. On the 
4th and 14th days of the course 10 mis of blood was 
taken at 7.55 a.m. and the 8 a.m. dose of phenelzine 
given. The 12.30 p.m. and 5 p.m. doses were omitted 
on those days. Further samples of blood (10 mis taken 
into lithium/heparin tubes) were taken at 9 a.m.,
11 a.m., 2 p.m., 5 p.m., 8 p.m. and 7*55 a.m. on the 
following day. The samples were centrifuged for 10 
minutes immediately after collection. The plasma 
was then frozen at -20^C until assay. The urine 
collection of Day 13 was used for phenelzine estimation 
and the patients were particularly closely supervised 
on that day in order that we might be sure of obtaining 
a complete collection,
cjiBER cmsipmmicms
As in the first study patients who had received a 
course of MAOIs in the six months prior to the study 
were excluded and if possible all other drugs were 
stopped for a week prior to commencing the study. In 
this second study the patients were rather more severely 
depressed than those in the first study and in some 
hypnotics could not foe withdrawn (for details see 
Appendix I), In tiiis inpatient study the dietary 
and drug restrictions were less worrying as the patients 
were being treated under closely controlled conditions.
A low tyramine diet was administered. They were advised
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only to eat the foods provided and no drugs incompatible 
with phenelzine were given, strict control over the 
actual ingestion of the tablets was maintained. They 
were given according to a timed schedule and counts of 
the tablets were made to see that this had indeed been 
carried out accurately. Dietary tryptophan influences 
urinary tryptamine levels (La Brosse et al, 1964).
Constant tryptophan diets could not be provided in the 
wards used and in any case they are very repetitive and 
rather unpalatable. Plasma tryptophan levels have been 
shown not to vary in psychiatric patients on a standard 
ward diet (Coppen et al, 1965) and it was therefore felt 
that dietary tryptophan was not likely to influence 
results in this study. There is also a question that 
variations in urinary pH might influence urinary 
tryptamine levels. Previous authors have felt that 
keeping the patients on a uniform diet provided adequate 
control of this source of variability (Coppen et al, 1965) 
and as the patients in this study were maintained on a 
uniform ward diet it was felt that this aspect was 
probably controlled.
In summary the regime for the second study was as 
followss
As outpatient ■» assessed for suitability for trial 
by Standardised Psychiatric Interview (Goldberg 
et al, 1970) and the neurotic/endogenous rating 
(Carney, Roth & Garside, 1965).
Following admission - Estimation of acetylator status 
(Price Evans, 1969),
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Administration of Modified Goldberg Score. 
Administration of side effects check list.
Twice daily ratings on visual analogue scale 
commenced and maintained until discharge.
Day 1 - 2 4  urine collections commenced and maintained 
for 24 days.
Phenelzine 30 mg. t.i.d. commenced.
Day 4 - 12.30 p.m. and 5 p.m. doses of phenelzine 
omitted. 7 blood samples taken.
Day 7 - Modified Goldberg Score administered.
Side Effects check list administered.
Day 14 - 12.30 p.m. and 5 p.m. doses of phenelzine
omitted - 7 blood samples taken. Modified Goldberg 
Score administered. Side Effects check list 
administered«
Day 21 - Modified Goldberg Score administered.
Side Effects check list administered.
Phenelzine stopped.
Day 24 - Modified Goldberg Score administered.
Side Effects check list administered.
Day 24 t 4 weeks - Modified Goldberg Score administered.
Day 2 4 + 8  weeks - Modified Goldberg Score administered.
The results of the biochemical estimations including 
determination of acetylator status were retained by the 
biochemist until the study was completed.
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RESULTS OF SECOND STUDY
Between 1.4.73 and 1.8.74 thirty patients who had 
neurotic depression according to the stated criteria 
agreed to enter the study. The number of patients 
collected was much smaller than that of the first 
study because many of the patients who were otherwise 
suitable were not prepared to come into hospital for 
four weeks. The patients in the study are therefore a 
somewhat selected sample of the neurotically depressed 
patients attending the clinic but the nature of the 
study made this unavoidable. None of the patients 
defaulted from the course of treatment. Details of 
the patients * case histories and the results in the 
individual cases are in appendices I and II. These 
patients were rather more severely ill than the 
outpatients in the first study. The mean overall 
severity score (modified Goldberg) before treatment 
was begun was 18.4 for the fast acetylators and 20.3 
for the slow. The corresponding figures for the first 
study were 14.8 for the fast acetylators and 15.0 for 
the slow.
Determination of acetylator phenotype was carried 
out by sulphadimidine loading as described by Evans 
(1969). Attempts were made to use the simple method 
described by Schroder (1972) for estimating the level 
of sulphadimidine. This method depends upon a colour 
change. Schroder states that in some samples this is 
difficult to detect. This was our experience and the 
method described in Evans (1969) paper was used. In
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10 of the patients* serum samples were used to confirm 
the results. In no case did this change the grouping. 
The results of the acetylator phenotyping are seen in 
Figure 10. In those patients in whom urine testing 
gave results between 65% and 69% sulphadimidine 
acetylated, the testing was repeated with serum at a 
later date and in all cases the result was within the 
range for fast acetylators.
Blood samples were collected for phenelzine 
estimation as described. During the study it became 
apparent that the serum levels of phenelzine achieved 
were too low for consistent reliable detection and 
that only levels in the urine would be obtained. The 
original protocol with omission of two phenelzine 
dosages on Days four and fourteen and the carrying out 
of seven venepunctures on each of these days was however 
followed so that the treatment procedures jwould be the 
same in all of the patients*
Continuous 24 hour urine collections were carried out 
throughout the study and urinary tryptamine levels were 
estimated on samples from Days 1, 3, 13 and a pool of 
Days 20, 21 and 22. 2 fast acetylators and 1 Slow
acetylator gave incomplete collections for Day 1. As 
this was intended as a basal estimation this result was 
omitted. 4 fast acetylators and 3 slow acetylators gave 
incomplete collections for Day 3. If the collection for 
Day 2 was complete this was substituted and this was the 
case in 1 fast and 2 slow acetylators• Where there was
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also doubt about the collection for Day 2 a pool of 
Days 5-8 were substituted. The collections for the 
other days were all thought to be complete* Where the 
collection for Day 3 had been substituted by that of 
Day 2 or a pool of Days 5-8, collections from Day 12 
or a pool of Days 15-18 were substituted for that of 
Day 13 for purposes of tryptamine estimation*
Estimations of free phenelzine were made on the 
urine collections for Day 13* These were satisfactory 
in 27 cases. In the case of 2 fast acetylators and 
1 slow acetylator the results were regarded by the 
biochemist as being falsely low and these have been 
omitted from the calculation of the results.
In calculating the results a comparison is being 
made between the findings in the 13 slow acetylators 
and the 17 fast acetylators. Comparisons were made by 
Students * t* test (unpaired).
Firstly, the overall severity scores (modified 
Goldberg) prior to treatment, after one week* s 
treatment, after two weeks' treatment, after three 
weeks* treatment and on the 24th day (3 days after 
treatment was stopped) were compared. (Table 23?
Figure 11). The differences between the initial score 
and the scores after 1 week, 2 weeks, 3 weeks and 3% 
weeks (24 days) were then compared (Table 24? Figure 12)* 
The visual analogue scale cannot foe used as an absolute 
figure as the point indicated by the patient is arbitrary. 
The results using the VAS were calculated as follows.
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The morning ratings on the anxiety, tension and 
depression lines were added together to make a single 
score. Average scores for each week were calculated 
and rate of change measured using the index week 
score (score of 2nd, 3rd or 4th week) as a percentage 
of the first week score. Comparisons between fast and 
slow acetylators using this measurement are seen in 
Table 25? Figure 13).
In the initial study it was felt that the method of 
determining the side effects was unsatisfactory as many 
of the patients achieved higher scores before starting 
the drug than they did while on the full dosage. It 
was determined in the second study to find which 
symptoms did in fact show a tendency to increase while 
the patients were on the drug (Tables 26 and 27), The 
side effects which showed a tendency to increase were 
quite consistent^ between the two groups although not 





The side effects were calculated in terms of these plus 
any other new symptoms spontaneously reported by the 
patients. Comparisons between the side effects at the 
different weeks of the study are shown in Table 28 and 
Figure 14.
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Excretion of tryptamine in pg/24 hours was compared
for Day 1, Day 3 (replaced by other days in the eases 
indicated in Appendix I) and a pool of Days 20, 21 and 
22n Comparisons between these results in fast and
slow acetylators are shown in Table 29 and Figure 15. 
The differences between the tryptamine excretion on 
Day 1 and that on Day 3, Day 13 and the pool of Days 
20-22, were then compared and the results are shown in 
Table 30 and Figure 16.
The excretion of free phenelzine in^pg/24 hours 
for Day 13 was compared between the two groups. On 
this day particular efforts were made to obtain 
certainly complete collections and the patients were 
observed constantly. There can be confidence that the 
collections for this day were complete* The results 
are shown in Table 31 and Figure 17.
The patients who were not removed from the study at 
the end of the 24 days were followed up for 8 weeks
and were rated on the modified Goldberg score at 4 
weeks and 8 weeks after completion of the treatment 
period, Comparisons of these ratings are shown in 
Table 32 and Figure 18.
The relationships between these variables in the 
individual cases are illustrated in Appendix 2, The 
relationships between the mean values of the fast and 
slow acetylators regarding these variables are 
illustrated in Figures 19-25.
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DISCUSSION
These studies were designed to test the hypothesis 
that the effects of phenelzine are dependent upon 
acetylator status, the drug being broken down by 
acétylation, a mechanism for which there is genetic 
polymorphism. It was predicted that, if the hypothesis 
were true:
1. The antidepressant effect of the drug would be 
greater in slow acetylators than in fast.
2. The difference between the efficacy of phenelzine 
and placebo would foe greater in slow acetylators 
than the same difference in fast.
3. The side effects of phenelzine would foe greater 
in slow acetylators than in fast.
4. Slow acetylators would achieve a greater degree 
of inhibition of monoamine oxidase than would 
fast acetylators.
5. Slow acetylators would achieve higher levels
of free phenelzine than would fast acetylators.
In the first study predictions (1), (2), and (3) were 
examined. A consistent trend whereby the antidepressant 
effect of phenelzine was greater in slow acetylators 
than in fast was shown and in those patients who were 
on active drug during the first three-week period this 
difference was statistically significant (Table 13).
For fast acetylators phenelzine was not significantly 
more effective than placebo as an antidepressant while
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for slow acetylators it was more effective to a highly 
significant degree (Tables 15 and 16)• With regard to 
side effects no significant differences and no consistent 
trends were demonstrated. These results are in keeping 
with the hypothesis but other possible explanations for 
the results must be considered: With regard to the
first result, namely that the depression of slow 
acetylators Improved to a more marked extent than did 
that of the fast, it could be postulated that the 
difference in improvement rates occurred for reasons 
unconnected with the administration of phenelzine. 
Spontaneous improvement rates in depressive illness 
are high (Klerman & Cole, 1965) and in many of these 
patients reactive factors were important. It is 
possible that there were more patients among the slow 
acetylators than the fast in whom such factors played 
a large part. Moreover it is possible that depressive 
illnesses in slow acetylators have an intrinsically 
better prognosis than those in fast. Acetylator status 
is genetically determined,(Evans, Manley & McKusick,
1960). In at least some depressive illnesses genetic 
factors are important (Winokur et al, 1971). Monoamine 
oxidase activity, which, if the monoamine theory of 
affective disorders is correct, is relevant for 
depressive illnesses, has been shown to be under 
genetic control (Nies et al, 1973)• It is possible 
that these factors are interdependent and that for 
genetic reasons the prognosis of depressive illness is 
better in slow acetylators than it is in fast. If
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either of these factors were important the slow 
acetylators would be expected to have improved more 
than the fast acetylators while they were on placebo 
as well as while they were on active drug. This did 
not happen (Tables 10, 11 and 12)• With regard to the 
result, that for fast acetylators phenelzine was not 
significantly more effective as an antidepressant than 
placebo but that for slow acetylators phenelzine was 
more effective to a highly significant degree, one 
could suggest that the difference was due to the fact 
that fast acetylators respond better to placebo than 
do slow acetylators. Indeed this suggestion has been 
put forward (Carr, 1974) but it is not reasonable.
Not only were there no significant differences 
established between fast and slow acetylators with 
regard to placebo response but there was not even a 
consistent trend (Tables 10, 11 and 12). One would 
not have expected such a difference to be shown. It 
has been demonstrated that it is difficult to support 
the concept that placebo reactors, or non-reactors, 
exist as a distinct entity (Wolf et al, 1957). These 
authors showed that intra-individual response to 
placebo varies as much as inter-individual response. 
This evidence is against the idea that placebo response 
could relate to a genetically determined characteristic.
Any explanation for these results has to account for 
the fact that while on phenelzine slow acetylators 
improve more than fast but while on placebo this is not 
the case. There is an explanation other than our
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hypothesis which fits these criteria. It has been 
suggested that 5-hydroxytryptamine and other naturally 
occurring amines are subject to polymorphic acétylation. 
Oxidative deamination to S-hydroxyindol-S-ylacetic 
acid was the only known biotransformation of 
5™hydroxytryptamin© until investigations in animals of 
the metabolism of the - labelled compound were 
carried out (Mclsaac and Page, 1959). It was 
demonstrated that 35-83% of the lalselled dose was 
metabolised by oxidative deamination and 5-25% by 
N“*acetylation.' In experiments using material from 
animals which had been pretreated with monoamine 
oxidase inhibitors it was shown that a wide variety 
of normally occurring amines, including 5-hydroxytryptamine, 
tryptamine and to a lesser extent noradrenaline, is 
acetylated by mamiïialian tissues (Weissbach, Redfield 
and Axelrod, 1961). If the acétylation to which 
these amines are subject were polymorphic one would 
expect that among patients in whom the activity in 
monoamine oxidase was blocked because they were on MAOIs 
slow acetylators would metabolise the amines more slowly 
than fast. If it is accepted that depression is 
associated with a deficiency of these amines polymorphic 
acétylation of the amines could explain why the slow
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acetylators on phenelzine achieved a greater antidepressant ^  
than the fast acetylators even if phenelzine were not 
subject to polymorphic acétylation. The nature of the 
acétylation to which 5-hydroxytryptamine is subject in 
human liver was examined in 1969 (White, Jenne and Evans
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1969). Their results showed that the capacity to 
aoetylate 5-hydroxytryptamine did not correlate with 
the capacity of the same livers to acetylat© 
isoniazid and a sulphonamide. They concluded from 
this that 5-hydroxytryptamine is not a substrate for 
the polymorphic enzyme N-acetyl transferase and that 
it might be acetylated by a different enzyme. If 
this is so the above explanation for my results is 
unlikely to foe tenable but conflicting findings were 
produced by Schloot et al (1969) who concluded that 
S-hydroxytryptamine was likely to foe a natural 
substrate for the polymorphic enzyme N-acetyl 
transferase. This question therefore remains open.
The results regarding the side effects neither 
support nor conflict with the hypothesis. It was 
always realised that the presence of side effects 
would be difficult to assess. In making this 
assessment one is entirely dependent upon the 
patient's subjective complaints of the symptoms and 
these may depend upon his personality and the degree 
of persisting depression as much as upon the actual 
severity of the drug-induced effect. These factors, 
particularly the possibility that those patients who 
remained most depressed would be likely to have 
least tolerance for somatic symptoms, may have blurred 
existing differences but there is no doubt that these 
were not demonstrated by this study. The results of 
this first study are relevant to the hypothesis only 
if the patients all took their medication or if the
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extent to which they failed to take it did not vary 
betwoen the two groupe. While it ie known that they
all took at l#a#t Bome of their medication, because 
phenelzine could be detected in their urine, there le 
no means of being certain that they took their tablets 
exactly as directed, There can be certainty about the 
patients* ingeetion of the tableta in the prescribed 
dosage in the second study* In this study the numbers 
of patim^ta are much smaller and there ie no placebo 
control* The reunite could be diatorted if the groups 
differed markedly in pergonal characteriatics euch as 
environment, previous personality, etc* Detailed 
accounts of the patients and their deproGcivo illnesses 
are therefore given in Appendix I* These factors 
are difficult to quantify but it may be seen that there 
were no marked differences between the groups.
The second study examines predictions (1), (3), (4) 
and (S), Prediction (1) was confirmed. The 
antidepressant effect as measured by the modified 
Goldberg score and the visual analogue scale was 
significantly greater in slow acetylators than in fast. 
(Tables 23, 24 and 2S: Figures 11, 12 and 13). The 
increased antidepressant effect in slow acetylators 
was lasting. At follow-up at 4 and 8 weeks after 
completion of the course slow acetylators continued to 
show a significantly lower score on the modified 
Goldberg score (Table 31 and Figure 17)$ These 
results only refer to patients who continued in the 
study. In i fast acetylators and 1 alow acetylator
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the outcome of the course of phenelzine was so 
unsatisfactory that they were removed from the study 
0X1 the 24th day (details in Appendix I) « One would 
expect that had these patients been included in the 
follow-up studies the difference between fast and slow 
acetylators would have tended to be increased rather 
than lessened. As in the first study no statistically 
significant differences were shown regarding side 
effects. A trend whereby slow acetylators tended to 
develop more side effects than fast at the study 
progressed was demonstrated (Table 28 and Figure 14).
The side effects were assessed in terms of a score 
derived from those symptoms which showed a tendency to 
increase while the patients were on the drug. The 
symptoms in this category were fairly consistent 
throughout all of the groups in the first and second 
studies (Tables 17, 18, 19, 20, 26 and 27) although 
in the first study the patients complained of headaches, 
fatigue and apathy while those in the second study did 
not. The difference with regard to fatigue and apathy 
is probably explained by the fact that the patients in 
the first study were outpatients attempting to cope 
with their normal activities whereas those in the second 
study were inpatients with no duties or current 
responsibilities•
The results regarding urinary tryptamine excretion 
differed between the two groups in that the slow 
acetylators excreted more tryptamine on Day 13 than 
did the fast and in that the difference between the
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excretion on Day 1 and that on Day 13 was greater for 
alow acetylators than for fast (Table 29 and Figure 15 
and Table 30 and Figure 16). The tryptamine excretion 
of the patients on Day 1 was below the normal range 
of 36-120 ug/day described by Sjoerdsma et al (1959). 
This compares with the finding of Coppen et al (1965) 
that excretion of tryptamine is low in depressed 
patients, It was known that some of the collections 
for Day 3 were incomplete and collections for other 
days were therefore substituted (for details see 
Appendix I). Where substitutions were made for Day 3 
substitutions were also made for Day 13 so that in all 
cases the third sample for tryptamine estimation was 
taken 10 days after the second. It does not seem likely 
that this variation in the collection day has 
influenced the results. The mean tryptamine excretion 
of the total group is very little different from that 
of those patients whose collection was in fact made on 
the stated day (Table 33)• The results shown in 
Tables 29 and 30 and Figures 15 & 16 indicate that slow 
acetylators achieve significantly greater inhibition 
of monoamine oxidase than do fast at Day 13 but that 
this difference is lost by Days 20-22 when the results 
for the two groups are almost the same. This suggests 
that inhibition of monoamine oxidase as a result of 
phenelzine administration occurs more slowly in fast 
acetylators than in slow acetylators. The significant 
difference in monoamine oxidase inhibition between the 
two groups precedes the significant difference in
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antidepressant response and the possibility is suggested 
that if the phenelzine had been continued in the fast 
acetylators for some time after they had achieved the. 
same degree of monoamine oxidase inhibition as the slows 
a greater antidepressant response might have been seen. 
Phenelzine levels were assessed on urine collections 
from Day 13, Great care was taken to obtain complete 
collections on that day. Slow acetylators excreted 
significantly more free phenelzine than did fast 
(Table 31 and Figure 17).
Of the five predictions set out at the beginning 
of the study, (1) , (2) , (4) and (5) f^ ere correct. 
Significant differences were established in the 
predicted direction in every case. Prediction (3) 
concerning the side effects was neither confirmed nor 
refuted. It has already been mentioned that polymorphic 
acétylation of 5-hydroxytryptamine could explain the 
results of the first study so that these cannot be held 
necessarily to mean that phenelzine is subject to 
polymorphic acétylation. Polymorphic acétylation of 
S-hydroxytryptamine could not explain the difference 
between fast and slow acetylators with regard to 
phenelzine levels and inhibition of monoamine oxidase.
If the relevant monoamines are polymorphically acetylated 
the difference in antidepressant response between fast 
and slow acetylators would be enhanced but it does appear 
that the explanation for the results of these two studies 
is that the hypothesis set out at the beginning is 
correct, that is to say that the monoamine oxidase
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inhibitor drug phenelzine is metabolised by polymorphic 
acétylation and its effects are dependent upon acetylator 
status.
The relationships between the means of variables 
are seen in Figures 19-25 and between the variables in 
the individual cases in Appendix II. In the majority 
of cases the assessment of the mental state on the 
modified Goldberg score correlates well with the 
patients* self-rating on the VAS although this is not 
always the case. There appears to be some relationship 
between the antidepressant response and the side effects 
score. It appears that the patients who are least 
depressed have fewest side effects (Figure 23). From 
this figure it may be seen that the mean modified 
Goldberg score of the 16 patients scoring 5 or less on 
the side effects score is 2 (SD. 3.79) while that of 
the 14 patients scoring 6 or more on the side effects 
score is 6 (SD. 4.29) (p^O.Ol). This confirms our 
suspicion that persisting depression is associated 
with an increased tendency to complain of side effects 
and it is possible that this may have masked a 
tendency for phenelzine to provoke an excess of side 
effects in slow acetylators.
A clear relationship between phenelzine level and 
antidepressant effect was not demonstrable (Figure 21).
On the basis of the fact that slow acetylators have a 
greater antidepressant response than fast and of the 
fact that slow acetylators achieve higher levels of
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phenelzine one might have expected higher levels of 
phenelzine to be associated with a greater antidepressant 
response. There is no definite tendency in this 
direction. To some extent this can be explained by the 
fact that some of the patients would have responded well 
to the drug if it had been a placebo. A placebo 
response of 35.2 - 2.2% of cases was shown in a large 
variety of conditions by Beecher (1955). Previous 
studies of the treatment of depressive illness of 
neurotic type have shown even higher placebo responses 
(Greenblatt, Grosser and Wechsler, 1964). This could 
explain the association between low phenelzine levels 
and considerable antidepressant response which occurred 
in several cases but it cannot explain the association 
between high phenelzine level and very limited 
antidepressant response which occurred in 2 cases. One 
fast and one slow acetylator achieved relatively high 
levels of phenelzine but their antidepressant response 
was so limited that they were removed from the study 
at day 24 and given alternative treatment (see Appendix I) 
It therefore appears that high phenelzine levels do not 
necessarily lead to a marked antidepressant effect.
There is some tendency for tryptamine level Day 13 
to relate to antidepressant response (Figure 19). In 
this figure the differences in modified Goldberg score 
may be seen to range from 4 to 23. The mean 
tryptamine level of those patients in whom the 
difference in modified Goldberg score is between 4 
and 13, is 68.3 (SD. 24) and the mean tryptamine level
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of the patients in whom the difference in modified 
Goldberg score is between 14 and 23 is 92,1 (SD. 54.8)
(p N.S.). There are however some cases in which % 
relatively high tryptamine excretion is associated 
with a relatively poor antidepressant response. There 
appears to be little relationship between monoamine 
oxidase inhibition as measured by urinary tryptamine 
excretion and excretion of free phenelzine. Some 
patients achieved high urinary tryptamine levels with 
relatively low phenelzine levels and some, despite 
high phenelzine levels, continued to show low 
excretions of tryptamine. This tends to suggest that 
the sensitivity of monoamine oxidase to inhibition by 
MAOIs is not constant throughout the population. There 
is no clear tendency for the presence of side effects 
to relate either to phenelzine excretion or tryptamine 
excretion (Figures 24 and 25).
m  cam usxm
These studies were conducted with a view to examining 
the hypothesis that the monoamine oxidase inhibitor drug, 
phenelzine, is metabolised by polymorphic acétylation and 
that therefore the results of its administration, 
including level of drug achieved, antidepressant effect, 
side effects and inhibition of mono amine oxidase, would 
depend upon the acetylator phenotype of the subjects.
To this end two studies were conducted to examine the 
effects of phenelzine and relate them to acetylator 
status in a total of one hundred and two neurotically 
depressed patients. It was predicted that if the
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hypothesis were true.
1) Slow acetylators would derive a greater 
antidepressant response than would fast.
2) The difference between response to phenelzine 
and to placebo would be greater in slow 
acetylators than in fast.
3) Side effects would be greater in slow 
acetylators than in fast.
4) Monoamine oxidase inhibition would be greater 
in slow acetylators than in fast.
5) Higher phenelzine levels would be obtained 
in slow acetylators than in fast.
Significant differences in the expected direction were 
demonstrated regarding all predictions save that about 
side effects concerning which the results were certainly 
not contradictory to the hypothesis. The hypothesis 
can therefore be said to have been shown to be correct. 
The demonstration that the effects of phenelzine are 
dependent upon acetylator status is of some practical 
importance. For fast acetylators phenelzine is not 
significantly more effective than placebo. Prior 
determination of acetylator status could prevent the 
giving of this moderately toxic drug to patients it is 
milikely to help. At present MAOIs are not drugs of 
first choice in the treatment of depressive illness. 
Tricyclic antidepressants have been shown to be more 
effective when given to an unselected population 
(Clinical Psychiatry Committee, 1965) and they do not
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necessitate dietary restrictions, The comparative 
efficacy of tricyclic and MAOI antidepressants in slow 
acetylators is unknown and it may foe that in these 
patients MAOIs might foe effective enough to justify a 
more widespread use than has hitherto been the case.
The results are also of theoretical importance.
As previously mentioned the uncertain antidepressant 
efficacy of MAOIs casts doubt upon the monoamine theory 
of the affective disorders for which the evidence is 
less than entirely convincing. The present findings 
offer an explanation for the variability of the results 
of previous studies •* naraely that the populations have 
not been controlled for acetylator status - a factor 
which is highly relevant to the effects of the drug.
These studies show that phenelzine, a drug which is 
capable of increasing levels of monoamine in the brain, 
is an effective antidepressant in cases in whom it is 
not metabolised too quickly. The finding of increased 
earlier inhibition in slow acetylators and the 
relationship shown between tryptamine excretion and 
antidepressant response suggest that phenelzine does 
act by inhibiting monoamine oxidase. These findings 
give evidence to support the monoamine theory of 
depressive illness and strengthen the idea that these 
disabling disorders have a biological cause which is 
at least potentially reversible.
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The monoamine theory of depressive illness postulates 
that depression is associated with a deficiency of 
monoamine transmitter at synaptic sites in the brain.
The evidence for this is in two sections. Some is based 
on pharmacological studies and some on more direct 
studies of monoamines and their metabolites. Different 
workers have tended to find rather conflicting results 
in the direct studies of monoamines. The pharmacological 
evidence concerns the fact that both main groups of 
antidepressants, the tricyclics and the monoamine oxidase 
inhibitors have properties which enable them to increase 
the amount of monoamine available at synapses. That 
tîiese drugs elevate mood by increasing the amount of 
monoamine at synapses and not by means of some other 
property is not established. The evidence that tricyclics 
are effective antidepressants is convincing. It would be 
technically impossible to demonstrate that in depressed 
patients these drugs act as antidepressants by means of 
increasing the amount of monoamine at synaptic sites.
The ability of MAOIs to increase the amount of monoamine 
available at synaptic sites depends upon their property 
of inhibiting monoamine oxidase and it is possible by 
various means to assess the degree of inhibition of 
monoamine oxidase in depressed patients, That the 
antidepressant efficacy of MAOIs is related to the 
degree of inhibition of monoamine oxidase that they 
produce is not established and indeed the evidence 
that they are effective antidepressants is less than
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convincing. The results of different workers are very 
variable. It appears that some patients respond and 
some do not and it has not been possible to differentiate 
these groups on clinical grounds. Several MAOIs are 
hydrasines. Other hydrazine derivatives have been shown 
to be metabolised by acétylation, a mechanism for which 
there is genetic polymorphism. The clinical effects of 
these drugs have been shown to relate to acetylator 
status. The studies discussed here were undertaken to 
examine the hypothesis that phenelzine, an MAOI which is 
a hydrazine derivative, is metabolised by acétylation 
and that the effects of this drug are dependent upon the 
acetylator status of the patient. It was predicted that 
if the hypothesis were true:
1) The antidepressant effect of the drug would foe 
greater in slow acetylators than in fast.
2) The difference between the efficacy of phenelzine 
and placebo would be greater in slow acetylators 
than in fast.
3) The side effects of phenelzine would foe greater 
in slow acetylators than in fast.
4) Slow acetylators would achieve a greater degree 
of inhibition of monoamine oxidase than would 
fast acetylators.
5) Slow acetylators would achieve higher levels of 
free phenelzine than would fast acetylators.
Two studies were carried out to examine this hypothesis. 
The first was a double-blind crossover trial of phenelzine 
/placebo in 72 neurotically depressed outpatients. The 
active drug was given for 3 weeks, the dosage being 15 mg.
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toi,de in the first week and 30 mg, t*i,d, in the 
subsequent 2 weeks. In this study phenelzine was shown 
to he significantly more effective as an antidepressant 
in slow acetylators than in fast. It was demonstrated 
that for fast acetylators phenelzine is not 
significantly more effective than placebo but that for 
slow acetylators it is more effective to a highly 
significant degree. Ho significant differences regarding 
side effects were established between the two groups.
The second study concerned 30 neurotically depressed 
inpatients, all of whom were treated with phenelzine 
30 mg. t.i.d. for 3 weeks• In this study phenelzine 
was again shown to be significantly more effective as 
an antidepressant in slow acetylators than in fast.
Slow acetylators achieved significantly greater levels 
of inhibition of monoamine oxidase than did fast and 
slow acetylators excreted significantly more free 
phenelzine than did fast. Again no significant 
differences were established between the two groups 
with regard to side effects.
All of the predictions except that about side 
effects were shown to foe correct and the hypothesis 
may foe said to foe confirmed. It is held that it has 
been established that phenelzine is metabolised by 
polymorphic acétylation and that the clinical effects 
of the drug depend upon the acetylator status of the 
patient, It may reasonably be suggested that neglect 
of this factor is responsible for the variable results 
of previous trials of this and similar drugs. These
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studies have established that in patients who do not 
metabolise them too quickly, monoamine oxidase inhibitors 
are effective antidepressants and that to some extent 
their antidepressant efficacy is related to inhibition 
of monoamine oxidase. These findings are consistent 
with the theory that depression is associated with a 
deficiency of monoamines at relevant sites.
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Score Week 3 
fast acetylators 
placebo






































FiüDlFJEO GOLDBERG SCORE 
ræan difference 
wîc 0 - m  3
MODIFIED GOLDBERG SCORE 
mean difference 
Hit 3 - Wk 6
Fasts
(on placebo) 8.13 0,6
Slows
{on placebo) 7.13 1.0
TABLE 13
Score Week 3 Score Week 3
fast acetylators slow acetylators
drug drug
N ^ 10 W « 16
M « 5.8 M « 2,18
SD = 4.55 SD - 2.48
t = 2.19 p <0.05 (2 tailed)
p (0.025 (1 tailed)
In view of the fact that a prediction has been made the use 
of the one tailed test is permissible and this is used 
throughout the stu<% witii reference to ccaiparisons about 
v^ch a prediction Irias been made.
TABLE 14
Week 3 ™ Week 6 
{difference)
fast acetylators drug





































t = 1.39 (non significant)
TABLE 16





















p {0.0025 (1 tailed)
TABLE 17
INDIVIDUAL SIDE EFFECTS














Headaches 9 8 5 3 4
Lnsotmia 7 4 5 7 4^ T *
Agitation 6 6 3 2 4^
Treoor 4 4 2 5 ^ f *
Seizures 0 0 0 0
Ataxia 3 5 6 4
Ghoreifom
iHovements 0 0 0 0
Fatigue 10 13 11 9 4^ *
■?^ thy 10 8 6 4 4
Irritability 9 8 5 4 4/
Sadness 15 14 10 5
Ltpotence 0 0 0 0
\i/ I'*Sweating 7 5 1 4
Nausea 7 6 6 5
Constipation 3 4 4 9 T*
Faint/Dizzy 1 4 5 10
Micturition
difficulty 0 0 0 1
/h *
Blurred
vision 0 1 3 2
Hyperpyrexia 1 1 1 1
Hot flushes 3 3 3 3
Palpitations 5 4 4 4 4^
Diarrhoea 4 4 4 0 4/
Rashes 1 0 0 0 4^
Jaundice 0 0 0 0
TABLE 16
ÏNDÏVDÜAL SIDE EFFECTS
FAST ACETYLATORS ACTIVE DRUG 2nd
SYMPTOM TOTAL TOTAL TOTAL TOTAL TENDENCY
SCORE SCORE SCORE SCORE
Week 0 Week 4 Week 5 Week 6
Headadies 20 12 13 12 4/ *
Insonnia 24 12 14 16 *
Agitation 20 9 7 1 4/
Tm'flor 16 6 8 6 \p 4^ *
Seizures 0 0 0 0
Ataxia 10 5 15 13 t 4^ *
Oioreifom
moveænts 0 0 0 0
Fatigue 25 11 20 11 4/ 4^  *
%atljy 22 3 8 4 4 4^  *
Irritability 26 5 5 1 4/
Sadness 32 8 8 4 4/
Lïpo'tence 0 0 0 0
Sweating 16 9 8 9
Nausea 8 8 8 1 4/
Constipation 6 2 5 6 s|/ ^  *
Faint/Dizzy 8 6 14 12 4//^  *
iilcturitian
difficulty 3 3 1 5 • *
Blurred
vision 7 4 9 7 4/1 *
Hyperpyrexia 3 3 3 3
Palpitations 10 ■ 10 10 7 4/
Hot Fluslies 12 12 9 8
Diarrhoea 3 3 2 2
Rashes 3 1 1 1
Jaundice 0 0 0 0
TABLE 19
INDIVIDUAL SIDE EFFECTS














Headadties 9 8 6 7
Inscmiia 8 5 6 5
Agitation 11 8 6 1
Tremor 11 6 6 9 \|/ 4^  *
Seizures 0 0 0 0
Ataxia 5 4 12 4 \[/ 4^  *
Choreifom
raovercents 1 1 1 1
Fatigue 18 15 17 9 4/ ^  *
Apathy 16 13 7 5
Irritability 15 11 3 2
Sadness 23 15 8 3
lïïpotenœ 0 0 0 0
Sweating 13 11 7 7
Nausea 5 5 3 2
Constipation 3 4 9 7 /|\ *
Fadnt/Diz^ 5 7 11 7 *
Mcturitiai
difficulty 1 0 3 0 4/ 4^  *
Blurred
vision 4 8 6 10
Hyperpyrexia 1 1 1 1
Palpitations 7 4 4 4 4/
Hot Flushes 10 9 6 4 4/
Diarrhoea 1 1 1 0 4
Rashes 1 1 1 1
Jaundice 0 0 0 0
TABLE 20
INDIVIDUAL SIDE EFFECTS














Headaches 18 10 14 13 * 4^  4'
Insamia 23 11 12 12
Agitation 22 9 7 4
Tremor 11 8 8 10 * >1/
Seizures 0 0 0 O
Ataxia 6 4 20 10
Qioreifom
movements 0 0 0 0
Fatigue 27 12 16 12 *4, t
%athy 26 6 10 10 * 4/ 'f
Irritability 28 12 8 5 4/
Sadness 36 12 10 5
Icipotence 2 0 0 0 \k
Sweating 14 11 13 13 4^  *
Nausea 12 10 10 10
Constipation 9 3 6 9
Faint/Dizzy 9 9 18 17 /fv *
Micturition
difficulty 1 0 3 7 4/ t  *
Blurred
vision 8 2 14 10 4/ /h *
Hyperpyrexia 2 2 2 2
Palpitations 10 4 3 2 4/
Hot Flushes 11 7 7 7 4k
Diarrhoea 7 3 3 3 4/
Rashes 4 2 1 1 4'
Jaundice 0 0 0 0
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individual symptoms on side
SYMPTOM Wk 0 Wk 1 Wk 2 Wk 3 Wk 3h Tendency
Headaches 21 10 10 10 1
Insomnia 21 11 8 9 1 'r *
Agitation 20 9 9 5 2
Trattor 12 9 7 9 7 \i/1 *
Seizures 0 0 0 0 0
Ataxia 4 12 13 12 6 *
Choreiform
movements 4 1 1 1
Fatigue 27 22 18 11 8 4^
i^thy 27 19 9 5 4 4/
Irritability 26 14 5 2 1 -4/
Sadness 28 17 6 3 3 4
3ïcpotence 0 0 0 0 0
Sweating 14 5 5 9 8 4 /) ' *
Nausea 12 5 5 2 0
Constipation 12 12 17 18 12 /f- *
Faint/Dizzy 8 11 9 13 3 it
Micturition
difficulty 3 4 ' ■ 3 4 2
A
Blurred
vision 8 9 8 10 5
^  *
Hyperpyrexia 0 0 0 0 0
Palpitations 8 8 6 5 3
Hot Flushes 6 4 3 3 3 4
Diarrhoea 1 I 0 0 0 4/
Bashes 2 2 2 0 0 4/







individual symptoms on side
SYMPTOM W3c 0 Wk 1 Wk 2 Wk 3 Wk 3% Tendenc]
Headaches 23 6 5 2 0 4
Insomia 22 12 11 9 11
Agitation 15 8 6 4 4 4
Tremor 12 6 4 4 4 4
Seizures 0 0 0 0 0
AtædLa 8 13 12 12 8
Cîloreifom
movements 0 0 0 0 0
Fatigue 28 21 17 16 12 4
Apathy 22 19 11 8 7 4
Irritability 20 13 7 3 3 4
Sadiaess 31 22 11 5 6 4/
Impotence 0 0 0 0 0
abating 24 9 8 12 8 4  t*
Nausea 11 9 4 1 0 4
Constipation 5 2 9 9 6 /f\*
Faint/Dizzy 10 16 13 12 6 *
Micturition
difficulty 0 1 1 5 1
^  *
Blu3.”red
vision 6 8 10 3 1
*
Hyperpyrexia 0 0 0 0 0
Palpitations 10 8 5 4 1
Hot Flushes 10 5 4 4 1 4
Diarrhoea 3 2 0 0 0 4
Rashes 2 0 0 0 0
Jaundice 0 0 0 0 0
t i l l
nil
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URINARY TRYPTAMINE EXCRETIONS OF TOTAL SAMPLE AS COMPARED 
WITH THOSE ON WHOM COLLECTIONS WERE ACTUALLY MADE ON THAT DAY.
GROUP STUDIED
Slew Acetylators, Day 3 
patients vôiose oolleetion was 
niade on tiiat day.
MEAN TRYPTAMINE EXCRETION 
jug/2 4 hr s.
59.7
Slew Acetylators. Day 3 
total sanple 60.4
Slow Acetylators. Day 13 
patients viiose collection was 
iwade on that day
103.9
Slow Acetylators. Day 13 
total sanple 99.5
Fast Acetylators. Day 3 
patients whose collection was 
made on tiiat day
60.4
Fast Acetylators. Day 3 
total sanple 60.8
Fast Acetylators. Day 13 
patients cdiose collection was 
made on tiiat day
70.5
Fast Acetylators. Day 13 
total sanple 69.9
Figure 1
Symptom Areas ** Standardised Psychiatric Interview 

























EXCESSIVE CONCERN WITH BODILY FUNCTIONS
DEPRESSIVE THOUGHT CONTENT
B'lgure 3

























OTHER (i.e. any complaint not mentioned 
volunteered by patient)
FIGURE 4
FAST A CETYLATORS Drug 1st
NUMBER
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Nside Effects Score (8 Symptom version) 




Urinary tryptamine in^g/24 hrs







difference between tryptamine excretion on 




























M  COd g
(D H pj mm
urinary tryptamine excretion ^ g/24 hrs,






































■urinary tryptamine excretion pg/24 hrs.























Pft Hi ( t
CO H- H-1_J b 0
0 H- P b
s: bP
M
yp W H-n I-* O %m P 0
rt < H tr
< P P p
H M m P
P P s:rt p




























































tj*fD p H y 
IQ Pj
W Pj O H- 
O Ml 
H Ml 














































s: tf 0CD P
p) a cno CD bCD H Jb!'
rt N











cf wpj Hi 
k; Hi (D






rl.t . ' P'
;i :l: ■ fi
p:r'-:v : ■' «
pÿ|:: : m
ft-•■; •; .m ^
(O
t:— V-:-- ■■ O
r : ;• O






tryptamine excretion p.g/24 hrs.
^  ^  .
o
O  AOO 0 X 
0 X X











































Naans AGB j&CBTYId&TOR 2HB&TUB




The patient complained of a "feeling that things she 
had done were never right"* She was unable to cope 
with her responsibilities, could not enjoy herself and 
wept all the time.
HISTORY OF PRESENTING COMP&AINT
The patient's symptoAts had developed 2-3 years before 
she was referred. There was no precipitant at that time 
but she had definitely deteriorated since the birth of 
her infant son 11 months prior to her attendance at the 
clinic. She had a constant feeling that something 
unpleasant was going to happen. She was not coping with 
her housework. She felt tired all the time and was 
distressed that she did not have the energy to play with 
her baby in the way that she felt she should. Her 
sleep was very poor - she repeatedly got up to make sure 
that the baby had not died in his cot. She was very 
irritable and difficult with her husband and her 
daughter. Her concentration was extremely poor and she 
could neither knit nor read nor sew. She could not make 
meals or shop efficiently. She was consistently in low 
spirits and wept a great deal. Her view of the future 
was uncertain rather than hopeless and she was not 
contemplating suicide as she felt she owed it to her 
husband and family to try to recover. She was never free 
from anxiety although she realised that her worries were 
trivial. She had become apprehensive about being alone 
in the house and about going out by herself. She had 
become preoccupied with the idea that people did not 
want her and were shunning her. She realised that this
Appendix 2
idea was baseless but could not get it out of her 
mind. She also thought a good deal about the behaviour 
of her first husband and blamed him for the way that 
she felt. Self-blame was not a feature of her illness. 





Dyspepsia of unknown cause 16 years previously.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil*
PERSONAL HISTORY
The patient was born and brought up in Glasgow, the 
younger of two daughters of a blacksmith, who died when 
the patient was seven years of age. Her own childhood 
was rather deprived an her mother had to work long 
hours in an unskilled occupation to support her 
daughters after the death of her husband. As a child 
the patient was regarded as nervous and highly-strung 
and was afraid of the dark. She attended a Junior 
Secondary School and left at 15 years of age. She 
quite enjoyed school and di# fairly well. She worked 
in a tobacco factory until she was married, for the 
first time, at the age of 19 years. Her first husband 
was a violent man and a heavy drinker. The marriage 
was never a success and ended in divorce after six 
years. After the birth of her daughter in the second 
year of her first marriage the patient worked full-time 
as an instructress in an electronics factory and she 
had continued in this employment until after she was 
married for the second time in 1969. Her second 
husband was an engineer, 3 years older than herself.
3wh# ha# aot ly mm m&rælage
wm& d#00#lh8# &8 vo#y hap## am^ had oa# $#a,
agmd month#* ^#8* Mf had ihle oh&l# as a
duty to ho# h#&ha#d æatho# than hm#am#a #h# w&#t#d 
a $egaa# Ob&Iê and w#& aft## he wa# he##*
They had m# Th^y lived &n
the Co#0o##ti#& #lat #h# mad h$# ha#
A,'ûfo#e tW ^ woad Km##iage* Thla 
at;G'.:'r:;':odau,loa waa c#a%#d am# in a p w ^
(iic . was aamiow W  w v e  awy* The
patient had alwaya h^e# an# had al?waya
W e n  inoilai#3d to foBl that people t m w  against her#
8 W  had 0%%joyod he# wo#3s la the faowry an# v#^y muoh 
the coBipmny the other wme# t W w #  8ho 
did mot "IIW hajag h<mo all day M #  her ohlM#
Burlmg t W  pa#t yea# #$# had had
'^Prothiadw*^ 1 cmpml# t.4#d*
1# mg#
Ma#epam $
$<ow M  had prodwed any a W  when $he
attended t W  eh^ h M  aWpped imklag all of them*
^he #mohe# 10 olgarettea po# day#' Bhe d M  not drink*
i'!'i ,ii L'itu',j
&. f f- f* sw ,A I * ^ *r »’■>«**"■^‘■'‘>-•‘1
Bhe presented as depressed and tmmo* ($he was 
sm%ewhat guardW in Witat she saM. Otherwise tliere 
was w  ahaomiallty 1# he# mental state#
Phyeloally # e  entirely well#
Barlm# ho# oonroe of phwelalne she had no oWie#
At the tl%e of the initial aewssmemt he# eoow 
on the ne%^#c^lo/eRdegemoue rating was #) *
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 33: 3% + 4 3^  + 8
Depression 3 3 2 1 1 1
Anxiety 4 4 2 2 3 2
Phobias 2 2 2 2 1 1
Obsessions 2 2- 1 1 2 0
Depressed 3 3 2 1 2 1
Anxious 3 3 2 2 2 2
Overall
severity 23 23 15 12 15 10
Tte patient's response was always limited and she deteriorated 
fnrkher after the cessation of the drug. She was therefore ranoved 
£mu the stu% and treated with E.C.T. and tricyclice. She improved 
W t  at best was tense, oversensitive and had a poor stress toleranoe#
MODIFIED 8IDB EFFECTS SCORE
0 1 2 3 33:
insomnia O 1 2 2 2
tremor 0 1 1 1 1
ataxia 1 1 1 1 0
sweating 1 1 2 1 1
constipation 0 0 0 0 0
faints/dizziness 1 I 0 1 0
micturition difficulty 0 0 0 0 0
blurred vision 1 1 0 0 0
Other 0 o 0 0 0
lotal 4 6 6 6 4
Appendix 5
m M E  AGE ACETYIATOR STATUS
Mrs. M.B. 32 Fast
PRESENTING COMPLAINT
The patient said that for two years she had not been 
the bright, cheerful person that she had been formerly 
and that eight weeks previously she had suddenly 
developed the idea that she was going to die and had 
since been unable to stop crying.
HISTORY OF PRESENTING COMPLAINT
This lady's acute symptoms were superimposed on a 
more long-standing state of vague despondency. There 
was no obvious precipitant* Her main symptom was a fear 
that she had cancer and was about to die. She realised 
that this preoccupation was unreasonable. She felt tired 
all the time and the simplest task was an effort. She 
was spending a great deal of the day in bed for this 
reason. Her sleep was not impaired. She was irritable 
and quarrelled with her husband for no reason. She kept 
weeping and could not control this. She did not feel 
hopeless and had no suicidal ideas. Guilt was not a 
marked feature although she was aware that she had 
neglected her responsibilities since she had become ill. 
She felt constantly anxious about trivia and in addition 
to her fears about her own health, she was afraid that 
her children would die and kept going into their rooms 
at night to make sure that they were breathing. She 
had become unable to go out alone because of her fears 
of death and had ceased doing her own shopping entirely. 
She had lost a stone in weight in six weeks and her 
appetite was very poor.
PAST PSYCHIATRIC HISTORY 
Nil.
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PAST MEDICAL HISTORY 
Nil.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil.
PERSONAL HISTORY
The patient was born and brought up in Glasgow, the 
eldest of four children of an engraver. Her parents were 
alive and well. Their home life was happy and the patient 
was an outgoing, friendly child. She attended Senior 
Secondary school and did well but insisted, against 
advice, on leaving at fifteen because all her friends 
were leaving. She became an office worker and worked 
successfully in this capacity until her marriage at 22 
years of age to a computer operator of the same age.
The marriage was said to be happy. Bhe had two daughters 
aged 6 and 2 years. The elder daughter was apprehensive 
and nervous and was unsettled at school. The patient 
described herself as always having been "nervous, jumpy 
and inclined to over-react" but she had never previously 
felt consistently depressed. She had numerous friends 
and led a fairly full social life.
DRUGS PRIOR TO ATTENDANCE
Diazepam 5 mg. g.i.d. for two weeks followed by 
chlordiazepoxide 10 mg. g.i.d. for two weeks followed 
by phanobarbitone 60 mg, t.i.d. All without effect.
She smoked 10 cigarettes per day,
Bhe drank spirits occasionally at social occasions.
AT INTERVIEW
She was rather tearful and despondent but her 
anxiety was a much more marked feature. She was very 
restless and constantly sought reassurance regarding 
her fears of malignancy. Otherwise her mental state
Appendix 7
was normal.
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs.
At the time of her initial assessment her score 
on the neurotic/endogenous rating was (4).
Appendix 8
MODIFIED GOLDBERG SCORE
0 0 1 2 3 33% 3:3 t 4 3^  + S
Depression 2 2 1 0 0 0 0 0
Anxiety 4 4 3 0 0 0 t0 1
Phobias 4 3 2 2 1 1 1 1
Obsessions 1 1 0 0 0 0 0 0
Depressed 2 2 1 0 0 0 0 0
Anxious 4 3 2 0 0 0 0 1
Overall
severity 23 20 12 2 1 1 1 4
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3%
insomnia 2 I 0 0 0
tremor 0 0 0 0 0
ataxia 0 1 0 0 0
sweating 2 0 0 1 0
constipation 0 0 0 0 0
faints/disziness 2 2 0 2 1
micturition difficulty 0 O 0 0 0
blurred vision 1 0 1 0 0
Other 0 0 Dry mouth 1
Dry mouth
1 0
Total 7 4 2 4 1
Days 2 and 12 substituted for Days 3 and 13 for 
tryptamine assessment.
Appendix 9
NAME AGE ACETYLATOR STATUS




The patient's symptoms had been steadily worsening 
over 2-2% years. He complained of a constant feeling 
of despondency, of a fear that "something dreadful" was 
going to happen and of a preoccupation with ideas of 
personal unworthiness.
HISTORY OF PRESENTING COmLAINT
Two events appeared to have precipitated this 
patient's symptoms. In 1971 he knocked down a child 
while driving his oar. The child was not seriously 
injured but the patient was very upset by this incident. 
Shortly afterwards he knocked his head against a plank 
while at work. He was not injured but he felt that this 
piece of carelessness showed that he was no longer 
competent at his job* From that time he became 
increasingly despondent and anxious. At the time of 
his presentation he had been off work because of his 
symptoms for about a year. He was in financial 
difficulties because he had refused to draw State 
benefits, feeling that he did not deserve them. He 
complained a good deal about headaches which he 
thought might indicate that he had had a brain tumour.
He felt tired and physically weak. His sleep was 
broken but this was a life-long trait which had been no 
worse since he had become ill. He felt low in spirits 
all the time and wept a good deal. His attitude 
towards the future was despondent but he had no 
suicidal ideas. He blamed himself for his condition 
and felt very guilty about injuring the child in the 
accident and about failing to support his family. He 
constantly felt anxious and any stress, however slight.
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caused him to feel panic stricken. He had begun to 
avoid social situations in case any argument might 
break out as he felt that this was something with 
which he could not cope. For this reason he could 
not go out into the street in case he met anyone he 
knew, had to get off buses unless they were almost 
empty and went out and paced the streets in the 
evening if relatives called. His appetite was poor 
and he had lost 1 stone in weight in a year.
PAST PSYCHIATRIC HISTORY 
Nil.
PAST MEDICAL HISTORY 
Nil,
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil.
PERSONAL HISTORY
The patient was born and brought up in Glasgow,
the second of four children of a lorry driver. He had
no neurotic traits in childhood. He attended an R.C. 
Junior Secondary school where he was an average scholar. 
He left at 15 years of age to be apprenticed as a 
shipwright. Until ceasing work because of his symptoms 
he had been employed by Upper Clyde Shipbuilders as a 
shipwright for ten years. He was married at 20 years 
of age to a girl of his own age. They had four
children. The marriage was described as happy. They
had a good deal of financial difficulty because of the 
patient's rather long illness and because of his 
objections to drawing sickness or unemployment benefit. 
He was not normally particularly anxious but all his 
adult life he had been very shy. He had no friends 
and made no attempt to make any. He had normally been 
in the habit of attending a few social functions in the 
company of his wife but since becoming ill had ceased
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to do so.
DRUGS PRIOR TO ATTENDANCE 
Diazepam 5 mg. t.i.d.
He smoked 20 cigarettes per day and drank alcohol 
occasionally.
AT INTERVIEW
He was very tense and he was depressed. He talked 
freely about his symptoms showing no psychomotor 
retardation. He was reluctant to speak much of the 
road traffic accident about which he felt guilty.
His guilty ideas did not amount to delusions and his 
belief that it was wrong to claim State benefits was 
of long-standing and was evidently shared by some 
other members of his family. There was no other 
abnormality in his mental state.
Physically he was entirely well*
During the course of phenelzine he was on no other 
drugs.
At the time of the initial assessment his score on 
the neurotic/endogenous rating was (4),
MODIFIED GOLDBERG SCORE
12
0 0 1 2 3 3*2 3% + 4 3*2 + 8
Depression 3 3 1 1 0 0 1 0
teciety 4 4 2 2 1 I 2 2
Bhobias 4 4 2 0 0 1 I 2
Obsessions 1 1 1 0 0 o 0 0
Depressed 3 3 2 1 0 0 1 0
Anxious 3 3 2 1 0 1 1 1
Overall
severity 24 24 14 7 1 4 8 6
modified SIDE EFFECTS SCORE
0 X 2 3 3^
insomnia 1 0 0 0 0
tremor 2 1 0 0 0
ataxia 1 1 0 1 1
sweatJUig 2 2 I I 1
constipation 1 1 2 0 0
faints/dizasiness 1 1 1 0 0
micturition difficulty 0 0 0 0 0
blurred vision 0 1 1 0 0
Other 0 o 0 0 0
3otal 8 7 5 2 2
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NAME AGE ACETYLATQR STATUS




The patient's symptoms began suddenly in 1971. She 
suffered a spontaneous, incomplete abortion followed a 
few days later by a haemorrhage which took place in a 
city store and caused her to lose consciousness. After 
this incident she felt tired, lethargic, low-spirited 
and apprehensive about going into public places. She 
brooded a good deal about the loss of this child and 
after a further spontaneous abortion in 1972 her 
symptoms deteriorated further. At the time of her 
presentation she complained of a constant preoccupation 
with sad thoughts. She thought a good deal about the 
possibility that she might have malignant disease and 
about her inadequacies as a housewife and mother. She 
was tired and lacking in energy and interest. Her 
sleep was fitful, she was easily irritated and her 
concentration had become poor. Her mood was depressed 
but her attitude to the future was not hopeless and 
she was certainly not suicidal. She said that she had 
a lifelong tendency to worry to excess, although she 
had a remarkably philosophical attitude towards the 
faraily's chronic financial difficulties. Her 
principal anxieties centred around the probable fate 
of her family if, as she feared, she was suffering 
from malignant disease. Her anxieties about going into 
public places had extended to a fear of being left 
alone and at the time of her presentation she was to 
some extent reluctant for her husband to obtain work.
Her appetite was poor but she had not lost weight.




Chronic dyspepsia of unknown aetiology*
FAMILY aiSTORY OF PSYCHIATRIC lIJLNBSS 
None #
PERSONAL HISTORY
The patient was horn and brought up in Glasgow* She 
was the only daughter of a labourer who was not in 
regular employment* She had 2 brothers, one older and 
one younger than herself* Their home life was described 
as happy although they were undoubtedly economically 
deprived* She had no neurotic traits in childhood*
She attended a Junior Secondary school where she was 
an average pupil* She enjoyed school and had many 
friends* She left school at 15 and thereafter worked 
in various factories until she was aged 19, when she 
gave up work because she was illegitimately pregnant*
She had hoped to marry the father of her child but he 
deserted her when he learned of the pregnancy* The 
child was brought up by the patient and her mother in 
the patient's parental home. After this daughter was 
born the patient only worked for short periods in 
part-time employraent. She married when she was 31 years 
of age, her husband being a single man of the same age. 
The patient * s daughter was thereafter largely brought 
up by her grandmother* The marriage was described as 
successful, although the patient's husband was
chronically unemployed. There were three sons of the
marriage, aged 10, 8 and 5 years and the patient had 
had spontaneous abortions in 1967, 1971, 1972* She 
and her husband both wanted more children* The 
patient * s mother died in 1970 and this was a 
considerable loss to the patient as she had always been 
dependent on her mother. She stated that she was
always inclined to worry to excess and to cope poorly
with adverse circumstances. In the past she had turned 
to her mother when in any difficulty. Although as a
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girl she was outgoing and sociable after the birth of 
her daughter she became seolusive and shy because she 
was ashamed of being an unmarried mother. She had 
few social contacts and no interests apart from her 
family and home.
DRUGS PRIOR TO ATTENDANCE
Diazepam 5 mg. q.i.d* «• this had no effect.
Doxepin 25 mg, t.i.d, for three months, finishing six 
weeks before her presentation,
Nitrazepam 10 mg. nocte.
The patient neither smoked nor drank.
AT INTERVIEW
She was mildly depressed and more severely anxious. 
She sought constant reassurance, particularly about her 
health. Her mental state was otherwise normal.
Physically she was entirely well.
During her course of phenelzine she continued to 
take nitrazepam 10 mg. nocte.
At the time of her initial assessment her score on 
the neurotic/endogenous rating was (1),
MODIFIED GOLDBERG SCORE
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O o 3^  3^+4 3h +
Depression 3 3 2 1 1 2 2 2
Anxiety 2 2 2 2 1 2 2 2
Phobias 4 4 4 3 2 2 2 2
Obsessions 1 0 0 0 0 0 0 0
Depressed 2 2 2 1 1 1 0 1
Anxious 3 3 2 2 2 2 2 1
Overall
severity 20 19 16 12 10 12 10 10
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3^
insomnia 2 0 0 1 2
tremor I 1 1 0 0
ataxia 1 1 1 1 1
sweating 1 1 0 0 1
constipation 0 0 1 1 0
faints/dizziness 1 1 1 1 1
micturition difficulty 0 0 0 1 0
blurred vision 1 1 1 1 1
Other 0 0 0 0 0
Total 7 5 5 6 6
agpenflis! 17
»» ÎB  AGE aCE'JlOAgOR GTATOS




She ocmplaimed that she had not felt well for 2-3 
year®. She complained of a feeling of pressure on top 
of her head which she felt slowed her down mentally.
She felt depressed and weepy and nervous and had not 
been able to work for two months.
HISTORY OF PRESENTING COMPiaiNT
The patient's symptoms had bean vary much worse in 
the past eight weeks although they had been present to 
some extent for a considerable time before that, No 
precipitant was detected* On questioning she explained 
that she felt constantly tired, slept poorly, was 
inclined to be irritable with the fmiily, concentrated 
very badly and had lost interest in everything, to such 
an extent that she could not foe bothered to keep tidy, 
wash her hair, etc. She felt very low in spirits and 
wept a good deal* She was despondent about the future 
and would not have cared if she had died although she 
had no intention of harming herself. She worried a 
good deal about her own future, about the health of her 
aged parents and about the future of her illegitimate 
son, 1er appetite rmminod constant and she had not 
lost weight.
PAST PSYCHIATRIC HISTORY 
Nil,
PAST mOICAL mSTORY 
Nil<
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FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil,
PERSONAL HISTORY
The patient was born and brought up in Glasgow, the 
youngest of three daughters. When she was a child her 
father was a regular serviceman but he was later employed 
as a joiner. Both parents survive, now being in their 
seventies. She attended a junior secondary school where 
she was an average pupil. She worked as a sales 
assistant in ladies gown shops for some years. When she 
was 23 her illegitimate son was born. The child's 
father was a negro and the fact of the patient being 
the unmarried mother of a child of mixed race caused a 
family upset which had never really settled. The patient 
regretted not having married her son's father and wished 
that she had not yielded to family pressure on this score. 
After the birth of her son the patient took up factory 
work, the child remaining in the family home being cared 
for by the patient's mother. In the five years prior to 
her attendance the patient had worked as a waitress.
The patient lived with her son and her aged parents in 
a decaying part of the city where most of the population 
was elderly. There was a good deal of strife in the 
house, particularly between the patient and her father.
Her social life was somewhat restricted although she did 
visit her married sisters a good deal at the weekends.
She did not regard herself normally as being anxious in 
nature and said that she usually had no problems in 
coping with her difficulties.
DRUGS PRIOR TO ATTENDANCE
Diazepam 5 mg. t.i.d, off and on for three years.
She smoked 15 cigarettes per day and was in the 
habit of taking 1-2 measures of spirits on Saturdays only.
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AT INTERVIEW
She appeared depressed and self-blame was a prominent 
feature of her thought content. She was also very tense 
and rather restless. There was no other abnormality in 
her mental state.
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs.
At the tiïiie of the initial assessment her score on 
the neurotic/endogenous rating was (3).
MODIFIED GOLDBERG SCORE
Appendix 20
0 0 1 2 3 3-3 3^  4- 4 3^2 t 8
Depression 3 3 1 0 0 O 1 2
Anxiety 3 3 2 1 0 0 1 1
Phobias 0 0 0 0 0 0 0 0
Obsessions 1 1 1 1 0 0 0 0
Depressed 3 2 2 1 0 0 1 2
Anxious 3 3 1 1 0 0 1 1
Overall
severity 19 17 10 6 0 0 6 9

























































Days 5-8 and. Days 15-18 substituted for Day 3 and Day 13 
for tryptamine assessment.
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NAME AGE ACETYLATQR STATUS




Patient had felt depressed, unable to cope, and 
totally lacking in interest since the death of his 
wife two years previously*
HISTORY OF PRESENTING COMPLAINT
The patient's symptoms were clearly precipitated 
by the death of his wife from carcinoma of the breast 
two years before he attended the clinic. His wife 
had had a mastectomy ten years before she died and had 
had repeated courses of various forms of treatment, 
including radiotherapy and further surgery, over the 
next few years but the patient did not appear ever to 
have realised that her illness was likely to have a 
fatal outcome. His symptoms had steadily deteriorated 
and three weeks before he attended he had given up 
work because of them* He felt apathetic and listless.
He was intolerant of others and easily irritated* His 
concentration was so poor that he really could not 
attend to the simplest task and it was for this reason 
that he had given up his job, feeling that he could 
not do it properly because he could not concentrate*
He felt depressed all the time and any reminder of his 
wife made him worse* He wept constantly* He felt 
"unwanted, hopeless and useless" and wanted to die 
although he would not have committed suicide. He 
felt that without his wife the future was meaningless.
He had a lifelong tendency to worry but since her 
death he had worried constantly about the most trivial 
matters. He could not stop thinking about his wife *
His appetite was not impaired and he had not lost weight,
Appendix 22




FAMILY HISTORY OF PSYCHIATRIC ILLNESS
Nil.
PERSONAL HISTORY
The patient was born and brought up in Glasgow. He 
was an only child. His mother chronically abused alcohol. 
His father was an unskilled man and often unemployed so 
that the family was frequently in financial difficulty.
He performed poorly at school and left at 14. As a 
child he was anxious, shy and never had many friends.
The patient always worked in unskilled jobs but was 
clearly a reliable worker, holding down jobs for many 
years. He worked for 22 years in the dispatch 
department of a firm until giving up his job three weeks 
before attending hospital. He was married for the first 
time in his early 20*s. The marriage lasted for seven 
years until his wife ran off with another man. There 
was one son of this marriage but the patient had not 
seen him for many years. He divorced his wife for 
adultery and remarried in his early 30*s. His wife 
was four years younger. There were 2 sons of this 
marriage, aged 17 and 15. Mrs. W  . . had developed
carcinoma of the breast ten years before her death 
but despite increasing ill-health had apparently coped 
very well with her home and family# The patient did 
not anticipate her death and was very shocked by it.
He had never been well since. He had been shy and 
anxious all his life and had relied upon his wife's 
support in making the simplest decision. He had no 
hobbies or interests and had been accustomed to 
spending every evening at home in his wife's company.
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DRUGS PRIOR TO ATTENDANCE 
None.
The patient smoked 10 cigarettes per day. He did 
not drink at all.
AT INTERVIEW
lie presented as a very tense, tearful, despondent 
man with limited assets of intelligence and personality* 
His mental state was otherwise normal.
Physically he was entirely well.
During his course of phenelzine he had no other 
drugs.
At the time of the initial assessment his score 
on the neurotic/endogenous rating was (1).
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3% 3^  + 4 3*3+8
Depression 4 3 2 0 0 0 0 1
Anxiety 4 4 1 O 1 1 I 1
Ptoblas 0 0 0 0 0 0 0 0
Obsessions 2 2 1 0 1 0 0 0
Depressed 3 3 1 0 1 1 1 1
Anxious 3 3 1 0 0 1 1 1
Overall
severity 22 21 8 0 4 5 5 6
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3%
insomnia 0 0 1 1 1
tremor 0 0 0 0 0
ataxia 0 0 1 1 0
sweating 1 1 1 1 1
constipation 0 0 0 0 0
faints/dizziness 0 0 1 1 0
micturition difficulty 0 0 0 1 0
blurred vision 0 0 1 1 0
Other 0 0 0 0 0
Total 1 1 5 6 2
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The patient had been preoccupied with ideas of 
personal failure and despondency about the future for 
eighteen months. For the last four months he had been 
very much worse and was depressed, worried and unable 
to concentrate at all,
HISTORY OF PRESENTING COMPLAINT
The patient * s symptoms originally dated from 
Autumn, 1972. At that time he gave up a post as a
sales clerk as he could not cope with it. This
disappointed his family and caused the patient to 
feel that he was a failure. The later deterioration 
of his symptoms, four months before his presentation, 
appeared to be precipitated by the breaking off of
his engagement to be married. In addition to his
spontaneous complaints, questioning revealed that he 
slept poorly, wakened early, was irritable with his 
family and lacked confidence in all of his abilities.
His depression was marked, he wept a good deal and 
could see no hope for the future. He had thought 
about suicide but had no real suicidal intent. He 
was preoccupied with self-depreciatory ideas. His 
concentration was poor and he had no interest in any 
of his former pursuits. He had a life-long tendency 
to be over-anxious but felt that this had become worse.
He was avoiding social occasions but this was really 
because he wished to avoid admitting to acquaintances 
that he was unemployed and felt that they would be 
bound to discover this during conversation. His 
appetite was unimpaired and he had not lost weight.
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PAST PSYCHIATRIC HISTORY 
None.
PAST MEDICAL HISTORY 
None.
FimiLY HISTORY OF PSYCHIATRIC ILLNESS
None.
PERSONAL HISTORY
Patient was born and brought up In Glasgow, the 
elder of 2 sons of a fitter. The family life was 
described as happy. The family was Church-going and 
had high ethical and moral standards. In particular 
they regarded as important to work hard and improve 
one's lot in life by one's own efforts. From early 
childhood the patient was shy and a poor mixer. He 
attended a Senior Secondary school and did well most 
of the time. When he was fifteen he failed some 
examinations, lost confidence in his ability to cope 
academically and left school. He was apprenticed as 
a pipe fitter. He served his five year apprenticeship 
and then continued for a further four years with the 
same firm. He was then declared redundant with 50 
others because the firm was in financial difficulties. 
He had great difficulty in obtaining work and could 
not get a position as a pipe fitter* After some months 
of unemployment he took a job as a sales clerk. He 
always disliked this job and found it difficult*
After two years he gave this up and obtained a job as 
a labourer, feeling he was fit for nothing else. He 
worked in this capacity for six months but gave it up 
in March, 1973, and when he presented had been 
unemployed for ten months. He and his family regarded 
this as disgraceful. The patient had always been shy 
of the opposite sex but he had met the girl who became 
his fiancee in 1971 at work, in November, 1973 she
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broke off the engagement because he was unemployed.
This upset the patient very much. The patient stated 
that he had always been shy, solitary, a worrier and 
afraid of failure. He had few friends. His only hobby 
was reading books about the Second World War.
DRUGS PRIOR TO ATTENDANCB
In the ten months before he attended the patient 
had had
amitriptyline 25 mg* t.i.d,
doxepin 25 mg. t.i.d, 
diazepam 5 mg. q.i.d.
None of these had produced any improvement and in the 
three weeks before attending he had stopped taking all 
tablets.
He did not drink alcohol and smoked 10 cigarettes per day,
AT INTERVIEW
H© presented as a very neat and extremely polite 
young man. He rather lacked spontaneity and seemed 
reluctant to discuss his difficulties* He was quite 
markedly depressed and initially seemed lacking in hope 
for the future but was brightened by the offer of 
treatment. Otherwise his mental state was normal.
He was physically entirely well.
During his course of phenelzine he had no other 
drugs.
At the time of the initial assessment his score 
on the neurotic/endogenous rating was (2).
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MODIFIED GOLDBERG SCORE
0 0 1 2 3 3*5 3h + 4 3^+8
Depression 4 3 3 3 2 2
Anxiety 3 2 2 2 1 1
Phobias 1 1 1 1 0 0
Obsessions 1 1 1 1 0 0
Depressed 3 2 2 2 I 1
zmxious 2 2 2 1 I 1
Overall
severity 19 15 15 13 7 7
The patient cleteiiorated after the 24tla day and was therefore removed 
frcm the study. He was placed in group psychotherapy and later 
treated with imiprandne and chloriprcmazina » His response was rattier 
slow but he returned to Wmt was thought to foa his previous ncaioal*
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 1 1 2 1 1
tremor 1 0 0 0 0
ataxia 0 1 1 1 0
sweating Ô O 0 2 0
constipation 0 0 0 1 1
faints/dizziness 0 1 1 1 1
micturition difficulty 0 0 0 0 0
blurred vision 0 0 0 0 0
Other 0 0 0 0 0
Ototal 2 3 4 6 3
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NAMB AGE ACETYLATQR 8TATU8
Mrs. J. McD. 44 Fast
OCCUPATION
Housewife/Supervisor in Biscuit Factory.
PRESENTING COMPLAINT
The patient complained that she felt she was getting 
into a muddle with everything, that she kept crying, that 
she sometimes just wanted to die and that she kept worrying.
HISTORY OF PRESENTING COMPLAINT
The onset of the patient's symptoms was indefinite but 
she thought it had been about five years previously.
During this period her symptoms had been present 
intermittently but in the three months befor her attendance 
they had been very much worse and the patient attributed 
this to the fact that her father was terminally ill.
During these three months she had not been at work and had 
not been going out because of her symptoms. She also 
complained of headaches, of profound lethargy, of marked 
insomnia and of irritability. She felt that her 
concentration had become so poor that she could not do 
anything properly. Her depression was constant and she 
cried every day. She felt hopeless about the future and 
had contemplated suicide. She felt that she was useless 
and thought that her lack of education had been a 
handicap to her husband. She had always been of an 
anxious disposition but since being ill had become much 
more so, to such an extent that she was never free from 
worry. She had become indecisive and brooded a good 
deal about her father's impending death.
PAST PSYCHIATRIC HISTORY
Until five years before her attendance she had had 
no symptoms suggestive of psychiatric disorder. In this 
five-year period she had attended her general practitioner 
on account of her symptoms of depression and anxiety and
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had been treated with minor tranquillisers. She had 
had a brief admission to a psychiatric unit eight 
months before this attendance,
PAST MEDICAL HISTORY 
Nil,
FAMILY HISTORY OF PSYCHIATRIC ILLNESS
Father has senile dementia,
PERSONAL HISTORY
The patient was born and brought up in Glasgow, one 
of six children, 5 daughters and 1 son. Her father 
was chronically unemployed and her mother supported the 
family by working as a hawker. She attended Junior 
Secondary school intermittently as her mother frequently 
kept her off to attend to the house or to help her with 
her hawking business. She left school at 14 and became 
a factory worker. She was married at the age of 20 to 
a joiner of 23. The marriage was described as happy.
They had two children, a son, now aged 23, who had 
tuberculous meningitis at the age of 7 and an orchidectomy 
for a testicular tumour when aged 17. Their daughter, 
aged 17, was well and gave no cause for concern. The 
patient's ^haband was in regular work and supported his 
family but the patient had returned to work ten years 
previously and had recently been promoted to supervisor. 
She had been to visit her sisters and father in the 
United States in the Summer of 1973 and felt that this 
had precipitated her deterioration as she had been 
very greatly distressed by seeing her father demented 
and ill and by the family quarrels which had taken place 
over who was to care for their father. When well the 
patient was very cheerful, gregarious and fond of 
social occasions. She was described as being extremely 
vivacious and talkative and the life and soul of the 
party. Normally she ran the home, coped with her job 
and had a full social life and helped her sister in 
the running of a stall at the local market. She was
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always anxious however and tended to over react to 
stress.
DRUGS PRIOR TO ATTENDANCE
Chlordiazepoxide 10 mg. t.i.d.
Nitrazepam 10 mg. nocte.
She did not smoke but took the occasional social 
drink.
AT INTERVIEW
The patient had a flamboyant manner but there was 
no doubt that she was markedly depressed. She was 
agitated and restless and talked at great length and 
under pressure. Otherwise her mental state was normal.
Physically she was entirely well.
During her course of phenelzine she continued to 
take nitrazepam 10 mg* nocte.
At the time of her initial assessment her score on 
the neurotic/endogenous rating was (4).
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MODIFIED GOLDBERG SCORE
O 0 1 2 3 3h 3*g + 4 3*3 t 8
Depression 4 4 2 0 0 0 O 0
Anxiety 4 4 1 0 0 o 0 1
Phobias 0 0 0 0 0 0 0 0
Obsessions 1 1 1 0 o 0 0 0
Depressed 4 4 1 0 0 0 0 o
Anxious 3 3 2 0 0 0 0 0
Overall
severity 23 23 lo 0 0 0 0 1
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 2 0 0 0
tremor 1 1 0 0 o
ataxia 1 0 0 0 0
sweating 2 0 0 0 0
constipation 2 0 0 0 0
faints/dizziness 1 0 0 0 0
mioturition difficulty O 0 0 0 0
blurred vision 0 0 0 0 0
Other 0 0 0 o 0
Total 9 3 0 o 0
Days 5-8 and 15-18 substituted for Days 3 and 13 
for tryptamine assessment.
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The patient complained that about three years 
previously she had begun to feel depressed# More recently 
she had felt increasingly lonely and more and more of a 
failure#
HISTORY OP PRESENTING COMPLAINT
The patient's symptoms clearly dated from the death, 
some three years previously, of her brother with whom she 
had lived. She had been depressed following this but 
with time this depression had deteriorated rather than 
Improved# In the year prior to her attendance she had 
become vary much worse « She had lost interest in all of 
her former pursuits and her concentration had become 
very poor. She had become preoccupied by the idea that 
she had failed her brother and perhaps caused his death. 
She felt very depressed and felt that she would be 
helped by weeping but could not weep. She thought that 
the future held nothing for her and that she would foe 
better off dead but she had no suicidal intent. Her 
sleep was poor but no worse than it had been for many 
years. She worried a good deal about trivia as well as 
important Issues but this was a lifelong habit. She 
had always been to some extent socially phobic and this 
had become rather worse. Her appetite had become very 
poor and she had lost 1% stones in weight over the past 
year#
PAST PSYCHIATRIC HISTORY
Lifelong tendency to excessive anxiety and attended 
general practitioner for anxiety symptoms over a twenty
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year period. 8he also had a long history of somatic 
symptoms of which the organic basis was ill-defined#
In 1967 her symptoms were so severe that she could not . 
work and she attended a psychiatric unit for a year, 
receiving group psychotherapy. She did not go back to 
work after this but retired at 54 years of age on 
grounds of nervous illness.
PAST MEDICAL HISTORY 
Appendioectomy 20 years ago.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil.
PERSONAL HISTORY
The patient was bron and brought up in Glasgow. Her
father was a heavy drinker and left the family when 
the patient was about 5 years of age. Her mother died 
when she was about 10 years of age. She had one brother 
sixteen years older than herself and was largely brought 
up by him. She was an average pupil at school and left 
at 14 years of age to become a cashier in a tobacco 
factory. She was employed there for 40 years but ceased 
working altogether at the age of 54 because of her chronic 
anxiety symptoms. Neither she nor her brother ever 
married and she kept house for him until his death three 
years before her attendance. About eight years before 
his death he became hemiplegic as a result of a oerebro- 
vascular accident and was cared for by the patient. He 
was by no means a total invalid during this time but was 
not fit to work. By all accounts the patient looked 
after him devotedly and had no reason to reproach herself. 
She had few friends or interests. All her life she had 
been shy and seclusive, had fussed about details and had 
been inclined to foe over-sensitive and easily hurt.
She has always been self-conscious about eating in 
restaurants. Despite these traits she had been a reliable
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and conscientious worker for years and normally 
maintained a high standard of housewifery, and 
entertaining among her limited circle of friends,
She had entirely ceased to foe able to carry out these 
activities.
DRUGS PRIOR TO ATTENDANCE
Diazepam 10 mg. q.i.d, )
Nitrazepam 10 mg. nocte ) three years.
She smoked 20 cigarettes per day and drank only on 
rare social occasions.
AT INTERVIEW
The patient was tearful and importunate. She was 
very garrulous. She was extremely indecisive and 
apprehensive. Her attitude towards the future was 
nihilistic and she could not foe reassured about the 
cause of her brother's death and her own part in this. 
There were no other abnormalities in her mental state.
Physically she was entirely well.
During her course of phenelzine this lady continued 
to take nitrazepam 10 mg, nocte as she had done for 
many years. She had no other drugs,
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (5),
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MODIFIED GOLDBERG SCORE
0 0 1 2 3 3% 3*2 + 4 3^+8
Depression 3 2 1 0 0 1 0 0
Anxiety 2 3 1 0 0 1 1 1
Phobias 1 1 0 0 1 0 0 0
Obsessions 1 1 1 1 0 0 0 0
Depressed 2 2 1 0 0 0 o 0
Anxious 3 3 1 1 1 1 1 1
Overall
severity 17 17 7 3 3 4 3 3
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 1 1 0 0
tremor 2 0 0 1 1
ataxia 1 1 1 1 1
sweating 2 0 0 1 0
constipation 0 0 0 1 1
faints/dizziness 1 1 1 0 0
micturition difficulty 0 1 1 0 0
blurred vision 0 0 0 0 0
Other 0 0 0 0 0
Total 8 4 4 4 3
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Patient oomplained that for five months she had felt 
low-spirited and weepy# She was lacking in energy and 
during this time had not felt able to work#
HISTORY OF PRESENTING COMPLAINT
The above features had developed to some extent for 
months prior to the patient*© giving up work and 
appeared to some extent to have been precipitated by 
the marriage of a female cousin who was really the only 
social contact of this isolated young woman# It was 
difficult to determine exactly when she last felt quite 
well# On direct questioning she said that in addition 
to the above symptoms, she had intermittent headaches, 
was irritable with her grandmother, felt anxious about 
trivia and felt apprehensive when out alone. She had 
become indecisive and brooded a good deal about the 
future with particular reference to how lonely ©he would 
be when her grandmother died* She brooded a good deal 
about her past failures# Although she was markedly 
lacking in hope for the future she had no suicidal ideation. 
Her appetite was unimpaired and she had not lost weight#
PAST HISTORY OF PSYCHIATRIC ILLNESS
Neurotic depressive illness treated with drugs on 
inpatient basis followed by a prolonged period of group 
psychotherapy,
PAST MEDICAL HISTORY 
Nil,
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FAMI&Y HISTORY OF PSYCHIATRIC ILLNESS
Patient's mother was a chronic attender at the 
psychiatric department suffering from a multiplicity of 
neurotic symptoms.
PERSONAL HISTORY
The patient was born in Glasgow. She was the daughter 
of her mother's first marriage which was never successful. 
She was brought up from infancy by her maternal 
grandmother. Her mother remarried and her second husband 
adopted the patient but she continued to live with her 
grandmother. She had one half sister, 15 years younger 
than herself* She coped reasonably wall at school but 
her social adjustment was poor from childhood and she 
had few close friends. She left school at 15 and had 
been employed as a filing clerkess. She had worked 
continuously for six years for the same firm until five 
months before this presentation, when she had stopped 
work because of her symptoms. She lived with her 
grandmother, aged 87* She had few interests or social 
contacts outwith her family.
DRUGS PRIOR TO ATTENDANCE
"Motival" 2 tablets per day for five months prior to 
attendance.
She smoked 10 cigarettes per day and drank only at social 
occasions.
AT INTERVIEW
She presented as anxious, apprehensive and indecisive 
and tearful. There was no other abnormality in her mental 
state.
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs.
At tlie time of the initial assessment her score on 
the neurotic/endogenous rating was (3).
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MODIFIED GOLDBERG SCORE
0 0 1 2 3 3^ 3% + 1
Depression 2 2 2 1 0 1 1
Anxiety 2 2 2 1 1 1 1
Phobias 2 2 2 2 1 0 2
Obsessions 1 2 2 1 0 0 1
Depressed 1 1 1 0 0 0 0
Anxious 2 2 2 0 0 0 2
Overall
severity 13 14 14 5 2 2 9
m  view of rapid relapse patient was removed froa follow-i;^  cue 
week after ompleticn of stu%.
MODIFIED BIDE EFFECTS SCORE
0 1 2 3
Insomnia 2 0 1 0 0
tremor 1 1 0 0 0
ataxia 1 2 1 1 1
sweating 2 0 1 1 1
constipation 0 0 1 1 0
faints/dis z iness 1 1 1 1 1
micturition difficulty 0 0 0 O 0
blurred vision 1 1 0 0 0
Other 0 0 0 0 0











The patient oomplained of tearfulness, restlessness 
and inability to cope with her domestic responsibilities. 
She was preoccupied with a multiplicity of vague somatic 
complaints which she feared indicated her impending death. 
She had become afraid of being in the house at night and 
would go out and pace the streets.
HISTORY OF PRESENTING COMPLAINT
The patient's symptoms were clearly precipitated by 
the death of her husband five months previously. Her 
husband had been known for years to have tuberculosis 
but was thought to be reasonably well and was able to go 
to work. He died one night of a severe haemoptysis.
Mrs* S was with him in the house when he became ill 
but was unable to get help before her husband died about 
15 minutes after he started bleeding. Three weeks before 
his death a gypsy had told the patient that her husband
was going to a place where he would be far, far happier
and that she would be going there too. The patient 
feared that the gypsy's prophecy had been fulfilled by 
her husband's death and she began to think that she was 
going to die and interpreted a variety of minor somatic 
complaints as evidence that this was so. She felt tired 
all the time and slept poorly. If she wakened through 
the night she would go out and walk the streets because
she could not tolerate the memories of her husband's
death. She felt that she was becoming impatient with 
her children and that her concentration and interest 
were failing. She constantly felt low-spirited and this 
feeling was worsened by circumstances which brought it 
home to her that she no longer had her husband to turn
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to. She wept a good deal and felt as if she would 
never be happy again but she had no suicidal intent.
She was becoming increasingly anxious and worried a 
good deal about trivia. She had a marked fear of 
being alone in her house and arranged for neighbours 
to come in during the day. She could not avoid 
thinking about her husband's death and going over the 
details of it in her mind. She was eating poorly and 
had lost a stone in weight since her husband's death.
PAST PSYCHIATRIC HISTORY 
Nil.
PAST MEDICAL HISTORY
"Back trouble" aged 16: 2 weeks hospitalisation.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil.
PERSONAL HISTORY
The patient was born and brought up in Glasgow, 
the youngest of four children of working class parents. 
Her home life as a child was happy but she was regarded 
by her mother as being "highly strung". No clear 
history of neurotic traits in childhood was obtained. 
She attended Junior Secondary school where she took 
domestic subjects. She left at 15 and worked for 
seven and a half years in the same box factory until 
her marriage at 23 to a man of 28 who was known to 
have drug-resistant tuberculosis. He remained 
relatively well until his death and worked regularly 
in unskilled jobs. There were three children of the 
marriage, aged 7, 6 and 2. The marriage was described 
as happy. The patient had no serious financial 
difficulties. She lived in a two-roomed flat without 
basic amenities in very old property. The patient was 
described as always having been of anxious personality 
and she had always been a dependent woman, relying on
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her husband to make even minor decisions for her#
DRUGS PRIOR TO ATTENDANCE
Chlordiasepoxide 10 mg, t.i.d.
She smoked 20 cigarettes per day and drank on 
social occasions.
AT INTERVIEW
She was tense, agitated and depressed. Her manner 
was a little histrionic and she was rather importunate, 
constantly seeking reassurance and support. Her mental 
state was otherwise normal.
Physically she appeared entirely well. She was 
investigated intensively for tuberculosis before being 
placed in the study.
During her course of phenelzine she had no other 
drugs.
At the time of her initial assessment her score 
on the neurotic/endogenous rating was (3).
Three weeks after her discharge the patient 
attended the clinic complaining of back and pubic 
pain. This was found to be due to osteitis pubis 
of non-tuberculous aetiology. She required inpatient 




0 0 1 2 3 3^ 3*2+4 3*2 + 8
Depression 3 3 3 2 1 1
Anxiety 3 3 2 2 1 1
Phobias 3 3 3 1 1 1
Obsessions 2 2 1 0 0 0
Depressed 3 2 2 1 1 1
Anxious 3 3 2 2 2 1
Overall
severity 23 21 17 11 9 7
MODIFIED SIDE effects score
0 1 2 3
insomnia 0 1 0 0 1
tremor 2 2 2 2 2
ataxia 1 2 1 1 0
sweating 2 1 1 2 2
constipation 2 2 2 2 2
faints/dizziness 2 2 2 2 0
micturition difficulty 0 0 0 0 0
blurred vision 1 1 1 1 0
Other 0 0 0 0 0
Total 10 11 9 10 7
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The patient oomplained of depression, irritability and 
loss of interest.
HISTORY OF PRESENTING COMPLAINT
The patient's symptoms had been present for 2 years 
and appeared to have been precipitated by her having a 
hysterectomy for menorrhagia. In addition to the above 
symptoms she complained of headaches, of anergia and of 
severe sleep disturbance. Her concentration had 
deteriorated so that she was burning meals, spoiling 
material when dressmaking, etc. Her depression was 
severe and constant. She wept a good deal, felt hopeless 
about the future and thought about suicide. She had in 
fact attempted suicide by self-poisoning one year and 
three months before being seen but said at the time of 
attendance that she had no siiicidal intent as she felt 
she must go on living to care for her children. She 
had always been inclined to be overanxious but she had 
lately become preoccupied with worries about her 
children to an extent that she realised was totally 
unreasonable. She had become afraid to go out. This 
was because she feared that she would "make a fool of 
herself" if people spoke to her. She had become 
indecisive even about trivial matters. Her appetite 
had become poor and she had lost 2 stones in weight 
in 2 years.




Appendiaectomy as a girl.
Hysterectomy for menorrhagia.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS.
Nil.
PERSONAL HISTORY
The patient was born and brought up in a poor area 
of Glasgow. She was the youngest of 13 children of 
an unskilled man. Only 6 of the children now survive. 
Their childhood was happy although they lived in very 
overcrowded, circumstances and were economically deprived. 
Despite her circumstances she did well at primary school 
and was granted a place in the top stream at the Convent 
of Our Lady & St. Francis where she did well. She left 
at fifteen because she wanted to work to bring money 
into the house, her father having died by that time.
She worked as a machinist until her marriage at 22 to 
a labourer of 24. The marriage was described as very 
happy and the patient and her husband appeared to have 
centred their lives around their family of 3 daughters, 
aged 13, 7 and 6 years, and 1 son, aged 11 years. The 
children were all well and gave no real cause for 
anxiety. They had no financial difficulties as the 
patient had always prided herself on being a good 
manager, doing all her own baking and making all of 
her own clothes and those of her three daughters.
She had been quite pleased about having the hysterectomy 
as she had conscientious objections to contraception 
but did not really wish to have a very large family.
She did not appear to have any guilt about this 
operation as there appeared to be no question in her 
mind that the operation might have been done for any 
reason other than medical necessity. Normally the 
patient was cheerful and very active. She and her 
husband belonged to social clubs connected with the
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Church and the patient served on the committees of 
these. She was a keen knitter, dressmaker and baker 
and also decorated her own home. She had always been 
inclined to be overanxious.
DRUGS PRIOR TO ATTENDANCE
Amitriptyline 25 mg, t.i.d. had been prescribed for 
months but she did not take it regularly.
When she attended she was having "Doxepin" 25 mg. 
g.i.d. without effect.
She was prescribed Nitrazepam 10 mg. nocte but did 
not take it regularly.
She smoked 10 cigarettes per day.
She did not drink.
AT INTERVIEW
She presented as very depressed with guilt and 
loss of hope for the future being prominent features. 
To a lesser degree she was agitated and tense. Her 
mental state was otherwise normal.
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs.
At the time of her initial assessment her score on 
the neurotic endogenous rating was (3).
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MODIFIED GOLDBERG SCORE
0 0 1 2 3 3*2 3% + 4 3% + 8
Depression 4 3 3 3 3 3
Anxiety 3 2 1 0 0 0
Phobias 2 2 2 2 2 2
Obsessions 1 1 1 I 1 I
Depressed 4 3 3 3 3 3
Anxious 3 3 2 1 1 1
Overall
severity 24 20 17 14 14 14
In view of her persisting significant depression this lady was
removed from the trial on the 24th day and given a course of ID 3CT
to #ich she made a partial response.
She was discharged and treated witîï hïdpraadne 50 mg. g.i.d. 
After 3 months on tliis she was well.
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 2 1 1 1
tremor 0 0 o 0 0
ataxia 0 1 1 1 1
sweating 2 0 0 0 0
constipation 0 0 1 1 1
faints/dizziness 2 2 1 1 0
micturition difficulty 0 0 0 0 o
blurred vision 0 1 1 0 0
Other 0 0 0 0 0
Total 6 6 5 4 3
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He complained of feeling depressed all the time, of 
loss of interest and of lack of confidence.
HISTORY OF PRESENTING COMPLAINT
His symptoms had been present for three years and had 
grown steadily worse during this time so that for the 
8 months prior to attending he had been unable to work.
He could describe no precipitant. In addition to his 
spontaneous complaints, on direct questioning he 
admitted to frequent headaches, to tiredness and lethargy 
and to indecision. He was not irritable, he slept well 
and did not feel any more anxious than usual. His 
appetite was unimpaired and he had not lost weight.
His depression was always present and was worsened by 
contact with other people. He was lacking in hope for 
tlie future and had thought about committing suicide.
He blamed himself for his illness.
PAST PSYCHIATRIC HISTORY
None until 3 years before this attendance. During 
tills 3 years he had attended several psychiatrists 
and had been given various treatments including E.C.T.
He had evidently derived no benefit.
PAST MEDICAL HISTORY 
Nil.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS
A sister had had a brief period of outpatient 
psychiatric attendance. There was no clear description
of her illness.
PERSONAL HISTORY
The patient was born and brought up in Kilmarnock, 
the second of four children of an office timekeeper.
His childhood was described as happy* He had no neurotic 
traits and got on well with his parents and siblings.
He attended senior Secondary school but left at IS* He 
was apprenticed as an electrician and completed his 
five-year apprenticeship. He thereafter worked on a 
contracting basis and travelled a good deal, both around 
Britain and abroad. He was unmarried and had no close 
friends of either sex. He had always been quiet, shy 
and lacking in confidence. After he became too unwell 
to work he went to live in his parents* home and was 
greatly distressed by his father's sudden death four 
months prior to his attendance at the clinic. There 
was no doubt that his symptoms had long antedated this.
DRUGS PRIOR TO ATTENDANCE
Over the three years of his illness he had had a 
variety of minor tranquillisers and tricyclic anti­
depressants. None of these had helped him. When he 
attended he was having Doxepin 25 mg. t.i.d. without 
benefit.
He smoked 20 cigarettes per day and spent about 
g3/week on alcohol.
AT INTERVIEW
He was taciturn and withdrawn. He was undoubtedly 
depressed but only very mildly anxious. Otherwise 
his mental state was normal.
Physically the patient was entirely well.
During his course of phenelzine he had no other 
drugs.
At the time of the initial assessment his score 
on the neurotic/endogenous rating was (3).
MODIFIED GOLDBERG SCORE
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O 0 1 2 3 3% 3»! + 4 3% + 8
Depression 3 3 1 1 0 1 1 1
Anxiety 1 1 2 1 1 O 1 1
Phobias 0 0 0 0 0 0 0 0
Obsessions 1 1 1 1 0 0 0 0
Depressed 3 3 1 1 0 1 1 1
Anxious 1 1 1 1 0 0 0 0
Overall
severity 13 13 8 7 1 3 4 4
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*3
insomnia 0 0 0 0 1
tremor 0 0 0 0 0
ataxia 0 0 0 0 0
sweating 1 0 0 1 1
qonstipation 1 0 1 o 0
faints/dizziness 0 1 1 1 0
mioturition difficulty 0 0 0 0 0
blurred vision 1 1 1 0 0
Other 0 0 Breathless1 0 0
Total 3 2 4 2 2








The patient stated that she had not felt well for 
a year but that she had deteriorated rapidly in the past 
three months. She complained of a feeling of pressure 
on her head and a choking feeling. She felt depressed 
and just wanted, "to lie and lie" rather than do 
anything. She felt as if she was shaking all the time. 
Because of these symptoms she had been off work for 
four months.
HISTORY OF PRESENTING COMPLAINT
There was no definite precipitant for her condition. 
For a year she had felt constantly tired and lacked 
interest in things. She had felt vaguely physically 
unwell during this time and in the last three months 
had had a frequent choking feeling which she was afraid 
was a sign of malignant disease. She had been thoroughly 
investigated from the physical point of view and had been 
told that she was well. She realised that it was 
ridiculous to continue to be preoccupied with a fear 
of malignancy but notitethe less brooded about this 
frequently. She was sleeping badly, wakening early 
after a restless night. She was very irritable and 
constantly picked quarrels with her daughter. She 
constantly felt low-spirited and wept a good deal. She 
felt despondent about the future and had wished for 
death although she had no intention of committing 
suicide. She had no guilty ideas and indeed tended to 
be extrapunitive. She worried a good deal about her 
children. This was a lifelong tendency but she could 
no longer put her worries to the back of her mind.
She had become apprehensive about being alone in the
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bouee in case she died and her daughter had therefore 
come to live with her. She was preoccupied with 
fear# of cancer and with thoughts of her dead husband 
and how she longed to fee with him. Her appetite was 
poor and she had lost a stone in weight in four months.
PAST PGyCHIATBIC HISTORY 
None.
PAST MEDICAL HISTORY
She had had surgery for a prolapsed lumb&r dise 
some years previously.
Dyspepsia ?due to peptio ulceration 20 years ago,
FAMILY HISTORY OP PSYCHIATRIC II&NB88 
None*
PERSONAL HISTORY
The patient was b o m  and brought up in Glasgow, 
the fifth of eight children of a butcher. The family 
was poor but their home life was happy. She was at 
various schools as the family moved about a good deal* 
8he left school at 13 years of age to keep house 
because of her mother's failing health. Her mother 
died when she was fifteen and she continued to care for 
the rest of the family until she was married at the 
age of 20 to a labourer of 23* Her marriage was 
described as extremely happy and the patient continued 
at the time of her presentation in 1073 to grieve for 
her husband who had died of a myocardial infarction 
in 1967. There were two children of the marriage, a 
son and a daughter, both married, the son living in 
London and the daughter in Glasgow* The patient 
worried a good deal about the financial circumstances 
of both her children, particularly the daughter who 
was inclined to get into debt as a result of hire 
purchase commitments * This was very contrary to the
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patient's teaching as she was entirely opposed to 
credit and took a pride in the fact that she had 
always managed to run a comfortable home on the modest 
wages provided by her father and her husband without 
being in debt on any occasion. She was very concerned 
about her daughter's foolishness over money and it was 
possible that her illness could have been precipitated 
by this to some extent, although this was by no means 
clear. Since her husband's death she had worked as a 
school cleaner and when well enjoyed the work. She 
normally visited a fairly wide circle of friends and 
in the company of other widows attended Church functions, 
She had no financial worries, She had always been a 
hardworking, rather obsessional woman who set high 
standards for herself and her family. She had relied 
a good deal on the company and support of her husband 
and being a reserved woman found it difficult to confide 
her worries to anyone at all after his death.
DRUGS PRIOR TO ATTENDANCE
In the year before she attended the patient had 
been treated with prochlorperazine {"Stemetil") 5 mg. 
t.i.d; clorazepate ("Tranxene") 15 mg. t.i.d. and
nitrazepam {"Mogadon") 10 mg. nocte. None of these 
had produced any improvement•
The patient neither smoked nor drank.
AT INTERVIEW
She was depressed, tense and lacked spontaneity. 
Otherwise her mental state was normal.
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs.
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (5).
MODIFIED GOLDBERG SCORE
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O O 3*2 3% + 4 3*3 + 8
Depression 4 3 3 1 1 1
Anxiety 3 2 2 1 1 1 Patient given
Phobias 2 1 1 1 0 1 E.C.T, at this
Obsessions 1 0 0 0 0 0 point.
Depressed 3 3 2 1 1 2
Anxious 3 2 2 2 2 2
Overall
severity 22 16 14 9 8 12
In of her failure to respaid the patient was rmioved frcm the 
study at Day 24 and given 8 E.C.T, This produced a significant 
iirprov^ fflent but she was not asy«ptcmatio.
MODIFIED SIDE EFFECTS SCORE
0 I 2 3 3*3
insomnia 1 0 1 1 1
tremor 1 0 0 0 0
ataxia 0 0 0 0 0
sweating 0 0 0 1 0
constipation 0 0 1 1 1
faints/dizziness 0 1 0 0 0
mteturition difficulty 0 0 0 1 0
blurred vision 0 0 1 1 . 0
other 0 0 0 0 0
Total 2 1 3 5 2
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The patient complained that despite the faot that she 
had no reason at all to be unhappy she had been depressed 
since the birth of her baby one year previously.
HISTORY OF PRESENTING COMPLAINT
The patient complained that during her second pregnancy 
she had felt tired and irritable but had attributed this 
to her condition. Since the birth of her baby these 
symptoms had worsened and she had begun to suffer from 
constant headaches, and to feel miserable most of the time. 
She wept a good deal and felt apprehensive about her 
ability to cope in the future but hirir attitude was by no 
means one of hopelessness and she certainly had no 
suicidal ideas* She worried a good deal over trivia but 
this was a life-long tendency. Her interest in her 
children had declined and she felt that she neglected 
them and was unreasonably irritable with them. She could 
no longer concentrate on television, reading or knitting 
and she felt too apathetic to go out socially with her 
husband. Her appetite was good and she had not lost 
weight.
PAST HISTORY OF PSYCHIATRIC ILLNESS 
Nil.
PAST MEDICAL HISTORY 
Nil.




The patient was born and brought up in Glasgow. Her 
father, a retired lorry driver, was 70 and her mother 
was 69, The patient was very much the younger of their 
two children, her only sister being 20 years older than 
herself. The patient had no neurotic traits in 
childhood and she described her home life as happy.
She attended a Junior Secondary school and left at 15 
years of age to become a clerkess. She worked in this 
capacity until her marriage at 24. She was pregnant 
on marriage. She had always felt very guilty about 
this and her parents were very upset about it. Her 
husband was one year older than herself and in regular 
employment as a joiner. He worked very long hours in 
order to obtain extra money and this caused difficulties 
between the patient and her husband as she felt that too 
much of the responsibility for the children rested on 
her. She had two daughters, aged 4 years and 1 year. 
Both were well but the patient found it difficult to 
control the behaviour of the elder girl. They had no 
serious financial difficulties. The patient has always 
been inclined to worry excessively about small matters 
but she was normally cheerful, optimistic and sociable. 
Since her marriage her social life has been very 
restricted and she was lonely in her home as she lived 
in a district where there were few other young women.
DRUGS PRIOR TO ATTENDANCE
Amitriptyline 50 mg. t.i.d. for one year without 
effect. Oral contraceptives since the birth of her 
second daughter and for 2 years after the birth of the 
first child. Nitrazepam 10 mg. nocte for one year.
She smoked 10 cigarettes per day but did not drink 
alcohol.
AT INTERVIEW
The patient was rather taciturn. She appeared
depressed although she tried to control this. Anxiety
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was present but it was not gross. Her mental state 
was otherwise normal.
Physically she was entirely well.
During her course of phenelzine she continued to take 
nitrazepam 10 mg, nocte but her oral contraceptives were 
stopped and she was given no other drugs.
At the time of the Initial assessment her score on 
the neurotic/endogenous rating was (4)•
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3*a 3*g + 4 3*2 + 8
Depression 2 3 2 0 0 0 1 1
Anxiety 2 2 2 0 0 0 1 1
Phobias 0 0 0 0 0 0 0 0
Obsessions 0 0 0 0 0 0 0 0
Depressed 3 2 1 0 0 o 0 I
Anxious 2 3 3 1 1 1 1 1
Overall
severity 14 15 12 2 2 2 4 6
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 0 0 0 0
tremor 1 1 1 1 1
ataxia 0 1 1 1 0
sweating 2 0 o 0 0
constipation 0 1 2 2 1
faints/dizziness 1 1 1 1 1
mioturition difficulty 0 0 0 1 0
blurred vision 0 1 1 0 0
Other 0 0 o 0 0
Total 6 5 6 6 3
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Miss M.W. 57 Fast
OCCUPATION
Sales Assistant in Dress Shop.
PRESENTING COMPLAINT
Patient complained of a "feeling of unreality and 
confusion"» She could not concentrate on what she was 
saying, did not want to speak to people and was avoiding 
serving at work. She could not do her housework and 
could not sit still, but did not want to go out of the 
house. She felt as if she was waiting for something 
dreadful to happen. For six weeks her symptoms had been 
80 bad that she could not work.
HISTORY OF PRESENTING COMPLAINT
The above features had developed gradually about 
one year prior to her attendance and had steadily 
worsened since. There was no detectable precipitant. 
On direct questioning she admitted also to having 
headaches, fatigue and insomnia. She had constant 
depression of mood and said that she had had fleeting 
thoughts of suicide. She had been anxious and of a 
worrying disposition all her life but these features 
had been worse lately. She had always been to some 
extent socially phobic and this too had become more 
severe. Her appetite was not impaired and she had 
not lost weight•
PAST PSYCHIATRIC HISTORY
1952 - operation for fibroids: depressed and anxious
thereafter, treated by G.P. with barbiturates. 
1960 - during mother's terminal Illness required 
treatment with barbiturates.
1971 - symptoms of depression and anxiety: attended 
psychiatric outpatient clinic, treated with 
anxiolytics - never quite well since.
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FMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil.
PERSONAL HISTORY
The patient was born in Cambuslang and had lived 
there all her life. Her father was a crane driver and 
died in 1965 of heart failure. Her mother died in 1960, 
having been ill for some years as a result of diabetes 
and coronary artery disease. The patient is the 4th of 
5 children and the only daughter. At the time of her 
illness she had lost touch with two of her brothers but 
visited one regularly and was in close contact with her 
orphaned niece, the daughter of her dead brother.
She had attended a Junior Secondary school, leaving at 
14, She worked in shops for a number of years but later 
worked in light engineering factories, being employed 
by one firm for 19 years until she became unwell in 
1971, She had then been unemployed for some time but 
had been employed as a sales assistant for one year 
prior to her attendance. She had never married and lived 
alone. She had few close friends and few interests.
DRUGS PRIOR TO ATTENDANCE
Six weeks prior to attendance had had amitriptyline 
25 mg. b.d, for ten days only with no effect.
Diazepam 5 mg. b.d. had been prescribed but she had 
not taken it regularly.
Haloperidol 1.5 mg. b.d. - currently prescribed.
Nitrazepam 5 mg. nocte occasionally in the past 
year.
She smoked 40 cigarettes per day but did not drink 
alcohol.
AT INTERVIEW
Her depressed mood was obvious and she was clearly 
anxious. There was no other abnormality in her mental
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state.
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs*
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (3).
MODIFIED GOLDBERG SCORE
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o 0 1 2 3 3*s 3*2 + 4 3^+8
Depression 4 2 2 0 0 0 0 O
Anxiety 2 3 1 O 0 0 1 0
Phobias 2 2 2 0 0 0 0 0
Obsessions 2 2 2 1 0 0 0 0
Depressed 3 2 2 0 0 0 0 0
Anxious 2 2 1 0 0 0 1 0
Overall
severity 20 17 13 1 0 0 3 0
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 2 1 1 1
tremor 1 O 0 0 0
ataxia 1 1 2 1 1
sweating 2 2 2 1 1
constipation 0 0 0 0 0
faints/dizsine ss 1 2 2 0 0
micturition difficulty 0 0 0 0 0
blurred vision 1 0 1 1 0
Other 0 bubbling in arms 
1
0 0 0
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had destroyed his career prospects. She had a lifelong 
tendency to worry to excess but felt that this had 
become much worse. She felt very anxious if left alone 
in the house but this too was a lifelong tendency. She 
described clear-cut episodes of depersonalisation which 
had occurred 3-4 times per week over about the past year.
PAST PSYCBIATRIC HISTORY
None before this eighteen-month episode but she had 
seen a psychiatrist in Lima and had attended two other 
clinics in Scotland when she had come back temporarily.
PAST MEDICAL HISTORY
Intermittent low back pain of unknown aetiology,
FAMILY HISTORY OF PSYCHIATRIC ILLNESS
The patient was the child of rather elderly parents 
and had one brother 10 years older than herself. Her 
father was a clerk. She was described as highly-strung 
and nervous as a child. She was afraid of the dark and 
her fear of being left in the house alone extended back 
into childhood. She attended a Senior Secondary school 
but did not do particularly well and left at 15 to 
train as a shorthand typist. She thereafter worked in 
one office until she was married at the age of 23 to 
a chartered accountant one year older than herself*
The patient * s parents were enthusiastic about this 
marriage, feeling that their daughter was improving 
her social position, but it did appear that the patient 
had always had some doubt about it and shared few of her 
husband * s cultural and intellectual interests * The 
sexual side of their marriage had never been successful 
but as neither partner had much interest in these 
matters this was not a great cause for dissension. They 
did quarrel over the patient * s wish for children. Her 
husband did not share this wish and had doubts about 
whether they should ever have a family. The patient had 
always been timid, anxious and dependent on her mother.
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Her main interests were in reading, sewing, knitting 
and the care of her personal appearance. She was a 
pretty woman and apparently when well spent much time 
upon her appearance but had neglected this since the 
beginning of her illness.
DRUGS PRIOR TO ATTEBDAHCE
In the eighteen months before attending the patient 
had had various tricyclic antidepressants and minor 
tranquillisers, all without beneficial effect. When 
she attended she was having "Doxepin" 25 mg. t.i.d., 
diazepam 5 mg. g.i.d. and amylobarbitone 200 mg. nocte.
She smoked 10 cigarettes per day and had the 
occasional social drink.
AT INTERVIEW
She presented as anxious and depressed. Her 
behaviour had an undoubted histrionic quality but she 
did demonstrate a consistently depressed mood. Otherwise 
her mental state was normal.
Physically she appeared entirely well.
At the end of her course of treatment she developed 
dysuria and urinary retention. She was found to have a 
urinary tract infection which was slow to respond to 
appropriate medication. An intravenous pyelogram 
revealed a congenital abnormality of the renal tract.
During the course of phenelzine she had nitrazepam 
10 mg. nocte.
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (4),
On the 21st day of the course of phenelzine the 
dosage was halved to 45 mg./day because of side effects.
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MODIFIED GOLDBERG SCORE
0 0 1 2 3 3%g 3*s + 4 3% +
Depression 3 3 1 1 1 0 0 0
Anxiety 3 2 1 1 1 1 0 0
Phobias 1 1 1 1 1 1 0 1
Obsessions 1 1 1 1 1 1 0 0
Depressed 3 3 1 1 1 1 0 0
Anxious 3 2 1 1 1 1 0 0
Overall
severity 20 17 8 8 8 7 0 1
Curing the two-iwcmtli foUow~i%) the patient had minimal closes of 
minor tranquillisers and it was not thought, that her improvement was 
due to jaedication.
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3%
Insomnia 1 1 2 1 1
tremor 1 0 1 1 1
ataxia 1 1 1 2 2
sweating 2 1 0 0 0
constipation 0 o 0 0 1
faints/dizziness 0 1 1 2 1
micturition difficulty 0 0 0 2 1














Total 5 7 8 8 7
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The patient had not been well for 4% years. She 
complained of feeling low-spirited and tired* She was 
restless, could not concentrate, slept poorly and her 
appetite was poor. She was preoccupied by a 
multiplicity of vague somatic complaints which she 
believed were an indication that she had a serious 
physical disease,
HISTORY OF PRESENTING COMPLAINT
The patient had always been of an anxious disposition. 
She was described by her general practitioner as always 
having had a dependent and rather histrionic personality. 
She had however coped satisfactorily with life and had 
no complaints, either somatic or psychiatric, until 4% 
years before she presented at the clinic. Two years 
before her presentation her mother had had a myocardial 
infarction and one year later she died. The patient’s 
symptoms worsened considerably after these events but 
they were undoubtedly present at an earlier date. At 
the time of her presentation she was totally preoccupied 
with the idea that she was likely to have an incurable 
disease. She complained of a multiplicity of vague 
somatic symptoms. She was constantly tired and slept 
only with hypnotics. She was irritable with others but 
this was principally because she felt that they did not 
realise how seriously ill she was. Her concentration 
had become so poor that she could not work, read, sew 
or watch television. She felt very low-spirited and 
felt hopeless about the future but had no thoughts of 
suicide. She felt anxious and worried all the time.
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Her anxieties mainly concerned her health but she also 
worried about trivia to a needless degree. She had 
become unable to go out alone because she feared that 
she would become seriously ill outside. Her appetite 
was poor but she had not lost weight,
PAST PSYCHIATRIC HISTORY 
Nil.
PAST MEDICAL HISTORY 
Nil.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil.
PERSONAL HISTORY
The patient was the only child of her parents. Her 
father died when she was three years of age. She was 
brought up by her mother and indulgent aunts* She led 
a somewhat sheltered life and was inclined to foe much 
in the company of her mother. She had no neurotic 
traits in childhood. She had a successful career at 
Senior Secondary school which she left at 17 years of 
age. After one year's secretarial training she obtained 
a post as a secretary and had worked in this capacity 
until she became unwell. Her work record was good - 
she had held several responsible secretarial positions 
for a nuiTflber of years. When she presented she had 
been off work for 10 months because of her symptoms.
She had never married. Although much of her social 
life was confined to her family circle she did have 
numerous friends. Her principal outside interest 
was amateur dramatics.
DRUGS PRIOR TO ATTENDANCE
In the ten months prior to attending the patient
had had
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Phenelzine IS mg* fo.d* for 10 days only - stopped 
this of her own accord as she was frightened by 
the dietary restrictions.
Amitriptyline 25 mg. g.i.d* for months.
Chlordiazepoxide 10 mg. g.i.d. intermittently.
When she attended she was having Diazepam 5 mg. 
t.i.d. and Mandrax 2 tabs, nocte.
She smoked 40 cigarettes per day and drank alcohol 
only on rare social occasions*
AT INTERVIEW
The patient appeared extremely depressed. She 
wept a good deal and was entirely preoccupied with 
hypochondriacal fears and ideas of self-blame. She 
was extremely agitated, wringing her hands ceaselessly 
and constantly seeking reassurance. There was no other 
abnormality in her mental state.
Physically she v/as entirely well.
During her course of phenelzine she also took 
nitrazepam 10 mg. nocte as she was most reluctant to 
be without hypnotics having taken them for years.
She had no other drugs.
At the time of the initial assessment her score 
on the neurotic/endogenous rating was (3).
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3% + 4 3^+8
Depression 3 3 3 2 0 0 0 0
Anxiety 4 4 3 2 1 1 1 1
Phobias 2 2 2 2 1 1 0 0
Obsessions 0 0 0 0 0 0 0 0
Depressed 3 3 3 2 0 0 0 0
Anxious 4 4 3 2 0 0 0 0
Overall
severity 23 23 20 14 2 2 1 1
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*3
insomnia 0 0 O 0 0
tremor 1 0 0 1 0
ataxia 1 1 1 1 1
sweating 0 0 0 2 2
constipation 2 2 2 2 2
faints/dizziness 1 1 1 2 0
micturition difficulty 2 2 2 1 1
blurred vision 2 2 2 2 1
Other 0 0 0 0 0
Total 9 8 8 11 7
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NAME AGE ACETYLATOR STATUS




The patient stated that she had been ill for four 
years but had been much worse in the eight weeks prior 
to her presentation. For four years she had lacked 
confidence and interest and had felt sad, nervous and 
tremulous all the time. For the last weight weeks she 
had been weeping all the time,
HISTORY OF PRESENTING COMPLAINT
The patient's symptoms originally developed in 1970 
after her discovery that her mother was suffering from 
malignant disease. She had never felt really well since 
then but in the intervening period had nursed her mother 
at home until her death and had then had grave cause 
for concern over her daughter who was discovered, at the 
age of 21, to have malignant hypertension which caused 
her to have a termination of pregnancy on medical 
grounds. There was no apparent precipitant for the 
patient's sudden deterioration eight weeks before her 
presentation. On systematic questioning it was found 
that in addition to her spontaneous complaints she felt 
very tired and apathetic, she was irritable and 
impatient with her children, she could not concentrate 
to knit or read, she felt despondent and hopeless about 
the future, she worried about trivia and had irrational 
fears about going out and about being left alone. She 
constantly feared that she might die and had the idea 
that she might have a cerebrovascular accident. She 
brooded a good deal about the termination of her 
daughter's pregnancy and felt that she should not have 
allowed this to take place. For eight weeks she had
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not been able to go to work because of her symptoms 
although in the many years that she had worked she 
had been absent very rarely except at the time of 
her mother's fatal illness. Her appetite was 
unimpaired and she had not lost weight.
PAST PSYCHIATRIC HISTORY
Nine years previously developed a depressive 
illness after her father's death. She was treated as 
an inpatient for three weeks and given tricyclic 
antidepressants which produced a complete response*
PAST MEDICAL HISTORY
Pelvic floor repair
Surgery to varicose veins•
FAMILY HISTORY OF PSYCHIATRIC XLLNBSS 
Nil.
PERSONAL HISTORY
The patient was born and brought up in Beith. She 
was the only child of a bootmaker* Her home life was 
happy and she had no neurotic traits* She had many 
friends at the Junior Secondary school which she 
attended until she was fourteen years of age* On 
leaving school she worked as a shop assistant until her 
marriage at 20 years of age. This marriage was never 
a success as her husband was a heavy drinker and 
chronically work-shy. After four years she divorced 
her husband for cruelty* The patient always worked 
outwith her home and at the time of her presentation 
had worked for many years in the Admiralty as a 
domestic. She had two children, a son aged 26, about 
whom she was concerned as he was courting a girl whom 
she regarded as unsuitable, and a daughter aged 23 who 
had severe malignant hypertension and was not expected 
to survive for many years. This girl had been engaged 
to be married at the time of her pregnancy and the
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discovery of her severe hypertension. When it was 
found that she was so hypertensive and would require 
a therapeutic abortion, her fiance, who was responsible 
for her pregnancy, broke off the engagement. These 
events were very distressing to the patient and she had 
the idea that if she had resisted the idea of 
termination more strongly her daughter would have been 
married and might have had a child, The patient had no 
serious financial worries or other social problems.
When well she was a very friendly, outgoing, competent 
person who had had no difficulties in bringing up her 
children singlehanded and who led a full social life,
DRUGS PRIOR TO ATTENDANCE
In the 3% years before attending the patient had been 
treated with a variety of tricyclic antidepressants and 
minor tranquillisers by her general practitioner and 
none of these had produced any improvement. She was on 
diazepam 5 mg, q.i.d, when she attended.
She smoked 15 cigarettes per day and drank only on 
rare social occasions.
AT INTERVIEW
She was very tense, wringing a handkerchief between 
her hands constantly and she was also depressed. 
Otherwise her mental state was normal.
Physically she was entirely well.
During her course of phenelzine she had no other
drugs,
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (4),
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MODIFIED GOLDBERG SCORE
0 0 1 2 3 3*5 3% + 4 3^+8
Depression 3 3 1 0 0 0 0 0
Anxiety 3 3 0 0 0 0 0 0
Phobias 4 4 4 3 0 0 0 0
Obsessions 2 2 0 0 0 0 0 0
Depressed 2 2 1 0 0 0 0 0
Anxious 3 3 1 0 0 0 0 0
Overall
severity 22 22 9 3 0 0 0 0
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insoimla 1 2 0 0 0
tremor 0 0 2 0 0
ataxia 0 2 0 1 0
sweating 0 1 2 1 0
constipation 0 0 0 2 1
fai-nts/dizziness 0 1 1 0 0
mioturition difficulty 0 1 0 1 1
blurred vision 0 1 0 0 0
Other 0 0 0 0 0
Total 1 8 5 5 2
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NAME AGE ACETYLATOR STATUS




Patient complained that three months previously she had 
suddenly developed a feeling of "weepiness and nervousness".
HISTORY OF PRESENTING COMPLAINT
The patient could give no precipitant for her complaints. 
She had begun to feel tired all the time although her sleep 
was not disturbed. She had become irritable and "difficult 
to live with". She had begun to feel miserable and tearful 
for no reason. She had few guilty ideas, she did not feel 
hopeless about the future and she was not suicidal. She 
brooded a good deal about her own inadequacies. She felt 
constantly anxious. She worried ceaselessly about trivia 
and although she realised that this was ridiculous she 
could not control it. She had become incapable of 
travelling, feeling that she would collapse if she went 
on a bus or train and she could no longer do her shopping 
because she felt afraid in the street alone. These 
features were of eight weeks duration, i.e. they had 
arisen four weeks after the original depressive feelings. 
She had become indecisive even upon trivial matters such 
as family menus. Her appetite was good and she had not 
lost weight.
PAST PSYCHIATRIC HISTORY 
NIL,
PAST MEDICAL HISTORY 
NIL.




The patient was born and brought up in Glasgow. She 
has one brother three years older than herself. Her 
father, who had worked in an unskilled capacity in a 
gas works, had died 10 years before her presentation.
Her mother was alive and well. She attended a Junior 
Secondary school where she mainly took domestic subjects. 
She was a happy child, free of neurotic traits. She 
left school at 15, working in a tobacco factory until 
her marriage at 23, to a man the same age as herself.
The marriage was described as happy. The patient 
depended a great deal on the support of her husband in 
most matters but this arrangement appeared to suit them 
both. They had three children, aged 11, 9 and 3, none 
of whom gave any cause for anxiety. The patient's 
husband had worked as a lorry driver but two years 
prior to her presentation had obtained his own taxi cab.
He was happier in this situation and the family was 
financially more comfortable than it had been in the 
past* The patient had for years been concerned about 
the fact that the family lived in a rather rough 
neighbourhood but with their increased affluence they 
had begun to have a prospect of moving away to a better 
district. The patient was described as normally being 
sociable, friendly and cheerful, if somewhat over anxious. 
She and her husband were active members of an or§nge lodge 
and participated freely in the varied social functions 
connected with that organisation. Since becoming ill she 
had cut herself off from all social activities.
DRUGS PRIOR TO ATTENDANCE
Diazepam 5 mg. g.i.d.. Nitrazepam 10 mg, nocte, both 
for three months.
She smoked 10 cigarettes per day and drank alcohol 
only when at social functions.
AT INTERVIEW
She was restless, tense and tearful* She endeavoured
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to conceal both her depressed mood and her tension 
but these became increasingly obvious as the interview 
progressed. Otherwise her mental state was normal.
At routine physical examination a small breast lump 
was found. The patient denied that she had ever 
noticed this and has always continued to maintain that 
she knew nothing of this lump until this examination.
An immediate excision biopsy was arranged and she was 
found to have a benign fibroadenoma. Her symptoms and 
mental state were in no way changed by this. She 
was continued on diazepam only for one month after her 
return from the surgical ward but she did not improve 
at all and was then placed in the phenelzine trial.
During her course of phenelzine she continued to 
take nitrazepam 10 mg. nocte.
At the time of her initial assessment her score on 
the neurotic/endogenous rating was (3).
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MODiFiED GOLDBERG SCORE
0 0 1 2 3 3*s 3% + 4 3*5+8
Depression 2 2 1 0 0 0 0 0
Anxiety 3 3 1 0 0 0 0 0
Phobias 3 3 2 1 0 0 0 o
Obsessions 1 1 0 0 0 0 0 0
Depressed 2 2 1 0 0 Ow' 0 o
Anxious 2 2 1 0 0 0 0 0
Overall
severity 17 17 8 1 0 0 0 0
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3%
insomnia 0 0 0 1 0
tremor 1 1 1 1 1
ataxial' 0 1 1 0 1
sweating 0 1 0 0 0
constipation 0 0 1 1 0
faint s/dissaine ss 1 0 0 0 0
micturition difficulty 0 0 0 0 0
blurred vision 0 0 0 1 0
Other 0 0 0 0 0
Total 2 3 3 4 2
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NAME AGE ACETYLATOR STATUS




The patient complained of a "sick, miserable feeling". 
She constantly felt as if something terrible was going 
to happen and also complained of a numbness at the back 
of her head and in her eyes.
HISTORY OF PRESENTING COMPLAINT
The patient had had a spontaneous abortion in 
November, 1973. This had been a disappointment to her 
but she had coped reasonably with this. Her neighbour 
had been confined in March, 1973, at the time of the 
patient's own expected date of delivery, and her 
symptoms dated from then. She was preoccupied with 
the idea that the feeling in her head might indicate 
that she had cancer. She felt tired all the time and 
for the four months since her neighbour's confinement 
she had been unable to do her housework. She was 
sleeping very poorly, having both early and late 
insomnia. Her concentration had declined and she was 
not able to attend to books, knitting, etc. She felt 
low-spirited most of the time and was worse if she saw 
a baby or if anyone made reference to infants. She 
wept uncontrollably every day. Although she felt 
lacking in hope for the future she had no suicidal 
thoughts. She had always been a tense, anxious person 
but she had begun to worry much more than usual. She 
had become preoccupied with a fear, which she recognised 
as irrational, that some harm would come to her husband 
if he was not with her and she had begun to telephone 
him at work to make sure that he was alright. She 
was afraid of being in the house alone and always 
arranged to have relatives or friends in when her husband
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was out. She was able to go out shopping but felt 
apprehensive on public transport. She thought* a 
good deal about her spontaneous abortion and went
I
over and over the unpleasant details of it. She 
could not put these thoughts from her mind. Her 
appetite was unimpaired and she had not lost weight.
PAST PSYCHIATRIC HISTORY 
Nil.
PAST MEDICAL HISTORY 
Nil.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS
Both her mother and one sister had at tiîïies 
attended their general practitioner because of anxiety 
symptoms and another sister had been treated for 
depression by her general practitioner following a 
miscarriage.
PERSONAL HISTORY
The patient was born and brought up in Glasgow, the
second of four children of a housepainter. She was 
regarded by her family as being shy and nervous from 
early childhood. The home life was happy. She 
attended Senior Secondary school and although she was 
doing quite well she left at 15, without obtaining a 
leaving certificate. She obtained a job as a wages 
clerkess and worked for three years with the same 
firm until her marriage at the age of 18 to a motor 
mechanic, two years older than herself. The marriage 
was happy and successful. They had two children, a 
daughter aged 5 and a son aged 4, Both the patient 
and her husband liked children and wanted to have a 
large family. She had been very disappointed about 
having the spontaneous abortion at 22 weeks in 
November, 1973. They had no financial difficulties 
and no real domestic problems. As a young girl the
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patient had been anxious and shy but she had become 
socially more confident in adult life, and when well 
enjoyed a variety of leisure pursuits.
DRUGS PRIOR TO ATTENDANCE
Imipramine 25 mg, q.i.d. for 3 weeks ™ v/ithout effect. 
Nitrazepam 10 mg. nocte since November, 1973.
She smoked 10 cigarettes per day and did not drink.
AT INTERVIEW
She was tearful, anxious and importunate. Her 
tension was obvious and her depression appeared marked 
with indecision and self-depreciatory ideas being 
prominent features, otherwise her mental state was 
normal.
Physically she was entirely well.
During her course of phenelzine she continued to 
take nitrazepam 10 mg. nocte.
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (1).
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MODIFIED GOLDBERG SCORE
0 0 1 2 3 3^ 3% + 4 3*2+8
Depression 3 3 0 0 0 O 0 0
Anxiety 3 3 0 0 0 o 0 1
Phobias 2 2 1 0 0 1 1 1
Obsessions 1 1 o 0 0 0 0 0
Depressed 3 3 0 0 0 o o 0
Anxious 3 3 0 0 0 0 0 1
Overall
severity 21 21 1 0 0 1 1 4
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 33!:
insomnia 2 0 0 0 0
tremor 1 G 0 0 0
ataxia 0 0 0 1 0
sweating 2 0 0 0 0
constipation 2 2 O 1 1
faints/dissinass 1 1 0 0 0
migturition difficulty 1 0 0 0 0
blurred vision 0 0 0 0 0
Other 0 0 0 0 0
Total 9 3 0 2 1
Days 5-8 and 15-18 substituted for Days 3 and 13 
for tryptamlne assessment.
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NAME AGE ACETYLATOR STATUS




The patient stated that she felt depressed, irritable,
nervy and jumpy. She felt that she would be greatly
helped if she could cry but that she could not.
HISTORY OF PRESENTING COMPLAINT
The patient * s symptoms arose after the death of her 
first husband four years before this attendance• Her 
husband had died of carcinoma of the kidney in 1970, 
after a year's painful illness during which the patient 
nursed him at home. After this she had felt "numb and
empty" for two years. She then ceased to be devoid of
feeling and felt profoundly depressed but could not cry. 
She brooded about her husband's death and about ways in 
which she had failed to help him. She felt tired and 
listless and had no interest in anything. Her sleep 
was poor and for the past four years she had never slept 
for more than 4-5 hours. She was irritable and 
quarrelsome, Her concentration had failed and she had 
given up her life-long interest of dressmaking. She 
felt that she was worrying all the time about trivia 
and about other people's worries. She stated that she 
had less real cause for worry than she had ever had and 
yet her mind could not foe at peace. She had always had 
mild obsessional tendencies but these had become worse.
She checked doors and gas taps three times and had to 
get dressed, do the housework, etc^ in a set order of 
steps. If this was broken she had to go back to the 
beginning. Although these features were undoubtedly 
present they did not limit her life to any extent. She 
had given up work eight weeks previously because of her 




Patient had attended hospital and had inpatient 
treatment in 1972. This was of no lasting benefit to 
her. Before her husband's death she had no psychiatric 
symptoms.
PAST MEDICAL HISTORY
Many years previously one of her ears was injured 
in a road traffic accident and she had since been deaf.
When she was 18 she had pulmonary tuberculosis.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
None,
PERSONAL HISTORY
The patient was born and brought up in Glasgow. Her 
father was a plater in a shipyard. The patient was the 
sixth of seven children of whom three died in early 
adult life from tuberculosis. Her childhood was happy. 
She attended a Junior Secondary school and left at 14. 
She then became a clerkess and worked at this until her 
marriage, aged 23, to a shipwright, 2 years her senior. 
Their marriage\.was happy. Throughout her marriage she 
worked in a biscuit factory. They had no children.
Her husband died of carcinoma of the kidney in 1970.
The patient had known of the diagnosis for a year 
previously but kept it from her husband whom she nursed 
at home. Her symptoms dated from his death. She felt 
lonely and isolated as her social life had really 
depended on her husband. She could not take her mind 
off his death and blamed herself for her shortcomings. 
She remarried in December, 1973 and her depression had 
become worse two months before this. She continued to 
deteriorate after her remarriage although she was 
greatly attached to her second husband and had no cause 
for unhappiness. All her life she had found social
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situations a strain. She was quiet, reserved and 
always to some extent obsessional,
DRUGS PRIOR TO ATTENDANCE
She had had various minor tranquillisers and tricyclic
antidepressants over the four years of her illness, all 
without lasting benefit. When she was assessed for the 
study she was on no drugs.
She did not smoke and drank only very rarely,
AT INTERVIEW
She was obviously very tense, clenching and 
unclenching her hands and arranging articles along the 
table in front of her. Her deafness was quite severe 
but she could co-operate with the interview situation.
She appeared depressed to a marked degree although 
she seemed to be attempting to minimise this.
Otherwise her mental state was normal.
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs,
At the time of her initial assessment her score 







0 1 2 3 3*5 3*2+4 3*2+8
Depression 3 0 0 0 0 0 O
Anxiety 3 0 0 0 0 0 0
Phobias 0 O 0 0 0 0 0
Obsessions 2 1 1 0 0 0 0
Depressed 3 1 0 0 0 0 O
Anxious 3 1 0 0 0 0 0
Overall
severity 20 5 1 0 0 0 0
MODIFIED EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 0 o O 0
tremor 0 0 0 0 0
ataxia 1 1 0 0 0
sweating 0 0 0 0 0
constipation 3 2 2 2
faints/dizziness 1 0 0 0 0
micturition difficulty 0 0 0 0 0
blurred vision 0 0 0 0 0
Other 0 0 0 0 0
Total 6 3 2 2 2
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NAME AGE ACETYLATQR STATUS




The patient complained that for 3-4 months she had felt 
that she was not doing anything properly. She had lost 
interest in everything, felt despondent about the future 
and was afraid to go out.
HISTORY OF PRESENTING COMPLAINT
The exact time of onset of the patient's symptoms was 
not clear as they developed gradually and were superimposed 
upon a chronically mildly anxious personality and a 
long-standing feeling of guilt about being divorced 
although a Catholic. Over the three months prior to her 
attendance her symptoms had become increasingly severe and 
had come to limit her activities to a serious extent. She 
felt tired all the time and her sleep had become poor.
Her insomnia was early* Her concentration had become 
very poor so that she could not even concentrate on short 
articles in magazines. She felt sad most of the time and 
tiiis depression appeared to be connected with thinking 
about her own inadequacies* She wept a good deal about 
this and at times felt hopeless about the future, 
although she had no suicidal thoughts* She worried a 
good deal principally about the health of her aging 
father and about the state of her mar&iage, but she did 
not feel that she was any more anxious about these 
matters than she would normally have been. She had 
developed a fear that she would collapse on public 
transport or in shops. This was of only six weeks duration 
at the time of her presentation, although her other 
symptoms had been present for longer. Previously shopping 
in large stores had been one of her main interests. She 
had become extremely indecisive about trivial as well as
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major issues. Her appetite remained good and she had 
not lost weight. Her symptoms had developed shortly 
after she had discovered that her husband, who had 
lived abroad all their married life apart from a few 
short holidays, would be returning to live in Scotland 
permanently. Although she stated she was pleased about 
this certainly she had considerable ambivalence towards 
her husband and had no wish to have children or be a 
housewife.




FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Hone.
PERSONAL HISTORY
The patient was born in Glasgow but during most of 
her childhood lived with her grandparents in Ayr 
because of the War. She was an only child. Her father 
was a toolmaker. Her mother died of cirrhosis of the 
liver (non-alcoholic) when the patient was 18. The 
patient was a happy child, free of neurotic traits.
She had a successful school career and hoped to train 
as a teacher but had to leave school at fifteen years 
of age because of her mother's failing health. On 
leaving school she worked for three years as a sales 
assistant, then taking up clerical work at which she 
had since successfully been employed. She was married 
for the first time at 20 but the marriage lasted only 
ten months, failing, by the patient's account, because 
of her husband's untruthfulness and chronic unemployment, 
She divorced him for desertion but always felt guilty 
about this as it was against her principles as a 
Catholic and meant that she was denied Communion. At
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33 years of age she remarried her husband being a 
joiner, two years older than herself, who had not 
previously been married. During the marriage he had 
mainly worked abroad and the patient had therefore 
continued to live with her father. This arrangement 
was said to be agreeable to all three parties. There 
were no children of either marriage and the patient 
was not sure that she wanted any. She had always been 
"a bit of a worrier" but was normally an effective 
worker and a cheerful, energetic and sociable person.
DRUGS PRIOR TO ATTENDANCE
Amitriptyline 25 fig. t.i.d and 50 mg. nocte for 
six weeks until two weeks before her presentation - 
this had no effect. Nitrazepam 10 mg. nocte for five 
months.
She smoked 30 cigarettes per day and drank on 
social occasions.
AT INTERVIEW
The patient appeared definitely retarded. All of 
her responses were slow and she had little spontaneous 
conversation. She was depressed and tense. There 
were no other abnormalities in her mental state.
Physically she was entirely well.
During her course of phenelzine she continued to 
take nitrazepam 10 mg. nocte as she was reluctant to 
do without it.
At the time of her initial assessment her score on 
the neurotic/endogenous rating was (4).
On the 21st day of the course of phenelzine the 
dosage was halved to 45 mg/day because of side effects
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3h 3% + 4 3^+8
Depression 3 2 1 1 1 1 1
Anxiety 2 1 0 0 0 0 0
Phobias 3 2 2 1 1 0 1
Obsessions 2 1 0 0 o 0 0
Depressed 3 2 1 1 1 1 1
Anxious 3 1 1 0 0 0 0
Overall
severity 22 12 7 4 4 3 4
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3h
insomnia 2 1 0 1 2
tremor 1 1 0 1 1
ataxia O 1 1 1 0
sweating If 0 0 0 1
constipation 0 0 O 0 0
£alnt&/dizzjLneaa 0 1 1 1 1
micturition difficulty 0 0 0 1 0
blurred vision 1 0 0 1 1
Other 0 0 0 0 0
Total 5 4 2 6 6
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This patient presented with a five month history of 
loss of interest, inability to cope with her domestic 
commitments, loss of confidence, fear of going out, 
fear of being left alone in the house, and a constant 
"sad empty feeling".
HISTORY OF PRESENTING COMPLAINT
The patient's symptoms clearly dated from her removal 
from her home in the slums of central Glasgow to a house 
in a Local Authority housing scheme on the periphery#
She had enjoyed the communal life of the city and found 
her new environment foreign and lonely# Relatives had 
come from Ireland to stay with her as it was felt by the 
family that company would help her but this had been of 
no avail and latterly she had drawn away from any company. 
In addition to her spontaneous complaints, on direct 
questioning she admitted that she brooded about the 
possibility that she might have malignant disease, that 
she felt tired all the time for no reason, that her 
sleep was fitful, that she was unreasonably irritable 
with her husband and children, that she could not 
concentrate on cooking, housework or knitting and that 
her feeling of depression was profound. She felt she 
she would be helped if she could cry but she could not.
She felt that the future was hopeless. She felt that 
she had brought her illness upon herself by her own 
inadequacies. She was not contemplating suicide as 
such an act would be totally against her religious 
principles. She felt constantly anxious. She was 
mainly worried about money. Although the family was 
poor they were in no greater financial difficulties
Appendix 92
than they had ever been and she had not previously 
been concerned about money. She had become afraid of 
being alone in the house, and of going out. She had 
always been a little apprehensive of being in large 
crowded stores but she had lately become unable to 
go into a small local shop. She described feeling 
detached from the rest of the world saying "I feel 
as if X am away on my own and that no-one else is 
there", This was a fleeting experience which she 
found distressing. Her appetite was not really 
impaired and she had lost no weight.
PAST PSYCHIATRIC HISTORY 
Nil.
PAST MEDICAL HISTORY 
Nil.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil.
PERSONAL HISTORY
This patient was born and brought up in an impoverished 
area of central Glasgow. She was the eldest child of an 
unemployed labourer of Irish extraction. She attended a 
Catholic Senior Secondary school and did well but 
because of the family circumstances left at 15 years of 
age and obtained work as a wages clerkess. As a child 
she was always regarded as being over anxious* She 
became panic stricken at examinations at school and had 
always been afraid to go in lifts. She was employed by 
one firm for six years until her marriage at the age of 
21 to an Irish labourer. She had two daughters, aged 
5 and 4. Although always of a somewhat anxious 
disposition, before she became unwell she was a competent 
housewife and mother and was described as being very 
cheerful and sociable. She and her husband normally 
went out a good deal to dances and socials connected
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with the local R.C. Church and Irish Societies. Since 
the onset of her symptoms she had abandoned all of 
these activities.
DRUGS PRIOR TO ATTENDANCE 
None.
The patient did not smoke or drink at all,
AT INTERVIEW
She was obviously markedly depressed and she was 
definitely retarded* H w  anxiety was not marked*
There was no other abnormality in her mental state.
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs.
At the time of her initial assessment her score 
on the neurotic/endogenous rating was (4).
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3^ 3% + 4 3% ♦ 8
Depression 4 4 4 1 0 0 0 0
Anxiety 3 3 3 1 0 0 0 0
Phobias 4 4 4 2 0 o 0 0
Obsessions 0 0 0 0 0 0 G 0
Depressed 3 3 3 1 0 0 0 0
Anxious 1 2 2 0 0 0 0 0
Overall
severity 19 21 21 6 0 0 0 0
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 2 Q 0 0
tremor 0 0 0 0 0
ataxia 0 0 0 1 0
sweating 0 0 0 0 0
constipation 0 0 2 2 0
ffaints/clisxiness 0 0 0 X 0
micturition difficulty 0 0 0 0 0
blurred vision 0 0 0 0 0
Other 0 0 0 0 0
Tot#l 2 2 2 4 0
Appendix 95
NAME AGE ACETYLATOR STATUS




Patient complained of nervousness, tension, poor 
concentration and a feeling of inadequacy in all respects. 
He felt as if he might weep and frequently did.
HISTORY OF PRESENTING COMPLAINT
The patient initially described the above complaints 
as being of two months duration but they had been present 
to a lesser extent for some months prior to that. He 
became unwell in the setting of occupational difficulty.
He had been employed for years in the business of a 
relative of his wife. This man had suffered a 
cerebrovascular accident and the business was being 
placed in his son's hands. The patient feared (correctly 
as later became evident) that the son would not continue 
to employ him. On questioning Mr. stated that
he was suffering from increasingly severe headaches and 
feared that these might indicate serious illness. He 
felt tired much of the time although he slept quite well. 
He was becoming increasingly irritable at home and had 
lost interest in his former leisure pursuits. He felt 
low-spirited and wanted to get away from people although 
he did not have any wish to die. He was worried all the 
time about his job and about his son who was in financial 
difficulty* He had always been inclined to worry to 
excess. He had felt so lacking in self-confidence that 
he had given up driving his car and he had begun to check 
his work to an undue extent. His appetite was poor and 
he had lost 1 stone in two months.
PAST PSYCHIATRIC HISTORY 
Nil.
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PAST MBDXCM. HISTORY 
Nil.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
Nil apart from wife.
PERSONAL HISTORY
The patient was born and brought up in Glasgow. His 
father worked in tiie shipyards and died in a drovming 
accident when the patient was 18 months old. The
patient had two older sisters and one younger brother.
His mother worked throughout his childhood in a 
variety of unskilled occupations. He was an average 
pupil at school, leaving at 14. He was apprenticed as 
an electrical engineer and during the War served in 
R.E.M.Y. After the War he worked in a variety of jobs, 
being 17 years with Beardmores until he was declared 
redundant. He then became employed as a storeman in 
the business of a relative of his wife, and at the 
time of his presentation this job was in jeopardy. He
was married at the end of the War and had two children,
both now married. Neither the patient nor his wife 
approved of the spouses of either of their children. 
Their own marriage was reasonably happy although Mrs,
Ft & was something of a chronic gynaecological
invalid and had had continuous psychiatric care for 12 
years following the birth of her second child. This 
was said to be a neurotic illness. The patient was 
described as always being anxious, inclined to be 
indecisive and to have difficulty in asserting himself. 
He and his wife had tended to adopt the mannerisms 
and lifestyle of persons of higher socio-economic status 
than themselves. They had few friends and what social 
life they had was among relatives, principally those 
of Mrs. Pf
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DRUGS PRIOR TO ATTENDANCE
"Ronstan" 2 caps/day for headache.
Diazepam 2 mg. b.d.
He smoked 30 cigarettes per day and drank only at 
occasions such as weddings and New Year.
AT INTERVIEW
The patient was very tense and smoked incessantly. 
At times he wept and he appeared significantly 
depressed. There was no other abnormality in his 
mental state.
Physically he was entirely well.
During his course of phenelzine he had no other 
drugs.
At the time of the initial assessment his score 
on the neurotic/endogenous rating was (4).
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3*2 3*2+4 3*X + 8
Depression 2 2 1 1 1 1 1 2
Anxiety 3 3 2 2 0 O 0 0
Phobias 2 1 1 1 0 1 0 0
Obsessions 2 2 2 2 0 0 0 0
Depressed 2 3 2 2 1 1 1 2
Anxious 3 3 2 2 1 1 2 2
Overall
severity 19 20 14 14 s 6 7 10
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*%
insomnia 2 1 1 1 1
tremor 1 1 1 1 L
ataxia O 0 1 1 0
sweating 2 1 0 0 0
constipation 0 0 1 1 I
faints/diaaIness 1 1 0 1 0
micturition difficulty 0 0 0 0 0
blurred vision 2 0 0 0 0
Other 2 2 2 1 0
Total 10 6 6 6 3
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NAME AGE. ACETYLATOR STATUS




The patient complained of depression, panic attacks, 
poor concentration and poor sleep*
HISTORY OF PRESENTING COMPLAINT
The patient had always regarded herself as highly-strung 
but had coped well with life until four years previously* 
Her symptoms then began to develop and appeared to foe 
precipitated by her younger daughter * s departure from the 
parental home on marriage. In addition to her spontaneous 
complaints, on direct questioning she admitted that she 
worried about her health and feared that she might have 
malignant disease. She slept poorly, her insomnia being 
mainly early, was irritable and quarrelsome with her 
husband about nothing. She concentrated poorly and had 
ceased to watch television, knit or sew. She complained 
of being depressed but her mood was by no means always 
depressed, fluctuating a good deal, and for brief periods 
she could be reasonably cheerful. She did not feel 
hopeless about the future and certainly was not suicidal. 
She thought a good deal about her own inadequacies and 
past failures. She stated that she was never free from 
worry although had no real reason for anxiety. She had 
become afraid to be in the house alone, afraid to go out 
alone and afraid to travel by car. She had become 
hopelessly indecisive, so much so, that she could spend 
hours deciding what to wear or what to make for a meal.




27 years previously, when puerperal, she had been 
treated with E.C.T. as an outpatient. This had not 
helped her and she had defaulted from attendance,
PAST MEDICAL HISTORY
Repeated minor chest infections over many years.
Hysterectomy six years ago for menorrhagia,
FAMILY HISTORY OF PSYCHIATRIC ILLNESS
None.
PERSONAL HISTORY
The patient was barn and brought up in Glasgow,
She was the sixth of nine children of whom five still 
survive. Her father had his own business and although 
he was a heavy drinker maintained a very comfortable 
home for the family during the patient's childhood- 
She attended a Senior Secondary school and did 
reasonably well but had to leave at 14 when her father 
went bankrupt. She obtained a job in a biscuit factory 
where she worked until her marriage at the age of 20 
to a man her own age. The marriage had never been 
particularly happy. Her husband drank fairly heavily 
and had little sympathy with his wife's desire to 
improve their social position or her worries about her 
health. He worked for the Corporation Housing 
Department. There were two daughters of the marriage, 
aged 31 and 27. The elder lived in England and the 
younger in Ayrshire, The younger girl had a child, 
aged 2, and the patient was distressed by the fact 
that she felt that her son-in-law did not really 
welcome her in his home. They had no financial worries 
and, although the patient would have preferred to own 
her home, she had no real complaints about the rented 
house in which they lived. She had always been an 
anxious woman and had never made friends easily, largely 
because she was much concerned with social distinctions
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and did not really wish to mix with her neighbours 
or others with whom she had much contact. She had 
normally coped well however and had led an active life, 
taking a great interest in her personal appearance and 
in the decoration of her home. She had ceased these 
activities when she presented at the clinic.
DRUGS PRIOR TO ATTENDANCE
Glutethimide ("Doriden") 750 mg, nocte for years. 
Diazepam 5 mg, t,i,d. for one year.
Amitriptyline 25 mg. t.i.d. three months before 
attending*
She had no benefit from these treatments.
The patient neither smoked nor drank,
AT INTERVIEW
She was obviously very tense and her depression, 
although present, was a less marked feature. Her 
manner was rather histrionic. Otherwise her mental 
state was normal,
Physically she was entirely well.
During her course of phenelzine she also had 
nitrazepam 10 mg. nocte.
At the time of the initial assessment her score 
on the neurotic/endogenous rating was (2).
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3*s 3*2+4 3*1 + 8
Depression 2 3 2 0 0 1 0 0
Anxiety 4 4 1 1 0 1 0 0
Phobias 2 3 2 2 2 2 O 0
Obsessions 2 2 1 1 o 0 0 0
Depressed a 2 1 0 0 0 0 o
Anxious 3 3 1 1 0 1 0 0
Overall
severity 21 22 10 6 2 6 0 0
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*8
insomnia 2 0 2 2 1
tremor 1 0 0 0 0
ataxia 0 0 1 0 1
sweating 2 0 0 © Ô
constipation 1 2 2 2 2
falnts/diaainess 0 Q 0 0 1
micturition difficulty 0 0 O 0 1
blurred vision 0 1 1 1 1
Other 0 0 0 o 0
Total 6 3 6 s 7
Days 2 and 12 substituted for Days 3 and 13 for 
tryptamlme assessment.
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The patient complained that she felt miserable, tired 
and ill and that she could not sleep. She thought that 
these feelings were secondary to a "burning, gnawing 
discomfort" which she had in her face,
HISTORY OF PRESENTING COMPLAINT
This lady's symptoms had been present for about two 
years. She was not a clear historian but it appeared 
that during this period she had had a multiplicity of 
somatic symptoms, all of which had been investigated at 
some length without any organic cause being demonstrated. 
Associated with these somatic complaints had been 
constant irritability, despondency, loss of interest 
and anxiety. Her sleep was very poor in that on 
average she thought that she slept for 4 hours per night. 
Her concentration was failing and she had no interest 
in any of her former pursuits. Her depressed mood was 
constant and nothing made her happy. She wept a good 
deal most days but she did add that she had always been 
inclined to weep easily. She did not feel at all 
hopeful that things would improve but she had no 
suicidal ideas* Although she said that she worried a 
good deal she was by no means constantly anxious. It 
appeared that she was no more worried than was usual 
for her. Her appetite was good and she had not lost 
weight,
PAST PSYCHIATRIC HISTORY
Until two years before she attended the patient had 
never had any form of psychiatric treatment but during
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this period she had attended several clinics and had 
been treated with various minor tranquillisers and 
tricyclic antidepressants without benefit.
PAST MEDICAL HISTORY
No serious illnesses and no operations but she 
apparently had a long-standing tendency to complain 
about minor somatic symptoms.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS
Patient's mother had had a course of E.C.T, as an 
inpatient.
Her sister had had depressive illnesses for which 
she had had inpatient treatment but was given drug 
therapy only,
PERSONAL HISTORY
The patient was born and brought up in Kilfoirnie, 
the fourth of six children of a steel worker. She 
enjoyed a happy home life as a child. She attended a 
Junior Secondary School where she took a non-academic 
course. Even at this level she did not do well. She 
left school at 15 and worked in a fish net factory 
until her marriage at 19, to a man of the same age.
She did not want to marry her husband but was 
persuaded by her parents to do so because she was 
pregnant. Nonetheless their married life had since 
been reasonably happy. There are 3 sons of the 
marriage, aged 18, 15 and 7, All of them were well 
and gave their parents no particular cause for concern. 
The patient * s husband was employed by the Admiralty 
in laboratory work connected with munitions, This had 
caused the family to have to move about a goad deal 
but this had pleased the patient rather than the reverse, 
Her symptoms had started when they were living in 
Gibraltar and had persisted since their return, They 
were happy in Gibraltar and no precipitant could be
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detected. The patient described herself as always 
being anxious and inclined to worry excessively. She 
appeared always to have been over-concerned about her 
own health and that of her family,
DRUGS PRIOR TO ATTENDANCE
In the two years of her illness Mrs. B: had had
a wide variety of minor tranquillisers and tricyclic
antidepressants. When she attended the clinic she was 
having
Doxepin 25 mg. t.i.d.
Diazepam 5 mg. t.i.d.
Chlorpromazine 25 mg. nocte.
She smoked 20 cigarettes per day and drank occasionally.
AT INTERVIEW
She appeared significantly depressed. She was 
rather hostile and defensive. Anxiety was not a marked 
feature• Otherwise her mental state was normal.
Physically she was entirely well.
During her course of phenelzine she had no other
drugs.
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (3).




0 0 1 2 3 3^ 3^  + 4 3% + $
Depression 3 3 1 1 0 0 0
Anxiety 1 1 1 1 1 1 1
Phobias 0 0 0 0 0 o 0
Obsessions 0 0 0 0 0 0 0
Depressed 3 3 1 1 0 0 0
Anxious 1 1 1 1 1 1 1
Overall
severity 12 12 6 6 3 3 3
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*g
insomnia 2 1 o 1 1
tremor 1 0 0 0 0
ataxia 0 1 1 1 0
sweating 2 0 2 1 1
constipation 1 0 1 0 0
faints/dizziness 1 1 1 a o
micturition difficulty 0 0 1 1 0






Total 7 S 6 7 2
Daya 2 and 12 eubatitwted for Day* 3 and 13
for tryptamin© assessment.
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Patient complained of weepiness, inability to cope, 
headaches and light-headedness. These symptoms had all 
been present to some extent for about one year but had 
been very much worse in the three months before her 
presentation. In this three-month period she had given 
up working outside her home and in the last month her 
mother had had to take over her housework*
HISTORY OF PRESENTING COMPLAINT
These features had developed gradually over about one 
year and had steadily worsened during this time, becoming 
incapacitating in the last three months* Eighteen months 
prior to her attendance the patient had had a hysterectomy 
for carcinoma of the cervix, discovered on routine 
screening. This appeared likely to have precipitated her 
condition but the patient denied that she was in .any way 
concerned about the possibility of recurrence and indeed 
she denied having any fears about her health. She 
complained also that she was very easily tired but that 
she slept poorly. She was unreasonably irritable towards 
her family and quarrelled a good deal. Her concentration 
had become very poor, to such an extent that she could 
not do her shopping at all. She felt sad and wept very 
easily. She felt a failure in many ways and she felt 
afraid of the future, although she was not able to be 
definite about this. She did not have any suicidal ideas. 
She worried a good deal about trivia and constantly brooded 
about how she would cope if her mother died, although she 
realised that this was a ridiculous preoccupation, her 
mother being a robust woman in her fifties. She had
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entirely ceased going out but stated that this was due 
to apathy rather than fear. Her appetite had become 
very poor and she had lost over a stone in weight in 
the past year. The patient had always been rather 
dependent upon her mother and her husband. Her stress 
tolerance had always been poor but prior to this episode 
any symptoms provoked by stress had been fleeting. She 
had normally numerous interests outwith her home but had 
neglected these in the past year,
PAST PSYCHIATRIC HISTORY
Six years previously the patient had poisoned herself 
impulsively following a quarrel with her husband. She 
had been admitted to a medical ward because of this but 
psychiatric advice was not sought.
PAST MEDICAL HISTORY 
Hysterectomy in 1972.
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
None.
PERSONAL HISTORY
The patient was born and brought up in Rilbirnie in 
Ayrshire, Her parents both worked in unskilled capacities. 
She had one younger brother. She was not regarded as 
being unduly nervous as a child and had no neurotic traits. 
She attended a Junior Secondary school. She enjoyed this 
although she was not academically successful and she left 
at 15, going to work in the dyeing department of a thread 
factory. She was employed there until her marriage at 18, 
to a man 12 years her senior. There were three- children 
of the marriage - sons aged 11, 8 and a daughter of 5 
years. The husband was employed in a semi-skilled 
capacity. They had no financial worries. The patient 
depended on her husband in most matters and the marriage 
was happy. She was closely involved in the activities
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of various ladies* organisations* She had worked for 
brief periods during her married life between the births 
of her children* She went back to work in November, 1972 
but had had to give up because of her symptoms in April, 
1973.
DRUGS PRIOR TO ATTENDANCE
Chlordiazepoxide 10 mg, t.i.d.
Amitriptyline 20 mg. nocte
The patient smoked 10 cigarettes per day. She did not 
drink alcohol.
AT INTERVIEW
She was very tense, anxious and indecisive. She wept 
frequently, constantly sought reassurance and had no 
confidence in her ability to answer even the simplest 
question accurately. Her mental state was otherwise 
normal.
She was physically entirely well. Because of her 
history of recent surgery for malignancy she was 
extensively Investigated for recurrence before inclusion 
in the study. No evidence of any abnormality was found 
and 15 months later she remained free of recurrence.
During her course of phenelzine she had no other 
drugs•
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (2).
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3*2 3*2+4 3*2 + 8
Depression 2 2 2 1 0 0 0 0
Anxiety 2 2 2 2 1 1 1 0
Phobias 1 1 1 1 0 0 0 0
Obsessions 2 2 2 1 0 0 0 0
Depressed 2 3 2 1 0 0 o 0
Anxious 3 3 3 1 0 0 0 0
Overall
severity 17 19 17 9 1 1 1 0
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 1 0 0 0
tremor 1 2 1 1 1
ataxia 1 2 2 1 0
sweating 0 1 2 2 1
constipation 0 2 2 2 0
faints/dis zine as 0 1 1 1 0
micturition difficulty 0 1 1 0 0
blurred vision 1 1 1 1 0
Other 0 0 0 0 0
Total 5 11 10 8 2
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Patient complained of a loss of interest in all pursuits 
and a feeling of sadness- These symptoms had been present 
for six months- For three weeks prior to her attendance 
she had been unable to work.
HISTORY OF PRESENTING COMPLAINT
The patient*s symptoms developed gradually following 
a road traffic accident which took place some six months 
before her attendance. No-one was injured in the accident 
which was the patient * s fault. After it she very much 
lacked confidence in her driving abilities and this lack 
of confidence gradually becaaie more generalised. She 
became more and more lacking in interest and became 
constantly sad. On direct questioning she admitted that 
she felt easily tired, and that she slept badly. Her 
insomnia was early and severe. She was quarrelling a 
good deal with her relatives but this was at least to 
some extent a habitual trait. Her concentration was 
extremely poor and she felt that she had become 
incapable of attending even to the simplest matter. This 
depression was severe and at times she thought about 
suicide. Her depression was not associated with self 
blame. She had always been an anxious person but in the 
six months prior to her attendance this tendency had 
become much more severe so that she was worried all the 
time. She had become very indecisive, principally because 
she lacked confidence in her ability to make any correct 
decisions. Her appetite had become poor and she had lost 
over a stone in weight.
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PAST PSYCHIATRIC HISTORY
Occasional attendance at general practitioner for 
anxiety symptoms intermittently over 20 years* No 
previous episode of lasting depression* No previous 
hospital attendance*
PAST MEDICAL HISTORY
Oophorectomy several years ago for ovarian cyst. 
Otherwise nil#
FAMILY HISTORY OJP PSYCHIATRIC ILLNESS#
Nil.
PERSONAL HISTORY
The patient was born and brought up in Glasgow, the 
only child of a self-employed furniture salesman. She 
had a happy childhood, being somewhat indulged by her 
parents. She was not regarded as a particularly nervous 
child and she had no neurotic traits in childhood. She 
attended a Senior Secondary school, taking a two language 
course but left at 15 to become a clerkess in an office. 
She was married at 19 and the marriage broke up after one 
year. She was "torn between her husband and her mother" 
and returned to her parental home a few weeks before the 
daughter of the marriage was born. She was divorced by 
her husband on grounds of desertion. Some years later 
she remarried but this marriage was not a success either. 
There are three children of the second marriage, aged 15, 
11 and 4%, Her husband only saw the youngest child once 
or twice. Most of the tiirie the family resided in the 
patient's parental home, the patient not wishing to leave 
to stay in the house her husband had provided for her.
She was divorced by her second husband on grounds of 
desertion. At the time of her attendance she was living 
with her mother as she had really always done. She 
operated a mobile grocery shop. She had been employed 
in this type of capacity for many years. She had few 
hobbies or interests although she had always greatly
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enjoyed any type of social occasion. She has always 
been of an anxious disposition and had a dependent and 
ambivalent relationship with her mother.
DRUGS PRIOR TO ATTENDANCE
Chlordiaasepoxide 10 mg* q.i.d. for six months*
She smokes 20 cigarettes per day and drinks socially - 
about 2 measures of spirits per week*
AT INTERVIEW
She was obviously depressed. She was slow to answer 
questions or to respond in any way. She was tense and 
constantly twisted a handkerchief between her fingers. 
There was no other abnormality in her mental state*
Physically she was entirely well.
During her course of phenelzine she had no other 
drugs.
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (5).
MODIFIED GOLDBERG SCORE
Appendix 114
0 0 1 2 3 3^ 3*2 + 4 3^  + 8
Depression 4 4 2 2 2 2
Anxiety 4 4 2 2 2 2
phobias 0 0 0 0 0 0
Obsessions 1 1 1 0 0 0
Depressed 3 3 3 2 2 2
Anxious 3 3 2 2 2 2
Overall
severity 21 21 15 12 12 12
In view of her failure to respond tiie patient was imoved frcm the 
study on the 24th day and treated with a course of 12 BCT which produced 
little tmprovenent. She responded very slowly to a course of imipramine 
and chlorprcmaztne given thereafter and after ei^t months was able to 
return to work.
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*2
insomnia 2 2 2 2 2
tremor 0 1 1 1 0
ataxia 0 1 1 1 1
sweating 1 0 0 1 0
constipation 1 0 1 1 1
faints/dizziness 0 1 1 1 0
micturition difficulty 0 0 0 0 0
blurred vision 0 1 1 1 1
Other 0 0 o o O
Total 4 6 7 8 5
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The patient complained that she felt miserable and 
upset all the time. In addition her life-long fear of 
rats and mice had become very much worse and as a result 
of this she had become afraid to go out.
HISTORY OF PRESENTING COMPLAINT
All Of the patient's syraptoms had arisen about one 
year prior to her attendance. They appeared to have been 
precipitated by her distress over the fact that her 
daughter had had to get married because she was pregnant. 
The patient regarded this as a reflection on the way that 
she had brought up her daughter and blamed herself for 
the situation. Her symptoms had worsened over the year 
and she had given up two jobs because of them. When she 
attended she had been unable to work for one month* In 
addition to the above spontaneous complaints, on direct 
questioning she admitted to frequent headaches, lack of 
energy, marked early insomnia, irritability and failing 
concentration and interest. The depression was marked 
and constant. She wept a great deal and locked herself 
in the bathroom when she could not control her outbursts 
of tears. She felt hopeless about the future and at times 
wished that she was dead although she had no suicidal 
intent. She felt guilty about her recent failure to cope 
at work and about her falling capacity to cope with her 
domestic responsibilities, and she blamed herself for 
her daughter's illegitimate pregnancy. She was never 
free from anxiety. All her life she had had an 
unreasonable fear of rats and mice, but this had not 
limited her life in any way. Since her other symptoms 
had developed this fear had become much more pronounced
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and she was constantly preoccupied with the idea that 
rats or mice might be present. She lacked confidence 
in her ability to do things properly and repeatedly 
checked doors, gas taps, etc# She had become 
indecisive. She was not eating and she had lost one 
and a half stones in a year.
PAST PSYCHIATRIC HISTORYIWI'I.Mfci i>i#,l| liaWWWWWWWMfcll i»,nW— >#WiW«.WIW#»rWnil i#
Nil#
PAST MEDICAL HISTORY#
Hysterectomy for menorrhagia in 1970*
FAMILY I^ISTORY OF PSYCHIATRIC ILLNESS
A sister had had inpatient psychiatric treatment. 
There was no clear description of her symptomatology.
PERSONAL HISTORY
The patient was born and brought up in Glasgow. Her 
father was a semi-skilled engineer. She was one of five 
siblings and enjoyed a very happy home life. She had no 
neurotic traits in childhood. She spent a good deal of 
time at dancing school as a child and left her Junior 
Secondary school at 14 to become a professional dancer. 
She was thus employed until her marriage at the age of 
18 to a postman, five years her senior. The marriage 
had always been very satisfactory. They had twins, now 
aged 23, both married and away from home. The patient * s 
symptoms developed following her daughter's precipitate 
marriage. The patient was normally cheerful and 
outgoing, she and her husband attended dances at clubs 
every week and they were very sociable. She was a keen 
sewer and normally made all her own, and her daughter's 
clothes and all her household furnishings. Since 
becoming unwell she had stopped all these activities.
At best she tended to "over-react to stress" and she 
had always had a fear of rats and mice.
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DRUGS PRIOR TO ATTENDANCE
Chlordlazepoxlde 10 mg* t.i.d. ) 
Nitrazepam 10 mg. nocte )
AT INTERVIEW
She was very tense. She talked rapidly and under 
pressure. She was depressed but this was a less 
marked feature than her tension. Otherwise her mental 
state was normal.
Physically she was entirely well.
During her course of phenelzine she had no other
drugs,
At the time of the initial assessment her score on 
the neurotic/endogenous rating was (4).
MODIFIED GOLDBERG SCORE
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0 0 1 2 3 3% 3*3+4 3*2 + 8
Depression 3 3 1 1 0 0 0 0
Anxiety 4 4 2 1 0 0 0 0
Phobias 3 3 3 1 1 1 0 0
Obsessions 2 2 1 0 0 0 0 0
Depressed 2 3 2 1 0 0 0 0
Anxious 3 3 2 1 1 0 0 0
Overall
severity 22 24 15 7 3 1 0 0
After her cxmrse of phenelzine was finished this patient had a course 
of Wmviour therapy for her residual phchio anxiety.
MODIFIED SIDE EFFECTS SCORE
0 1 2 3 3*5
insomnia 2 0 1 1 0
tremor 2 1 1 1 1
ataxia 0 0 0 2 0
sweating 2 0 0 0 1
constipation 1 0 0 1 0
faints/diaziness 0 1 2 2 1
micturition difficulty 0 0 0 0 0
blurred vision 1 1 1 1 1
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